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Protein	 engineering	 strategies	 for	 increasing	 stability	 can	 be	 improved	 by	




of	 stabilizing	 mutations,	 and	 may	 allow	 the	 reconstruction	 of	 thermostable	
ancestral	 sequences.	 Various	 computational	 tools	 make	 it	 possible	 to	 design	
stabilizing	features,	such	as	hydrophobic	clusters	and	surface	charges.	Different	























Stability	under	practical	 conditions	 is	 one	of	 the	most	 critical	 properties	when	
biotechnological	applications	of	proteins	are	explored[1].	High	thermostability	is	
often	accompanied	by	good	performance	under	unfavorable	conditions,	such	as	
the	presence	of	 cosolvents.	 Improved	 thermal	 stability	may	also	 correlate	with	
higher	 expression	 yields	 in	 heterologous	 hosts,	 improved	 long‐term	 survival	
under	 mild	 conditions,	 increased	 ability	 to	 remain	 active	 in	 non‐aqueous	
solvents,	and	a	 longer	half‐life	under	harsh	 industrial	process	conditions[2].	For	
medicinal	 proteins,	 thermostability	 may	 correlate	 with	 high	 serum	 survival	
times[3].	 In	 protein	 engineering,	 many	 function‐gaining	 mutations,	 such	 as	
modified	 enzyme	 selectivity,	 diminish	 stability.	 As	 a	 result,	 thermostable	
proteins	can	tolerate	a	 larger	number	of	mutations	than	mesostable	proteins[4],	
and	give	better	 results	when	used	as	 a	 starting	point	 in	protein	 engineering[5].	





thermostabilization	by	mutagenesis	 have	been	developed,	 providing	 important	
insights	into	the	structural	features	that	govern	thermostability.	These	principles	
and	 examples	 have	 been	 reviewed	 elsewhere[4,	6].	 On	 the	 other	 hand,	 directed	
evolution	 has	 emerged	 as	 a	 powerful	 approach,	 especially	 in	 the	 absence	 of	




The	 first	 section	 of	 this	 review	 highlights	 recent	 progress	 in	 identifying	 target	
positions	 for	 mutagenesis	 and	 substitutions	 that	 enhance	 stability.	 The	 next	




in	 a	 particular	 region	 of	 the	 protein,	whereas	 similar	 substitutions	 introduced	
elsewhere	in	the	protein	may	have	a	negligible	effect	on	thermostability[6a].	The	
explanation	 for	 this	 phenomenon	 is	 that	 the	 strongly	 stabilizing	mutations	 are	
located	at	a	spot	where	 the	protein	starts	 to	unfold[6a].	Mutations	 that	 improve	





controlled	unfolding	pathway.	However,	 the	 pathways	 of	 unfolding	 are	 usually	
unknown,	making	 a	 knowledge‐driven	 approach	 difficult.	 Yet,	 several	methods	
have	been	explored	 to	predict	which	positions	are	most	 likely	 to	 contribute	 to	
thermostability	and	should	be	targeted	by	mutagenesis[7].	
An	approach	that	employs	crystallographic	information	to	identify	target	
positions	 is	 the	 B‐fit	 method[7a],	 in	 which	 residues	 with	 the	 highest	
crystallographic	 B‐factors	 are	 selected	 for	 mutagenesis.	 The	 rationale	 is	 that	
highly	 flexible	 residues	 are	 more	 likely	 to	 unfold	 in	 an	 early	 stage,	 and	 that	
substitutions	at	these	positions	have	a	higher	chance	to	stabilize	the	folded	state.	
Several	successes	have	been	reported	(Table	1‐1)	[7b‐e].	A	recent	investigation	of	
an	 esterase	 that	was	 improved	 by	 the	 B‐fit	method	 showed	 that	 the	 observed	
increase	in	temperature	at	which	50%	of	the	enzyme	was	inactivated	by	heating	
was	 in	 fact	 due	 to	 improved	 refolding	 after	 heat	 treatment[7f].	 Whereas	 the	
mutant	 esterase	 can	 refold	 after	 heating	 (95°C),	 it	 unfolds	 at	 an	 even	 lower	
temperature	than	the	wild‐type	esterase,	suggesting	that	the	B‐fit	approach	can	
also	 yield	 substitutions	 that	 increase	 reversibility	 of	 unfolding	 rather	 than	
enhancing	thermostability.	
Besides	 crystallographic	 B‐factors,	 which	 may	 be	 influenced	 by	 crystal	
contacts	 and	 solvent	 conditions,	 various	 theoretical	 methods	 can	 be	 used	 to	
predict	 flexible	 regions	 that	 may	 serve	 as	 targets	 for	 stabilization.	 A	 recent	
example	is	provided	by	the	stabilization	of	xylanase,	for	which	flexible	residues	
were	located	either	by	MD	simulations	at	different	temperatures	or	by	molecular	
mechanics	 based	 flexibility	 predictions[8]	 (http://www.flexweb.asu).	 Using	 the	




five	different	mutations	were	 incorporated	 in	 the	 same	xylanase,	which	gave	a	
4°C	higher	apparent	melting	temperature	and	a	30‐fold	longer	half‐life[10].	
Constraint	Network	Analysis	 (CNA)	 can	provide	 insight	 in	 the	unfolding	
mechanisms	 of	 proteins,	 including	 the	 identification	 of	 residues	 involved	 in	
critical	 unfolding	 steps[11].	 In	 CNA,	 hydrogen	 bonds	 act	 as	 constraints	 of	 the	
structure	and	residues	that	are	connected	by	a	continuous	network	of	hydrogen	
bonds	 are	 considered	 to	 be	 folded.	 The	 strength	 of	 each	 H‐bond	 is	 calculated	






much	 smaller	 clusters,	 which	 corresponds	 to	 melting	 of	 the	 protein.	 The	 H‐
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increase 
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Part of protein 
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esterase +9 A 1 consensus library [7b] 
epoxide hydrolase +21 A 3 NDT codon library [7c] 
α-amino ester 
hydrolase +7
 A 3 consensus design [7d] 
heme peroxidase +4 3 computational design [7e] 
xylanase +2 4 computational design [9] 
xylanase +5 3 computational design [10] 
haloalkane 
dehalogenase +18 4 random and site-directed 
[12] 

















thioredoxin +32 NA ancestral method [14] 
triosephosphate 
isomerase +8 8 ancestral method 
[15] 
β-amylase +9 4 ancestral method [16] 
acylphosphosphatase +9 5 computational design [17] 
GTPase +9 4 computational design [17] 
methionine amino 
peptidase +18 2
D computational design [18] 
xylanase +8 3 computational design [19] 
cellobiohydrolase +9A 10 computational and consensus 
[20] 
methyl parathion 
hydrolase +12 3 computational design 
[21] 
sesquiterpenoid 




B NA chimeric enzyme [23] 
aldo-keto reductase - NA chimeric enzyme [24] 
polyol dehydrogenases +12B NA chimeric enzyme [25] 
cellulase +8.5AC NA SCHEMA [26] 
cytochrome P450 +14.5AC NA chimeric enzyme [27] 
green fluorescent 
protein +5 NA circularization 
[28] 
 
A Based on 50 % residual activity after heat treatment, values of which can differ extremely from the TM,app 
measured by other techniques [7f] B Compared to the melting temperature of the thermolabile parent of the 
chimera C Compared to the melting temperature of the thermostable parent of the chimera D Only residues 




yielding	 an	 enzyme	 variant	 that	 was	 also	 less	 inhibited	 by	 DMSO,	 which	 was	
attributed	 to	 more	 difficult	 entrance	 to	 the	 active	 site.	 For	 a	 β‐galactosidase,	
mutation	 of	 tunnel	 residues	 yielded	 an	 enzyme	 with	 a	 10°C	 increase	 of	 the	
optimal	 temperature	 for	catalytic	activity.	The	authors	concluded	that	selective	





The	 ancestral	 stabilization	 method	 allows	 for	 the	 stabilization	 of	 proteins	
without	the	use	of	structural	information.	The	method	is	based	on	the	hypothesis	
that	 far	 ancestors	 of	 current	 organisms	 were	 thermophiles	 that	 possessed	
proteins,	which	were	more	thermostable	than	extant	homologs.	Thus,	mutations	
for	 improving	 stability	 are	 derived	 from	 predicted	 sequences	 of	 common	
ancestors	 of	 a	 protein	 family.	 This	 method	 has	 been	 developed	 from	 1990	
onwards[29]	 and	 was	 successfully	 used	 to	 stabilize	 several	 proteins.	 Recent	
progress	includes	a	study	on	the	stabilization	of	the	B‐subunit	of	the	DNA	gyrase,	
in	which	 the	ancestral	method	was	compared	to	 the	consensus	method[30].	The	
consensus	 method	 replaces	 amino	 acids	 by	 residues	 that	 are	 most	 frequently	
present	in	multiple	sequence	alignments.	The	constructed	ancestral	protein	was	
4–5	 °C	 more	 stable	 (TM,app)	 compared	 to	 the	 protein	 created	 on	 basis	 of	 the	
consensus	 method.	 The	 ancestral	 method	 was	 also	 used	 for	 recreating	 a	
thioredoxin	that	should	have	occurred	in	organisms	that	existed	about	a	billion	
years	ago,	 instead	of	millions	of	years	ago	as	explored	used	in	other	studies[14].	
The	 proposed	 recreated	 precambrian	 thioredoxin	 variants	 were	 32°C	 more	




were	 used	 to	 create	 the	 consensus	 alignment	 originated	 from	 mesostable	
organisms,	 but	 they	 could	 still	 contribute	 to	 the	 stability	 of	 a	 thermostable	
protein[31].	Consensus	mutations	were	also	shown	to	enhance	the	evolvability	of	
a	Kemp	eliminase.	Such	mutations	were	included	alongside	functional	mutations	
to	 counteracting	 destabilizing	 mutations	 that	 were	 selected	 because	 they	







methods	 by	 including	 structural	 information.	 As	 an	 example,	 consensus	
mutations	combined	with	structural	 information	on	B‐factors	and	inter‐subunit	
disulphide	bonds,	 led	 to	a	7°C	 increase	 in	 the	half‐life	of	activity	of	an	α‐amino	
ester	 hydrolase[7d].	 For	 the	 ancestral	method,	 a	 study	 on	 the	 stabilization	 of	 a	
triosephosphate	 isomerase	 introduced	 two	 new	 parameters	 (residues	 that	 are	
correlated	 to	 other	 residues	 and	 residues	 that	 were	 nearly	 invariant	 and	
therefore	might	have	‘hidden	correlations’	to	other	residues)	to	exclude	residues	




amylase	 combined	 the	 ancestral	 method	 with	 structural	 information	 and	






the	 algorithm	 is	 used	 to	 discover	 mutations	 that	 stabilize	 the	 folded	 protein	
structure.	 The	 use	 of	 computational	 design	 can	 reduce	 the	 screening	 effort	
required	 to	 find	 a	 desired	 stability	 enhancement	 by	 orders	 of	 magnitude	 as	
compared	to	random	directed	evolution	methods.	Two	different	approaches	are	
currently	 employed	 in	 the	 computational	 design	 of	 thermostable	 enzymes.	
Mutations	are	either	selected	on	the	basis	of	their	predicted	effect	on	the	overall	
folding	 energy	 (ΔΔGFold),	 or	 computational	 tools	 are	 applied	 to	 improve	
particular	features	that	stabilize	proteins.	
Several	 methods	 can	 improve	 stabilizing	 features	 in	 a	 protein,	 such	 as	
loops,	 hydrophobic	 clusters,	 and	 surface	 charges.	 In	 all	 these	 approaches,	 the	
energy	 function	within	 the	software	 is	used	 to	verify	 that	 the	designed	protein	
structure	 is	 lower	 in	 energy	 than	 the	 native	 structure.	 One	 approach	 is	 the	
computational	design	of	a	favorable	network	of	positive	and	negative	charges	on	








antibodies	were	also	monomeric	 in	 solution,	 unlike	 the	native	 antibody,	which	
formed	 aggregates.	 A	 commonly	 used	 computational	 approach	 involves	
improving	 the	 hydrophobic	 packing	 interactions	 between	 buried	 protein	
residues[9‐10,	18‐19].	Software	to	detect	hydrophobic	networks	was	used	to	analyze	
hydrophobic	clusters	in	different	xylanases.	Introduction	of	promising	mutations	
into	 the	 target	 xylanase	 gave	 three	 mutations	 which	 increased	 the	 TM,app	 by	






energy	 function.	 This	 work	 is	 mostly	 done	 with	 energy	 functions	 that	 are	
specifically	parameterized	to	predict	differences	in	ΔGfold	due	to	point	mutations.	
Examples	 of	 suitable	 algorithms	 include	 FoldX[36],	 PoPMuSiC[37],	 and	
PreTherMut[21].	 Application	 of	 FoldX	 in	 combination	 with	 consensus	 design	









subdomains	 of	 different	 proteins.	 This	 way,	 favorable	 features	 from	 different	
parents	 can	 be	 combined.	 For	 example,	 chimeric	 variants	 of	 Baeyer–Villiger	
monooxygenases	 (BVMOs)	 were	 obtained	 by	 combining	 subdomains	 from	





keto	reductase	showed	that	 it	 is	possible	 to	combine	 favorable	 features,	 in	 this	
case	stability	and	activity,	of	archaeal	and	human	proteins[24].	 Such	a	stabilized	
chimera	 can	 even	 be	 obtained	 without	 using	 a	 thermostable	 variant,	 as	





Finally,	 a	 chimeric	 enzyme	 can	 also	 be	 constructed	 by	 proteins	 with	 a	 low	
sequence	 similarity	 (<30%),	 as	was	 shown	by	 replacing	parts	of	a	 (βα)8‐barrel	
protein	 by	 parts	 of	 flavodoxin‐like	 proteins[42].	 The	 replacement	 was	 possible	
since	 the	 structure	 of	 flavodoxin‐like	 proteins	 resembles	 a	 part	 of	 the	 (βα)8‐
barrel.	The	resulting	chimera	between	the	two	proteins	adopted	a	fold	strongly	
resembling	the	(βα)8‐barrel	scaffold	and	was	thermostable.	
A	 sophisticated	 method	 for	 creating	 such	 chimeras	 is	 the	 SCHEMA	
approach[43]	,	which	uses	an	algorithm	to	calculate	the	most	favorable	crossover	
positions	between	 subdomains.	The	 calculation	 selects	positions	 that	minimize	
the	 number	 of	 interactions	 that	 are	 broken	when	 combining	 subdomains.	 The	
method	was	 applied	 to	 the	 stabilization	 of	 a	 cellulase	 by	 recombination	 of	 an	
enzyme	 from	 three	 different	 parents[26].	 By	 analyzing	 and	 modeling	 the	
thermostabilities	 of	 54	 characterized	 members	 of	 a	 family	 of	 fungal	
cellobiohydrolases,	one	of	the	subdomains	appeared	critical	for	stability	and	its	
replacement	led	to	an	8.5°C	increase	in	apparent	melting	temperature	(TM,app).	In	
another	 study,	 the	 SCHEMA	 method	 was	 combined	 with	 an	 active	 learning	
algorithm,	which	analyzed	data	from	a	training	set	of	chimeras	to	predict	a	large	
collection	of	stabilizing	chimeras[44].	This	method	revealed	a	negative	correlation	
between	 the	 isoelectric	 point	 of	 a	 chimeric	 enzyme	 and	 its	 long‐term	 stability,	
which	 was	 used	 to	 construct	 enzymes	 with	 enhanced	 long‐term	 stability.	
Recently,	 a	 chimeric	 P450	 enzyme	was	 created	which	was	 14.5°C	more	 stable	
compared	 to	 its	parent[27].	This	 thermostable	enzyme	was	created	by	modeling	
the	 protein	 fitness	 landscape	 and	 constructing	 the	 most	 stabilizing	 variants.	
Bayesian	 statistics	were	 used	 to	 predict,	 to	 a	 reasonable	 extent,	 the	mean	 and	
variance	fitness	of	any	sequence.	
Other	possible	stabilization	methods	are	 truncation	and	cyclization.	 It	 is	
well	known	that	the	removal	of	thermolabile	parts	or	even	whole	domains	from	
a	protein	can	significantly	improve	its	stability[45].	Recent	achievements	include	
the	 stabilization	 of	 an	 endo‐β‐1,4‐glucanase	 by	 removing	 a	 cellulose	 binding	
domain,	which	in	this	case	is	not	needed	for	biotechnological	use	of	the	enzyme.	
This	truncation	resulted	in	a	threefold	increase	in	half‐life	of	the	protein	at	65	°C,	
while	 the	 catalytic	 activity	 increased.	 Circularization	 of	 the	 proteins	 sequence	
can	 also	 enhance	 stability.	 The	N‐terminus	 and	 C‐terminus	 are	 often	 the	most	
flexible	part	of	a	protein	and	easily	become	the	 targets	of	proteolytic	enzymes.	









Even	 though	 directed	 evolution	 is	 a	 highly	 successful	 method	 for	 improving	
protein	stability,	there	is	a	demand	for	additional	powerful	techniques,	especially	
in	 case	 of	 proteins	 that	 cannot	 be	 expressed	 and	 assayed	 in	 high‐throughput	
format[47].	 Sequence‐based	 bioinformatics	 approaches	 and	 computational	
methods	exploiting	protein	structures	are	especially	successful.	When	integrated	
into	directed	evolution	protocols,	 these	newer	method	can	boost	 the	efficiency	
and	 reliability	 of	 directed	 evolution	 protocols.	 For	 example,	 the	B‐fit	 approach	
and	 the	consensus	method	assist	 the	design	of	 small	 sets	of	variants	 (or	 smart	
libraries)	 from	 which	 improved	 enzymes	 may	 be	 obtained	 by	 screening	 only	
small	 numbers.	 Furthermore,	when	 three‐dimensional	 structures	 are	 available,	
energy	calculations	may	 identify	substitutions	that	 improve	hydrophobic	cores,	




Figure	1‐1.	 TM,app	 improvements	 obtained	 by	 protein	 engineering	 of	 enzymes	
from	2007	to	2012.	Primary	publications	were	searched	on	Web	of	Science	using	
different	 key	 word	 combinations	 to	 find	 protein	 engineering	 studies	 aimed	 at	
increasing	 enzyme	 thermostability.	 If	 a	 publication	 was	 a	 follow‐up	 study	 in	








An	 important	 remaining	 challenge	 is	 to	 obtain	 large	 improvements	 of	
thermostability.	 Currently,	 the	 increase	 in	 thermostability	 by	 mutagenesis	
typically	amounts	to	2–15°C	in	TM,app	(Figure	1‐1).	For	many	applications	this	is	
acceptable	 because	 even	 a	 modest	 increase	 often	 corresponds	 to	 a	 >10‐fold	
longer	 life‐time	(e.g.	 [9‐10,	48]).	However,	 the	differences	in	TM,app	between	natural	










Enantioselective	 enzymes	 can	 be	 used	 in	 the	 biocatalytic	 production	 of	
enantiopure	chiral	compounds,	either	by	kinetic	resolution	of	racemic	mixtures	
or	 in	 asymmetric	 synthesis	 from	 prochiral	 precursors.	 The	 degree	 of	
enantiodiscrimination	of	 enzymes	 can	be	 improved	by	protein	 engineering,	 for	
which	directed	evolution	employing	global	or	localized	random	or	semi‐random	
mutagenesis	 has	 emerged	 as	 a	 powerful	 strategy.	 However,	 directed	 evolution	
projects	usually	require	screening	of	a	large	number	of	mutants	and	suffer	from	
poor	 predictability	 of	 the	 final	 outcome.	 This	 review	 discusses	 rational	
approaches	 that	 aim	 to	 reduce	 the	 required	 screening	 effort,	 either	 by	
integrating	sequence	information	in	library	design	or	by	using	protein	structure	
information	 to	preselect	promising	mutations.	We	discuss	various	methods	 for	
computational	 prediction	 of	 mutations	 that	 improve	 enantioselectivity	 or	 that	
can	 rank	 enzymes	 variants	 according	 to	 their	 probability	 of	 carrying	 out	







The	 capability	 of	 enzymes	 to	 catalyze	 stereoselective	 reactions	 makes	 it	
attractive	to	apply	them	in	the	preparation	of	chiral	pharmaceutical	products[49].	
Since	 a	 high	 enantiomeric	 excess	 is	 usually	 required,	 the	 degree	 of	
stereodiscrimination	is	a	key	property	that	may	allow	or	prohibit	the	application	
of	 an	 enzyme	 in	 a	 biocatalytic	 production	 process.	 Fortunately,	 protein	
engineering	methods	have	been	developed	 that	make	 it	possible	 to	enhance	or	
even	 invert	 the	 enantioselectivity	 of	 enzymes[50].	 The	 most	 successful	 protein	
engineering	 technique	 to	 increase	 enzyme	 enantioselectivity	 is	 directed	
evolution,	 which	 uses	 several	 cycles	 of	 (semi)‐random	 mutagenesis	 and	
screening	 to	 discover	mutants	 with	 the	 desired	 catalytic	 properties.	 Examples	
are	summarized	in	several	reviews[50a,	51].		
The	 current	 manuscript	 focuses	 on	 the	 incorporation	 of	 rational	
approaches	in	the	improvement	of	enzyme	enantioselectivity.	When	libraries	are	
constructed	 by	 random	mutagenesis,	 only	 a	 fraction	 of	 the	 mutants	 will	 have	
beneficial	properties	since	most	mutations	are	neutral	or	detrimental	for	activity	
and	 selectivity[52].	 As	 a	 result,	 typically	 several	 hundred	 to	 several	 thousand	
mutants	need	to	be	screened	to	discover	the	desired	variants	(Table	1‐2).	When	
high‐throughput	assays	are	available,	e.g.	using	a	fluorogenic	substrate,	this	may	
be	 feasible,	 but	 screening	 for	 improved	 enantioselectivity	 often	 requires	 time‐
consuming	 chiral	 chromatography[50a].	 To	 solve	 this	 problem	 and	 make	 it	
possible	 to	 discover	 improved	 variants	with	 low‐throughput	 screening,	 efforts	
are	 being	made	 to	 construct	 libraries	 that	 are	 enriched	 in	 variants	 that	 carry	
mostly	 useful	 mutations.	 This	 can	 be	 achieved	 by	 focusing	 on	 a	 restricted	
number	 of	 positions,	 e.g.	 residues	 located	 around	 the	 active	 site.	 Furthermore,	
restricted	sets	of	amino	acids	can	be	incorporated	at	the	selected	target	positions,	
instead	of	 testing	all	20	proteinogenic	amino	acids	at	each	position.	Restricting	
mutagenesis	 to	 positions	 and	 substitutions	 that	 have	 the	 potential	 to	 improve	
enantioselectivity	may	result	 in	 libraries	that	contain	less	inactive	or	otherwise	
useless	 variants,	 and	 therefore	 are	more	 suitable	 for	 the	 discovery	 of	 desired	
mutants	with	 less	screening.	The	design	of	such	rational	 libraries	can	be	based	
on	inspection	of	structures,	on	comparison	of	sequences	of	homologous	proteins,	
or	 it	 may	 incorporate	 results	 of	 computational	 analysis	 of	 enzyme‐substrate	









enantioselectivity	 is	 preferred	 binding	 or	 faster	 conversion	 of	 one	 enantiomer	
over	 the	 other[54].	 Well	 known	 examples	 are	 lipases[55],	 esterases[56],	 epoxide	
hydrolases[57],	 halohydrin	 dehalogenase[58],	 alcohol	 dehydrogenases[59],	
hydroxynitrile	lyase[60]	and	haloalkane	dehalogenase[61].	
Table 1-2. Comparison of the methods used for (semi)-rational design of enzyme enantioselectivity.




















 Phylogeny based methods 
Enzyme structure and multiple 




design Manual design 
Enzyme structure, substrate 
binding position and catalytic 
mechanism 
-A Lipases[69] 
 MD simulation or docking aided 
Enzyme structure or homology 
model and catalytic mechanism -
 A 











Rational design of improved 







Enzyme structure, substrate 
docking catalytic mechanism 




         
    A Only successful mutations reported. 
	
A	more	attractive	process	is	asymmetric	synthesis,	where	a	chiral	center	
is	 formed	 when	 an	 enzyme	 converts	 in	 a	 stereoselective	 manner	 a	 prochiral	
compound.	 Examples	 are	 the	 asymmetric	 conversion	 of	 one	 of	 two	 equivalent	
groups	of	a	substrate,	resulting	in	desymmetrization	of	the	molecule[77],	and	the	









e.g.	 during	 the	 selective	 hydrolysis	 of	 alicyclic	 epoxides	 by	 limonene	 epoxide	
hydrolase[78].		
Both	 for	 asymmetric	 synthesis	 starting	 with	 a	 prochiral	 or	 meso	
compound,	 and	 kinetic	 resolution	 of	 a	 mixture	 of	 enantiomers,	 the	 enzyme	
enantioselectivity	 can	 be	 expressed	 by	 the	 E‐value[79],	 which	 is	 defined	 as,	
respectively:	




These	 E‐values	 are	 catalyst	 properties,	 which	 may	 be	 influenced	 by	
mutations	and	reaction	conditions.	In	case	of	a	asymmetric	conversion,	product	
ee	 is	 independent	 of	 the	 degree	 of	 substrate	 conversion	 and	 can	 be	 used	 to	




Sequence‐	 or	 structure‐inspired	 site‐saturation	 mutagenesis	 continues	 to	 be	 a	
successful	 tool	 in	 directed	 evolution.	 By	 careful	 selection	 of	 the	 number	 of	
positions	that	is	mutated,	library	size	is	reduced	without	reducing	the	number	of	
improved	 variants.	 This	 approach	 uses	 structural	 inspection	 or	 sequence	
alignments	to	predict	positions	where	mutations	are	expected	to	have	an	effect	
on	 enantioselectivity	 without	 destruction	 of	 catalytic	 activity[56,	 68,	 80].	 Such	
influential	 positions	 may	 also	 be	 discovered	 by	 employing	 a	 random	 method	
such	as	error‐prone	PCR,	after	which	saturation	mutagenesis	may	be	used	to	test	
all	 proteinogenic	 amino	 acids.	 Instead	 of	 random	 mutagenesis,	 structural	
information	may	be	used,	either	in	the	form	of	a	crystal	structure	if	available,	or	
by	 constructing	 a	 homology	 model.	 Suggestions	 for	 specific	 mutations	 can	 be	
obtained	 by	 comparing	 structures	 of	 homologous	 enzymes	 with	 different	





inspired	 directed	 evolution	 method[57,	 62a,	 63,	 66,	 80b].	 Based	 on	 structural	





mutated	 combinatorially	 and	 the	 best	 combination	mutant	 obtained	 from	 one	
subsite	is	used	as	the	initial	variant	when	exploring	mutants	at	the	next	site[81].	







By	 using	 the	 ISM	method,	 it	 is	 possible	 to	 change	 the	 enantioselectivity	
without	 having	 a	 detailed	 understanding	 of	 the	 interactions	 that	 determine	
enantiodiscrimination.	ISM	was	used	to	improve	the	enantioselectivity	of	a	lipase	
from	 Pseudomonas	 aeruginosa	 for	 the	 kinetic	 resolution	 of	 rac‐2‐
phenylpropanoic	acid	p‐nitrophenyl	ester	(Scheme	1‐1).	Four	mutations	 in	 two	
different	 subsites	 resulted	 in	 an	 improvement	 of	 the	 selectivity	 from	 E=2	 to	




the	 enantioselectivity	 of	 an	Aspergillus	niger	 epoxide	 hydrolase	 for	 the	 kinetic	
resolution	 of	 racemic	 glycidyl	 phenyl	 ether.	 By	 the	 ISM	 method	 mutant	 was	
obtained,	which	 possessed	 an	E	 of	 160	 in	 this	 conversion,	while	 the	wild	 type	




Scheme	 1‐1.	 Kinetic	 resolution	 of	 rac‐2‐phenylpropanoic	 acid	 p‐nitrophenyl	
ester	by	an	(S)‐selective	P.	aeruginosa	lipase.			
This	 ISM	 method	 can	 also	 be	 used	 to	 improve	 the	 enantioselectivity	










four	 different	mutations,	 which	were	 suggested	 to	 reshape	 the	 active	 site	 and	
thereby	 reposition	 the	 substrate	 (Figure	 1‐2B)[63].	 For	 this	 enzyme,	 the	
regioselectivity	of	nucleophilic	water	attack	on	the	meso‐epoxide	determines	the	
stereoconfiguration	 of	 the	 product.	 The	 mutations	 appeared	 to	 significantly	
shorten	the	distance	between	the	catalytic	water	molecule	and	one	epoxide	ring		










of	 the	 substrate	 during	 catalysis	 are	 indicated.	 Residues	 with	 similar	 color	
(except	 green)	 were	 mutated	 as	 one	 subsite	 during	 the	 ISM	 approach	 to	
influence	regioselectivity	of	this	enzyme.		
In	many	 systems,	 an	 important	 source	 of	 enantioselectivity	 is	 the	 steric	
hindrance	 between	 active	 site	 residues	 and	 the	 slower	 reacting	 enantiomer.	
Structures	containing	a	docked	substrate	can	be	used	to	identify	positions	where	
mutations	can	 increase	 this	hindrance.	This	approach	was	used	 to	 improve	 the	
enantioselectivity	 of	 a	 monoamine	 oxidase	 from	 A.	 niger	 to	 become	
enantioselective	 for	 the	 deracemization	 of	 4‐chlorobenzhydrylamine	 (Scheme	
1‐2)	 and	 1‐phenyltetrahydroisoquinoline,	 both	 compounds	 are	 important	
building	 blocks	 in	 the	 synthesis	 of	 pharmaceuticals	 containing	 chiral	 amine	
groups[64].	 The	employed	 strategy	aims	 to	 stoichiometrically	 convert	 a	 racemic	
amine	 into	 one	 enantiomer	 of	 the	 same	 compound.	 Therefore	 it	 uses	 cycles	 of	
enzyme‐catalyzed	selective	oxidation	of	the	amine	to	an	imine	and	non‐selective	




accumulation	 of	 a	 single	 non‐converted	 enantiomer	 of	 the	 starting	 compound,	
comparable	 to	 complete	 conversion	 to	 one	 product	 enantiomer	 in	 a	 dynamic	
kinetic	 resolution	 (Scheme	 1‐2)[83].	 Two	 large	 residues	 flanking	 the	 active	 site	
were	 proposed	 to	 have	 steric	 interactions	 that	 influence	 the	 binding	 of	 4‐
chlorobenzhydrylamine	 enantiomers.	Mutations	 of	 these	 residues	 could	 create	
more	space	in	the	active‐site	pocket	and	thereby	allow	for	better	binding	of	the	
chloro‐phenyl	 substituent	 of	 the	 desired	 (S)‐enantiomer.	 Subsequently,	 site‐
saturation	 mutagenesis	 was	 performed	 at	 these	 two	 positions.	 Screening	
resulted	 in	 the	 discovery	 of	 five	 variants	 that	 were	 able	 to	 convert	 4‐
chlorobenzhydrylamine	with	high	enantioselectivity.	This	study	demonstrated	a	
















Scheme	 1‐2.	 Deracemization	 of	 4‐chlorobenzhydrylamine	 by	 a	 monoamine	
oxidase	and	a	non‐selective	reducing	agent	(NaBH4)[64].	The	bold	arrow	indicates	
the	 net	 formation	 of	 one	 enantiomer	 of	 the	 starting	 material	 by	 the	 used	
procedure.		
The	 applicability	 of	 structure‐inspired	mutagenesis	 can	 be	 enhanced	 by	
using	homology	models	in	addition	to	crystal	structures.	For	example,	Savile	and	
co‐authors	modified	a	 transaminase	 for	 the	asymmetric	production	of	 the	drug	
sitagliptin,	which	has	an	amine	group	at	a	chiral	 carbon	atom	(Scheme	1‐3)[65].	
Residues	 that	 interact	 with	 the	 substrate	 were	 predicted	 by	 docking	 the	
substrate	 in	 a	homology	model.	 Subsequently,	 site	 saturation	mutagenesis	was	




























the	 position	 of	 a	 cofactor	 relative	 to	 the	 substrate.	 To	 reverse	 the	
enantioselectivity	 of	 P450	 enzymes	 the	 ISM	 approach	was	 used	 to	 change	 the	
positions	 of	 both	 the	 substrate	 and	 the	 oxygen‐activating	 heme	 cofactor.	 Tang	
and	 co‐authors	 used	 this	 approach	 to	 improve	 the	 P450pyr	 enzyme	 from	




a	 remarkable	 achievement,	 since	 reversing	 the	 enantioselectivity	 is	 often	quite	
difficult	 to	 achieve.	 The	 same	 enzyme	 was	 also	 improved	 for	 the	 selective	




that	 the	ISM	method	 is	applicable	 for	 the	engineering	of	P450s,	which	are	very	







be	 introduced	 during	 directed	 evolution	 to	 achieve	 a	 certain	 effect.	 To	
significantly	reduce	the	number	of	unstable	or	inactive	variants,	several	methods	
use	phylogeny‐derived	information	to	make	a	preselection	of	the	amino	acids	to	




Restricted	 codon	 sets	 was	 used	 to	 engineer	 a	 haloalkane	 dehalogenase	








steric	 effects	 that	 influence	 the	 binding	 of	 the	 substrate.	 This	 resulted	 in	 the	
discovery	of	two	variants	that	either	produced	(R)‐2,3‐dichloropropan‐1‐ol	with	
an	ee	of	90%	or	(S)‐2,3‐dichloropropan‐1‐ol	with	an	ee	of	97%,	respectively[67].		
In	 another	 example	 of	 the	 use	 of	 phylogeny	 based	 information,	 the	
composition	of	a	restricted	codon	set	was	based	on	the	observed	frequencies	of	
residues	among	homologous	proteins	in	the	3DM	family	database	(Table	1‐3)[84].	
The	 3DM	 database	 contains	 superfamily	 sequence	 alignments	 and	 structural	
information	to	derive	sequence‐activity	relationships[85].	Using	a	preselection	of	
residues	based	on	this	database,	an	esterase	from	Pseudomonas	fluorescens	was	
improved	 for	 the	 kinetic	 resolution	 of	 3‐phenylbutyric	 acid	 ethyl	 ester[56]. A 
variant  containing  three  mutations  was  obtained  that  had  an  E  of  80  for  the 
production of the (R)‐enantiomer[56].  
 
Table 1-3. Use of a restricted codon set during the protein engineering of an esterase from P. 
fluorescens for the asymmetric hydrolysis of 3-phenylbutyric acid ethyl ester 
Position Desired amino acids Disallowed amino acids CodonA Encoded amino acidsB 
28 A, V, I, L, F, W, Y, S, T, G, N, K C, M, P, H, Q, D, E, R KBS A, V, L, F, W, S, G, C (7/8)C 
121 A, V, I, L, S, T, G, P, N F, W, Y, C, M, H, Q, D, E, K, R RBC A, V, I, S, T, G (5/5)C 
198 A, V, I, L, F, W, Y, M, T, G, P, N C, S, H, Q, D, E, K, R KKK V, L, F, W, G, C (4/6)
C 
225 A, V, I, L, C, M, T, P, D F, W, Y, S, G, H, N, Q, E, K, R DYA A, V, I, L, S, T (5/6)C 
 
A KBS, RBC, KKK and DYA are ambiguous DNA triplets (K: T or G base; B: C, T or G; S: G or C; R: A or G; D: A, G 
or T; Y: C or T).  B Disallowed amino acids in the encoded amino acids are shown in bold.  C Number of desired 
amino acids encoded as compared to total number of amino acids encoded. Data from Jochens et al.[56]. 
Rational	design	based	on	structural	inspection	
Rational	 design	 aims	 to	 predict	 specific	 substitutions	 to	 improve	 enzyme	
enantioselectivity	 based	 on	 inspection	 of	 enzyme	 structures	 and	 enzyme	
substrate‐complexes[69‐70,	71‐72,	86].	 This	 requires	 a	detailed	understanding	of	 the	
structural	 determinants	 of	 enantioselectivity.	 An	 important	 possibility	 is	 to	
introduce	mutations	that	increase	steric	hindrance	for	the	undesired	enantiomer.	
This	 strategy	 was	 used	 to	 engineer	 a	 lipase	 from	Burkholderia	cepacia	 for	 the	
kinetic	resolution	of	racemic	1‐phenylethanol[69a].	Changing	an	Ile	near	the	active	
site	into	a	larger	Phe	residue	increased	the	E‐value	for	the	(S)‐enantiomer	from	





this,	 two	mutations	were	predicted,	one	of	which	was	 supposed	 to	 repulse	 the	
(S)‐enantiomer,	while	 the	 other	would	 create	 space	 for	 the	 binding	 of	 the	 (R)‐
enantiomer.	 The	 designed	 variant	 was	 found	 to	 have	 an	 E‐value	 of	 over	 200,	
while	the	E	of	the	wild	type	for	this	conversion	was	5[69b].		
The	rational	design	of	steric	hindrance	can	also	be	inspired	by	sequence	
comparisons,	 which	 was	 demonstrated	 in	 another	 study	 on	 a	 lipase	 from	
Candida	rugosa.	The	authors	observed	that	the	sequences	of	 isoenzymes	of	this	
lipase,	 which	 display	 different	 enantioselectivities,	 vary	 at	 two	 important	
positions[70a].	 Subsequently,	 using	 MD	 simulations	 they	 confirmed	 that	 these	
residues	governed	enantioselectivity.	Residues	in	the	oxyanion	hole	had	different	
interactions	 with	 the	 tetrahedral	 intermediate	 formed	 after	 reaction	 with	 the	






either	 (R)‐selective	 with	 an	 E	 of	 45	 or	 (S)‐selective	 with	 an	 E‐value	 of	 over	
200[70a].		
A	 possible	 approach	 to	 improve	 the	 enantioselectivity	 during	 kinetic	
resolution	 is	 to	 increase	 the	 space	 available	 for	 the	 binding	 of	 the	 desired	
enantiomer	 in	 the	 active	 site.	This	was	used	 to	 increase	 the	 (S)‐selectivity	of	 a	
Candida	 antarctica	 lipase	 for	 the	 kinetic	 resolution	 of	 secondary	 alcohols	
containing	 a	 bulky	 side‐groups,	 such	 as	 1‐phenylethanol[70b].	 Docking	 studies	
revealed	 that	 the	phenyl	 group	of	 the	 (S)‐substrate	would	 sterically	 clash	with	
the	 enzyme.	 Accordingly,	 mutations	 were	 designed	 to	 create	 space	 for	 the	
binding	of	 this	substituent.	The	wild	 type	possessed	an	E	of	more	 than	200	for	
the	 (R)‐enantiomer,	 while	 the	 obtained	 mutant	 was	 slightly	 (S)‐selective	 with	










orientation	 of	 a	 substrate	 in	 an	 active	 site	 during	 asymmetric	 synthesis.	
Subsequently,	 mutations	 can	 be	 predicted	 that	 change	 the	 orientation	 of	 the	
substrate	 in	 the	 active	 site	 and	 result	 in	 the	 preferred	 formation	 of	 one	
enantiomer	of	the	product.	This	approach	was	used	to	engineer	a	hydroxynitrile	
lyase	 from	 Prunus	 amygdalus	 for	 asymmetric	 synthesis	 of	 (R)‐2‐hydroxy‐4‐
phenylbutene	 nitrile[71].	 Formation	 of	 the	 (R)‐product	 would	 be	 impaired	 by	
repulsive	interactions	between	the	active	site	residues	and	the	alkyl	side‐chain	of	
(R)‐product	 (Figure	 1‐3).	 Therefore,	 substitutions	 were	 predicted	 which	
increased	 the	 space	 available	 for	 improved	 binding	 of	 the	 substrate	 in	 the	






potential	 product	 and	 the	 active	 site.	 For	 a	 hydroxynitrile	 lyase,	 this	 analysis	
revealed	 clashes	 between	 the	 (R)‐product	 and	 active	 site	 residues,	 which	
indicates	that	the	substrate	cannot	bind	in	the	pro‐(R)	configuration.	The	authors	
thus	 proposed	 mutagenesis	 at	 the	 highlighted	 positions	 to	 change	 substrate	
orientation.	Figure	from	Weis	et	al.[71].	
A	different	study	used	docking	to	analyze	binding	of	a	substrate	in	either	
the	 pro‐(R)	 or	 pro‐(S)	 orientation	 during	 asymmetric	 synthesis	 of	 2‐
aminotetralin	 by	 the	 ω‐transaminase	 from	 Chromobacterium	 violaceum.	 By	
analyzing	 the	 outcomes	 of	 these	 docking	 experiments,	 it	 was	 discovered	 that	
substrate	was	able	to	bind	in	a	pro‐(S)	configuration,	but	a	pro‐(R)	configuration	








in	 the	 pro‐(S)	 orientation.	 Experimentally,	 this	 changed	 the	 E‐value	 for	 the	
synthesis	of	2‐aminotetralin	from	3.9	(S)	to	63	(R‐selective)[86].		
Another	 approach	 to	 invert	 the	 enantioselectivity	 during	 asymmetric	
synthesis	 is	 to	change	 the	position	of	 the	most	 important	catalytic	 residue	 to	a	
mirrored	 location	within	 the	active	site.	Such	an	approach	was	used	to	reverse	
the	enantioselectivity	of	a	decarboxylase	from	Alcaligenes	bronchisepticus	for	the	
asymmetric	 decarboxylation	 of	 arylmethylmalonate	 to	 arylpropionate	 (Scheme	
1‐6).	No	structure	of	the	enzyme	was	available,	so	all	rational	design	was	based	
on	a	homology	model.	By	changing	the	position	of	the	cysteine	nucleophile	from	
the	 si‐face	 to	 the	 re‐face	 of	 the	 enolate	 intermediate,	 the	 authors	 could	 almost	
completely	 inverse	 the	 enantioselectivity,	 from	 an	 E‐value	 of	 65	 for	 the	 (R)‐









Scheme	1‐6.	 Decarboxylation	 of	 rac‐2‐methyl‐2‐(naphthalen‐2‐yl)malonic	 acid	
to	 (R)‐2‐(naphthalen‐2‐yl)propanoic	acid,	 catalyzed	by	a	decarboxylase	 from	A.	
bronchisepticus.	
Molecular	dynamics	simulations	combined	with	visual	inspection		
Detailed	 computational	 modeling	 of	 the	 interaction	 of	 the	 substrate	 with	 the	
surrounding	 amino	 acids	 can	 be	 used	 to	 identify	 interactions,	 including	 those	
related	 to	 substrate‐induced	 conformational	 changes	 that	 steer	 the	 binding	 of	
the	 substrate	 during	 kinetic	 resolution,	 or	 influence	 the	 orientation	 of	 the	
substrate	during	asymmetric	synthesis.	Subsequently	mutations	can	be	deduced	
that	 result	 in	 more	 enantioselective	 catalysis.	 The	 structure	 of	 the	 resulting	
mutants	can	be	predicted	and	analyzed	using	the	same	modeling	approaches,	to	
yield	 cycles	 of	 design	 and	 modeling.	 This	 approach	 was	 used	 to	 improve	 the	
enantioselectivity	of	a	lipase	from	Candida	antarctica	for	esterification	of	1‐halo‐
2‐octanols	 compounds	 during	 a	 kinetic	 resolution[75b].	 A	 combination	 of	
molecular	docking	and	interaction	energy	calculations	showed	that	there	are	no	
selective	 interactions	 governing	 the	 binding	 of	 the	 halogen	moiety	 in	 the	wild	
type	enzyme;	therefore	there	was	no	preference	for	binding	either	enantiomer.	
Subsequently,	positions	where	mutations	could	introduce	such	interactions	were	
visually	 identified.	 At	 these	 positions,	 mutations	 were	 introduced	 in	 silico,	




structures	 were	 analyzed	 visually[75b].	 Four	 mutants	 were	 predicted	 based	 on	
this	inspection	and	were	tested	experimentally.	This	resulted	in	the	discovery	of	
two	 enantioselective	mutants.	 The	 best	 variant	 possessed	 a	 two‐fold	 higher	E‐
value	of	28	for	the	resolution	of	1‐chloro‐2‐octanol.		
A	 different	 strategy	 uses	 the	 structure	 of	 a	 transition	 state	 inhibitor	 to	
predict	 the	 orientation	 of	 the	 substrate	 and	 product	 during	 catalysis.	 MD	
simulations	of	the	enzyme	with	this	transition	state	inhibitor	bound	gave	insight	
into	 the	dynamics	of	 these	 interactions.	Based	on	 these	 simulations,	mutations	
were	predicted	that	should	hinder	catalysis	with	the	undesired	(R)‐enantiomer.	
This	approach	was	employed	to	change	the	selectivity	of	a	esterase	from	Bacillus	
subtilis	 for	 the	 kinetic	 resolution	 of	 the	 tertiary	 alcohol	 3‐phenylbut‐1‐yn‐3‐yl	
acetate	 (Scheme	 1‐7)[75c].	 Simulations	 revealed	 important	 hydrogen	 bonding	
interactions	 that	 were	 expected	 to	 influence	 the	 reaction	 rate	 with	 different	
enantiomers	in	the	active	site.	Based	on	this	analysis,	a	Glu	residue	was	predicted	
to	be	a	key	element	of	a	hydrogen‐bonding	network	that	stabilized	the	transition	
state	 for	 catalysis	 with	 the	 (R)‐enantiomer.	 Experimentally,	 modifying	 this	
hydrogen‐bonding	network	by	 replacing	 this	Glu	 by	 a	 Phe	 indeed	 inverted	 the	
enantioselectivity	for	the	kinetic	resolution	of	3‐phenylbut‐1‐yn‐3‐yl	acetate.	The	
wild	type	is	(R)‐selective	with	an	E	of	5,	while	this	mutant	is	(S)‐selective	with	an	
E‐value	of	2.	Thus,	 only	 a	 small	 change	 in	 the	 enantioselectivity	of	 the	 enzyme	
was	obtained	by	 this	method.	However,	 the	discovered	position	was	 important	
for	 (R)‐selectivity,	 since	 replacing	 this	 Glu	 by	 a	 smaller	 Ala	 or	 Asp	 residue	
enhanced	 the	 (R)‐selectivity	 of	 the	 enzyme	 tenfold	 up	 to	 E‐values	 of	 56	 and	
46[75c].		
A	 similar	 approach	 was	 used	 to	 invert	 the	 enantioselectivity	 of	 a	
diisopropyl	fluorophosphatase	to	enhance	its	applicability	for	the	degradation	of	
several	 nerve	 gases[76].	 The	 wild	 type	 enzyme	 is	 able	 to	 hydrolyze	 the	
organophosphorus	 nerve	 agents	 sarin,	 cyclosarin	 and	 soman.	 However,	 it	
preferably	degrades	the	less	toxic	(R)‐enantiomers	of	these	compounds,	while	it	
has	a	very	low	activity	for	the	more	toxic	(S)‐enantiomers.	Therefore,	the	enzyme	
was	engineered	 to	be	more	active	 for	 the	degradation	of	 the	 (S)‐enantiomer	of	
cyclosarin,	while	maintaining	 some	 activity	 for	 the	 (R)‐enantiomer.	 To	 achieve	
this	 goal,	 both	 enantiomers	 of	 the	 substrate	 cyclosarin	 were	 docked	 into	 the	
active	 site	 and	 the	 interactions	 between	 the	 enzyme	 and	 the	 substrate	 were	
investigated	 using	 docking	 and	MD	 simulations.	 These	 experiments	 revealed	 a	
binding	cleft	in	the	active	site	for	the	alkoxy‐substituent	of	the	substrate,	which	






position	 in	 the	 active	 site.	 This	 resulted	 in	 the	 prediction	 of	 a	 (S)‐selective	
quadruple	mutant.	Experimentally,	the	mutant	indeed	was	(S)‐selective	(E‐value	
of	 3.77),	 while	 the	 wild	 type	 was	 (R)‐selective	 (E‐value	 of	 50).	 The	 obtained	
mutant	 enzyme	 was	 also	 (S)‐selective	 for	 the	 conversion	 of	 the	 analogous	








based	 on	 docking	 and	 MD	 simulations	 to	 improve	 a	 kinetic	 resolution.	 The	
proposed	 positions	 of	 the	 alkoxy	 substituents	 of	 either	 enantiomer	 of	 the	
substrate	 cyclosarin	 are	 indicated	 in	 the	 crystal	 structure	 of	 a	 diisopropyl	
fluorophosphatase.	 To	 allow	 for	 the	 reaction	with	 (S)‐enantiomer,	more	 space	
was	created	for	binding	of	its	alkoxy	substituent.	Figure	from	Melzer	et	al.	[76].	
A	different	approach	employed	a	combination	of	MD	simulations,	density	
functional	 theory	calculations	and	docking	simulations	 to	 find	 interactions	 that	
influence	 the	 orientation	 of	 the	 substrate	 in	 the	 active	 site	 during	 asymmetric	
synthesis.	 Pratter	 and	 co‐authors	 used	 these	 methods	 to	 change	 the	
enantioselectivity	of	a	mononuclear	non‐heme	FeII‐dependent	hydroxylase	from	
Streptomyces	coelicolor	 for	 the	 enantioselective	hydroxylation	of	phenylpyruvic	
acid	 to	 (R)‐mandelate[73].	 First,	 they	 discovered	 in	 their	 simulations	 that	 a	




product,	 but	 did	 not	 accommodate	 the	 (R)‐product.	 Second,	 the	 aromatic	
substituent	 of	 the	 (R)‐product	 would	 collide	 with	 a	 tyrosine	 residue	 of	 the	
enzyme.	 To	 change	 the	 enantioselectivity	 of	 this	 enzyme,	 ten	 variants	 were	
constructed	 which	 would	 better	 accommodate	 the	 aromatic	 ring	 of	 the	 (R)‐
product	 and	 would	 not	 be	 able	 to	 bind	 the	 (S)‐product.	 The	 combined	
introduction	of	the	three	best	mutations	resulted	in	a	variant	that	produced	(R)‐
mandelate	with	an	ee	of	95%,	a	9,300‐fold	change	in	specificity	compared	to	the	
wild	 type	enzyme[73].	This	study	demonstrated	 that	 is	possible	 to	obtain	a	very	
large	 specificity	 change	 in	 enantioselectivity	 by	 combining	 computational	
methods.	
An	 important	 step	 in	 directed	 evolution	 is	 to	 efficiently	 combine	
mutations	 discovered	 in	 parallel	 rounds.	 An	 interesting	 solution	 used	
computational	 modeling	 to	 analyze	 possible	 combinations	 and	 select	 the	 best	
ones.	This	approach	combined	mutations	of	a	 lipase	 from	Burkholderia	cepacia	
with	 enhanced	 enantioselectivity	 for	 the	 kinetic	 resolution	 of	 2‐chloroethyl‐2‐
bromophenylacetate[75a].	 All	 possible	 double	 mutants	 were	 modeled	 by	 MD	
simulations	and	path‐planning	algorithms.	These	algorithms	quantify	the	effects	
of	 mutations	 on	 the	 ability	 of	 a	 substrate	 to	 enter	 the	 active‐site.	 During	 this	
computational	 procedure	 both	 enantiomers	 of	 the	 substrate	were	 docked	 into	
the	predicted	 structures	 and	 the	 substrate	 orientations	during	MD	 simulations	
were	analyzed.	Furthermore,	 the	movement	of	enantiomers	 into	 the	active	site	
was	modeled	using	path‐planning	algorithms,	 in	order	 to	discover	 if	mutations	
improved	 the	 entrance	 of	 substrates	 into	 the	 active	 site.	 The	 thirteen	 best	
behaving	 double	 mutants	 were	 constructed	 experimentally	 and	 three	 indeed	
possessed	very	high	enantioselectivity.	The	best	variant	possessed	an	E	 of	178	




computationally	 modeled	 structures	 or	 simulations	 to	 predict	 mutations	 that	
improve	 enantioselectivity[62b,	75‐76].	 They	 do	 not	 predict	 the	 enantioselectivity	
qualitatively,	 but	 provide	 qualitative	 interpretations	 of	 structural	 changes	
leading	 to	 changes	 in	 selectivity.	 This	 limits	 their	 throughput	 and	 makes	 it	
difficult	 to	 quantify	 and	 compare	 effects	 of	 predicted	 mutations	 between	
different	 experiments.	 It	 remains	 a	 challenge	 to	 select	mutations	 that	 improve	





on	 their	 predicted	 effects	 on	 the	 binding	 of	 different	 enantiomers,	 on	 the	
predominant	orientation	of	 the	substrate	 in	 the	active	site,	or	on	differences	 in	
reaction	 energy	 barriers	with	 substrate	 enantiomers	 or	 substrate	 orientations.	






could	 be	 a	 promising	 method	 for	 in	 silico	 analysis	 and	 prediction	 of	
enantioselective	 mutants.	 However,	 it	 requires	 large	 computational	 resources	
and	therefore	 its	applicability	 is	 limited	to	small	systems	with	the	size	of	a	 few	
hundred	atoms.		
QM/MM	has	not	yet	been	used	to	compare	a	 large	number	of	mutants	a	
priori	 but	 has	 been	 used	 to	 rationalize	 the	 outcome	 of	 directed	 evolution	
experiments	 aiming	 for	 enantioselective	 enzymes[78,	89].	 	 Mutants	 of	 limonene	




for	 the	 nucleophilic	 attack	 by	 a	water	molecule	 at	 either	 the	 C1	 or	 C2	 carbon	
atom	 by	 the	 wild	 type	 enzyme	 and	 the	 evolved	 mutants.	 These	 calculations	
confirmed	 the	 experimentally	 obtained	 results;	 (R,R)‐selective	 mutants	 had	 a	
lower	energy	barrier	for	attack	on	the	C2	atom,	while	(S,S)‐selective	variants	had	
a	 lower	energy	barrier	 for	attack	on	 the	C1	carbon	atom.	The	calculations	also	
showed	 that	 steric	 repulsions	between	 the	mutated	 residues	and	 the	 substrate	
resulted	 in	 different	 substrate	 orientations,	 which	 caused	 these	 differences	 in	
energy	 barrier.	 The	 applied	QM/MM	method	was	 able	 to	 predict	 these	 energy	
differences	 qualitatively	 but	 not	 quantitatively	 (Figure	 1‐5A)[78],	 thus	 it	 will	





enantioselective	mutants.	This	analysis	 is	based	on	 the	NAC	 theory	 formulated	




geometrically	 similar	 to	 those	 of	 the	 transition	 state[90]	 and	 the	 substrate‐
enzyme	complex	has	to	pass	through	the	NAC	to	reach	the	transition	state	of	the	
reaction.	 A	 NAC	 is	 considered	 to	 be	 formed	 when	 the	 angles,	 distances	 and	
dihedrals	are	within	a	set	of	defined	criteria,	for	example	the	reacting	atoms	are	
within	 van	 der	 Waals	 contact	 distance	 and	 the	 angles	 of	 the	 reacting	 atoms	




By	comparing	 the	occurrence	of	NACs	 for	 complexes	of	an	enzyme	with	
the	enantiomers	of	a	substrate	during	separate	simulations,	a	ratio	of	NACs	for	





prediction	 of	 enantioselectivity,	 but	 it	 has	 been	 used	 to	 rationalize	 the	
differences	 in	 enantioselectivity	 observed	 during	 the	 kinetic	 resolution	 of	
α‐bromoamides	 by	 a	 haloalkane	 dehalogenase[61a],	 ‐bromoesters	 and	 ‐
bromoalkanes	by	different	haloalkane	dehalogenases[92]	and	for	the	hydrolysis	of	
glycidyl	phenyl	ether	enantiomers	by	an	epoxide	hydrolase[61b].	
In	 the	 first	example,	 the	enantioselectivity	of	a	haloalkane	dehalogenase	
from	 Sphingomonas	 paucimobilis	 UT26	 for	 the	 kinetic	 resolution	 of	 different	
α‐bromoamides	was	predicted	by	comparing	NAC	frequencies	for	the	substrate	
enantiomers[61a].	During	this	study,	NACs	were	defined	as	substrate	orientations	
that	 would	 allow	 nucleophilic	 attack	 of	 the	 aspartate	 oxygen	 on	 the	 halogen‐
substituted	carbon	atom	and	facilitate	the	development	of	negative	charge	on	the	
halogen	atom.	The	criteria	were	expressed	as	distances	and	angles	between	the	
substrate,	 the	 catalytic	 oxygen	 atom	 of	 the	 nucleophilic	 Asp,	 and	 the	 polar	
hydrogen	 atoms	 of	 the	 Asn	 and	 Trp	 that	 stabilize	 the	 transition	 state	 by	
polarizing	the	halogen	atom	(Figure	1‐5B).	Using	these	criteria,	it	was	found	that	
the	ratio	between	the	NAC	frequencies	observed	 in	MD	trajectories	with	(R)	or	
(S)‐N‐benzyl‐2‐bromobutanamide	 correlated	 well	 with	 the	 observed	
enantioselectivity	(Figure	1‐5C)[61a].	
In	 a	 second	 example,	 NACs	 were	 used	 to	 rationalize	 the	 outcome	 of	 a	
directed	 evolution	 experiment	 that	 improved	 the	 enantioselectivity	 of	 an	
epoxide	hydrolase	for	the	kinetic	resolution	of	glycidyl	phenyl	ether[61b].	For	the	





epoxide	 was	 used	 to	 define	 the	 NAC.	 This	 distance	 was	 recorded	 during	 MD	
simulation	 of	 the	 enzyme	 with	 either	 the	 (R)‐	 or	 (S)‐epoxide	 bound.	 The	
difference	 between	 these	 values	 correlated	 well	 with	 the	 experimentally	
observed	 differences	 in	 enantioselectivity	 for	 the	 kinetic	 resolution	 of	 glycidyl	
phenyl	 ether	 between	 the	 two	 variants[61b].	 The	 use	 of	 NACs	 for	 the	









values)	 between	 the	 wild	 type	 and	 several	 mutant	 enzymes,	 figures	 obtained	
from[78].	B)	NAC	criteria	for	the	nucleophilic	attack	of	the	aspartate	oxygen	on	an	
electrophilic	 carbon	 atom	 of	 a	 haloalkane	 in	 haloalkane	 dehalogenase.	 C)	
Example	 of	 a	 screening	 of	 NACs	 using	 MD	 simulations	 to	 investigate	 the	
dehalogenation	 of	 t‐butyl	 2‐(2‐bromopropanamido)acetate.	 The	 observed	
nucleophilic	 attack	 angle	 θ1	 versus	 simulation	 time	 is	 plotted	 and	 compared	







The	 work	 discussed	 in	 this	 review	 has	 shown	 that	 structure‐	 or	 phylogeny‐
inspired	 directed	 evolution	 is	 a	mature	 approach,	which	 has	 been	 successfully	
used	 to	 improve	 the	 enantioselectivity	 of	 variety	 of	 enzymes[56‐57, 62a, 63‐68, 80b].	
Rational	 design	 was	 successful	 only	 for	 a	 limited	 number	 of	 enzymes,	 mostly	
lipases	 and	 transaminases[69‐70,	 71‐72,	 86],	 mainly	 because	 prediction	 by	 visual	
inspection	of	mutations	that	 influence	enantioselectivity	remains	a	challenge	of	
which	 success	 partially	 depends	 on	 subjective	 and	 poorly	 defined	 criteria.	 To	
replace	it	by	computational	methods,	several	groups	have	used	MD	simulations	
for	inspection	of	mutants	[62b,	73,	75‐76],	which	resulted	in	the	correct	prediction	of	
enantioselective	 variants.	 An	 important	 future	 development	 would	 be	 the	







changes	 in	 spatial	 organization	 of	 the	 active	 site	 and	 differences	 in	 substrate	
binding	mode,	and	thereby	provide	an	explanation	for	the	functional	interactions	
underlying	 changes	 in	 enzyme	 enantioselectivity[61b,	64].	 Crystal	 structures	 are	
also	used	to	explain	the	enantioselectivity	of	natural	enzymes[93].	Proteins	can	be	
co‐crystallized	or	soaked	with	ligands	to	reveal	enzyme‐substrate	interactions	in	
detail[93a].	 As	 an	 alternative,	 the	 substrate	 can	 be	 computationally	 docked	 into	
the	active	site	to	reveal	discriminating	enzyme‐substrate	interactions[61b,	64,	76].		
In	 case	 of	 rationally	 engineered	 enzymes,	 protein	 crystallography	 can	
clarify	if	the	observed	kinetic	effects	are	indeed	related	to	the	intended	structural	
changes.	 This	 is	 not	 always	 the	 case.	 Docking	 experiments	 with	 (R)‐	 and	 (S)‐
cyclosarin	in	the	structures	of	an	engineered	diisopropyl	fluorophosphatase	did	
not	reveal	a	preference	for	binding	of	one	or	the	other	enantiomer[76],	which	was	
in	 contrast	 to	 the	 original	 goal	 to	 improve	 the	 binding	 of	 the	 (S)‐cyclosarin	
(Figure	 1‐4).	 It	 was	 subsequently	 proposed	 that	 the	 enantioselectivity	 was	
improved	 due	 to	 a	 different	mechanism;	 the	mutant	 enzyme	was	 suggested	 to	
stabilize	 the	 phosphoenzyme	 intermediate	 of	 the	 reaction	 with	 the	 (S)‐
enantiomer	more	than	the	intermediate	with	the	(R)‐enantiomer[76].		






increase	 or	 decrease	 of	 NACs	 or	 changes	 in	 important	 distances	 or	 angles	
between	catalytic	residues	during	simulations.	This	was	done	for	an	engineered	
epoxide	 hydrolase,	 which	 revealed	 that	 a	 change	 in	 the	 distance	 between	 the	
carboxyl	 group	of	 the	 catalytic	Asp	 and	 the	C2	 atom	of	 the	 (R)‐	 or	 (S)‐epoxide	
caused	 the	 improvement	 in	 enantioselectivity[61b].	 Furthermore,	 several	
rearrangements	 in	 the	 active	 site	 occurred	 when	 mutations	 were	 introduced,	
which	caused	steric	clashes	between	the	undesired	(R)‐enantiomer	and	several	
active‐site	 residues.	 The	 flexibility	 of	 a	 part	 of	 the	 active	 site	 that	 allows	 for	
binding	of	the	(S)‐enantiomer	was	also	increased.	These	structural	observations	
were	supported	by	kinetic	 studies,	which	both	concluded	 that	 the	main	reason	





on	 a	 monoamine	 oxidase	 constructed	 for	 kinetic	 resolution	 of	
4‐chlorobenzhydrylamine[64].	The	crystal	 structure	of	 this	variant	 revealed	 that	












structure	 of	 a	mononuclear	 non‐heme	 FeII	dependent	 hydroxylase[73]	 rationally	
engineered	for	 the	enantioselective	hydroxylation	of	phenylpyruvic	acid	to	(R)‐











of	 the	 engineered	 arylmalonate	 decarboxylase	 described	 above	 revealed	 that	
two	mutations	resulted	in	the	removal	of	the	cysteine	nucleophile	on	one	side	of	
the	 active	 site	 and	 the	 introduction	 of	 a	 cysteine	 nucleophile	 at	 a	 mirrored	
position	in	the	active	site	(Scheme	1‐6,	Figure	1‐6B)[93a].	During	the	reaction	this	
caused	 the	 protonation	 of	 the	 re‐face	 of	 the	 enolate	 intermediate	 by	 the	 SH‐
group	of	the	cysteine,	in	contrast	to	the	protonation	of	the	si‐face	in	the	catalytic	
cycle	 of	 the	 wild	 type	 enzyme.	 These	 differences	 in	 protonation	 result	 in	 a	
difference	 in	 enantioselectivity[93a].	 Thus,	 the	 structure	 confirmed	 that	 the	





Figure	 1‐6.	 Examples	 of	 crystal	 structures	 that	 reveal	 structural	 effects	
improving	the	enantioselectivity	of	engineered	enzymes.	A)	A	crystal	structure	of	
an	 engineered	 monoamine	 oxidase	 with	 the	 docked	 substrate	 4‐
chlorobenzhydrylamine.	 Figure	 obtained	 from	 Ghislieri	 et	 al.	 [64].	 Several	
mutations	 increase	 the	 size	 of	 the	 substrate	 entrance	 tunnel,	 while	 other	
mutations	 allow	 binding	 of	 the	 phenyl	 group	 of	 the	 	 (R)‐enantiomer.	 B)	
Comparison	 of	 wild	 type	 and	mutant	 structures	 of	 ligand‐bound	 arylmalonate	
decarboxylase.	 In	 the	 second	 figure	 the	mutant	 structure	 (in	white)	 is	overlaid	
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Both	enzyme	variants	outperformed	 the	wild‐type	enzyme	 in	 the	 cyanolysis	of	
ethyl	 (S)‐3,4‐epoxybutyrate,	 a	 conversion	 yielding	 ethyl	 (R)‐4‐cyano‐3‐
hydroxybutyrate,	an	important	chiral	building	block	for	statin	synthesis.	One	of	
the	 enzyme	 variants,	 HheC2360,	 displayed	 catalytic	 rates	 for	 this	 cyanolysis	
reaction	 enhanced	 up	 to	 tenfold.	 Furthermore,	 the	 enantioselectivity	 of	 this	
variant	 was	 the	 opposite	 of	 that	 of	 the	 wild‐type	 enzyme,	 both	 for	
dehalogenation	 and	 for	 cyanolysis	 reactions.	 The	 37‐fold	 mutant	 HheC2360	
showed	an	increase	in	thermal	stability	of	8 °C	relative	to	the	wild‐type	enzyme.	
Crystal	 structures	 of	 this	 enzyme	were	 elucidated	with	 chloride	 and	 ethyl	 (S)‐
3,4‐epoxybutyrate	 or	 with	 ethyl	 (R)‐4‐cyano‐3‐hydroxybutyrate	 bound	 in	 the	
active	 site.	 The	 observed	 increase	 in	 temperature	 stability	 was	 explained	 in	
terms	of	 a	 substantial	 increase	 in	buried	 surface	 area	 relative	 to	 the	wild‐type	
HheC,	together	with	enhanced	interfacial	interactions	between	the	subunits	that	




steric	 clashes	 or	 to	 allow	 backbone	 movements	 to	 occur.	 The	 importance	 of	
interactions	 between	 substitutions	 suggests	 that	 efficient	 directed	 evolution	












Halohydrin	dehalogenases	 (EC	4.5.1.–)	 catalyze	 the	elimination	of	halides	 from	
vicinal	haloalcohols,	resulting	in	epoxide	ring	formation[1].	Although	the	natural	
role	of	 these	enzymes	is	 in	the	dehalogenation	of	halogenated	xenobiotics	such	
as	epichlorohydrin[2],	 they	 can	also	be	used	 for	 the	preparation	of	enantiopure	
haloalcohols	 and	 epoxides[3].	 The	 halohydrin	 dehalogenase	 HheC	
from	Agrobacterium	 radiobacter	 AD1	 can	 be	 recombinantly	 produced	
in	Escherichia	coli	in	high	yields,	 and	 this	has	allowed	detailed	biochemical	 and	
mechanistic	 investigation[4],	 as	 well	 as	 engineering	 studies[4‐5].	 The	 enzyme	 is	
active	 as	 a	 homotetramer[6]	 and	 belongs,	 together	 with	 other	 halohydrin	
dehalogenases,	 to	 the	 short‐chain	 dehydrogenase/reductase	 (SDR)	 enzyme	
superfamily[7].		
Halohydrin	 dehalogenases	 each	 possess	 a	 proton‐abstracting	 catalytic	
triad	 (Ser‐Tyr‐Arg),	 which	 has	 a	 function	 similar	 to	 that	 of	 the	 commonly	
observed	 catalytic	 triad	 in	 SDR	 enzymes	 (Ser‐Tyr‐Lys).	 Halohydrin	
dehalogenases	 also	 exhibit	 the	 Rossmann‐fold	 structural	 unit	 present	 in	
dehydrogenases,	 but	 lack	 the	 typical	 Gly‐rich	 motif	 required	 for	 nucleotide	
cofactor	 binding[6].	 Instead,	 halohydrin	 dehalogenases	 each	 contain	 a	 spacious	
anion	 binding	 pocket	 formed	by	 a	 loop	 that—in	 SDR	proteins—participates	 in	
substrate	 and	 cofactor	 binding.	 Mechanistic[8],	 structural[6,	 9], and	
computational[10] studies	have	explained	 the	observed	high	 regioselectivity	and	
enantiopreference	 of	 the	 HheC‐type	 halohydrin	 dehalogenase	 for	R‐configured	
substrates.	
HheC	 catalyzes	 haloalcohol	 dehalogenation	 in	 equilibrium	 with	 the	
reverse	 reaction	 of	 halide‐mediated	 epoxide	 ring	 opening.	 As	 a	 promiscuous	
activity,	 HheC	 also	 catalyzes	 nucleophilic	 epoxide	 ring	 opening	 with	 various	
small	 anions	 such	 as	 cyanide,	 azide,	 nitrite,	 and	 cyanate[11].	 Some	 examples	 of	
these	 biotechnologically	 interesting	 reactions	 are	 the	 preparation	 of	 optically	
active	 oxazolidinones[12]	 and	 (R)‐azidoalcohols[13]	 as	 valuable	 optically	 active	
intermediates.	
The	 formation	 of	 carbon‐carbon	 bonds	 through	 enzyme‐catalyzed	
epoxide	 cyanolysis	 was	 one	 of	 the	 first	 promiscuous	 activities	 observed	 for	
halohydrin	dehalogenases	and	has	been	exploited	for	the	production	of	optically	
pure	 β‐hydroxynitriles	 such	 as	 (R)‐γ‐chloro‐β‐hydroxybutyronitrile[14].	 Other	
aliphatic	 and	 aromatic	 epoxides	 have	 also	 been	 shown	 to	 be	 converted	 to	 the	








of	 L‐carnitine,	whereas	 (S)‐1	 is	 the	 direct	 precursor	 for	 the	 preparation	 of	 the	




Scheme	2‐1.	 Precursors	 for	 the	 statin	 side	 chain	 [compounds	 (S)‐1	and	 (R)‐2]	
and	other	halohydrin	dehalogenase	substrates	or	products	(7	to	18).	
Statins	 are	 a	 class	 of	 drug	 compounds	 that	 inhibit	 3‐hydroxy‐3‐
methylglutaryl‐coenzyme	 A	 reductase,	 the	 key	 enzyme	 that	 regulates	 the	
cholesterol	 biosynthesis	 pathway[18].	 One	 of	 the	most	widely	 prescribed	 drugs	
for	 the	 treatment	 of	 elevated	 blood	 cholesterol	 levels	 is	 Lipitor	 (atorvastatin	
calcium),	with	 global	 annual	 sales	 exceeding	US$	10	billion[19].	Most	 routes	 for	
the	synthesis	of	the	(3R,5S)‐3,5‐dihydroxyhexanoate	(also	as	lactone)	statin	side	
chain	employ	(R)‐2	as	a	chiral	building	block;[17,	20]	 this	results	 in	a	demand	for	
more	 than	 100 000	 kg	 (R)‐2	each	 year[19].	 A	 variety	 of	 chemoenzymatic	 routes	
for	the	synthesis	of	optically	pure	(R)‐2	have	been	explored[17‐18,	20]. These	routes	
involve	whole	cells	or	enzymes	such	as	dehydrogenases,	 lipases,	and	nitrilases.	
One	possible	 process	 employs	 variants	 of	 a	 ketoreductase	 and	 a	HheC‐derived	
halohydrin	 dehalogenase	 in	 a	 three‐step/two‐enzyme	process	 (Scheme	2‐2)	 to	
produce	 optically	 pure	 ethyl	 (R)‐4‐cyano‐3‐hydroxybutyrate	 [(R)‐6)]	 from	
prochiral	ethyl	4‐chloroacetoacetate	(3)[19,	21].	 In	this	process,	3	 is	reduced	by	a	
ketoreductase	 variant	 from	 Candida	 magnolia	 to	 ethyl	 (S)‐4‐chloro‐3‐
hydroxybutyrate	 [(S)‐4].	 In	 a	 second	 step,	 (S)‐4	 is	 converted	 into	 the	
corresponding	ethyl	(S)‐3,4‐epoxybutyrate	[(S)‐5]	by	use	of	an	engineered	HheC	
variant.	Subsequently,	(R)‐6	is	produced	from	(S)‐5	by	cyanolysis	with	use	of	the	




establishing	 protein	 sequence	 activity	 relationships	 (ProSAR),	 the	 best	 variant	
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individual	 process	 variants	 have	 not	 been	 published,	 except	 for	 patent	
disclosures	 of	 sequences	 encoding	 variants	 with	 25	 and	 37	 mutations	 and	 at	








Knowledge	 of	 the	 biochemical	 and	 structural	 properties	 of	 a	 highly	
evolved	 enzyme	 variant	 would	 provide	 useful	 information	 on	 functional	 and	
structural	 changes	 that	 occur	 during	 extensive	 directed	 evolution.	 However,	
structures	 of	 laboratory‐evolved	 enzymes	 containing	 large	 numbers	 of	
mutations	 are	 rare.	 Most	 structural	 data	 for	 enzymes	 improved	 by	 directed	
evolution	 studies	 are	 for	 mutants	 with	 no	 more	 than	 four	 amino	 acid	




nitrobenzyl	 esterase	 variant	 8g8	 from	 B.	 subtilis,[26]	 and	 an	 E.	 coli	 aspartate	
aminotransferase	 variant	 ATB17[27],	 which	 contain	 between	 six	 and	 17	 amino	
acid	 exchanges	 per	mutant.	 Structural	 information	 on	 such	 heavily	 engineered	
enzymes	 can	 also	 provide	 explanations	 for	 their	 modified	 properties,	 such	 as	
higher	 catalytic	 rates	 or	 increased	 thermal	 stabilities,	 and	might	 contribute	 to	
the	 design	 of	 directed	 evolution	 libraries	 through,	 for	 example,	 adoption	 of	




improved	 catalytic	 rates,	 enhanced	 temperature	 stability,	 and	 opposite	
enantioselectivity	 relative	 to	 its	 parent	 HheC.	 Furthermore,	 its	 X‐ray	 structure	


























HheC	was	 tailored	by	 Fox	 and	 co‐workers	 for	 the	 improved	 conversion	 of	 (S)‐
4	to	 (R)‐6	 under	 industrial	 process	 conditions[21a].	 As	 a	 result,	 a	 set	 of	 1151	
unique	HheC	sequences	was	described,	with	a	maximum	of	42	substitutions	per	
sequence[21b].	
To	 obtain	 insight	 into	 the	 sequence	 variation	 responsible	 for	 the	
improved	 catalytic	 properties,	 the	 substitutions	 occurring	 in	 the	 reported	
sequence	population	were	analyzed.	This	analysis	revealed	that	153	of	the	254	
HheC	residues	are	mutated	in	less	than	1 %	of	the	cases	(i.e.,	in	11	or	fewer	of	the	
sequences)	 and	 that	 a	 further	 49	 residues	 are	mutated	 in	 less	 than	5 %	of	 the	
reported	 HheC	 sequences.	 Of	 the	 remaining	 HheC	 residues,	 two	 subsets	 of	 25	
and	27	positions	were	 classified	either	 as	 frequently	mutated	 (in	>66 %	of	 the	
sequences)	 or	 moderately	 mutated	 (altered	 in	 5–37 %	 of	 the	 sequences),	
respectively.	 It	 was	 expected	 that	 the	 set	 of	 most	 frequent	 mutations	 would	
include	the	substitutions	that	are	of	major	 importance	for	the	relevant	changes	





parts	 of	 the	 enzyme	 structure.	 Only	 two	 mutations	 target	 buried	 residues	
(A100T,	 G174A),	 whereas	 the	 other	 23	 affected	 residues	 each	 have	 a	 solvent‐
exposed	area	of	≥5	Å2.	Furthermore,	of	these	frequent	substitutions,	only	F186Y	
is	among	the	six	first‐shell	residues	within	a	5	Å	distance	from	the	catalytic	triad	






detailed	 investigation	 because	 they	 each	 contain	 at	 least	 24	 of	 the	 mutations	
strongly	 enriched	 in	 the	 ProSAR	 procedure,	 but	 originate	 from	 different	
branches	of	the	diversity	that	was	generated[21].	Each	of	these	variants	contains	
37	mutations	 in	 total.	Variant	HheC2360	contains	all	of	 the	 frequent	mutations	
mentioned	 above	with	 the	 exception	 of	 two	 different	 amino	 acid	 substitutions	




V112A,	 K121R,	 P135S,	 Y166H,	 Y177G,	 L178V,	 H179D,	 V201W,	 V205Y,	 I246V).	
Variant	HheC2656	differs	from	HheC2360	in	its	sequence	at	18	positions	(K10L,	
E95G,	 A100,	 V112,	 P135,	 T146S,	 A152T,	 Y166,	 S180T,	 A152T,	 Y177F,	 L178,	
S180T,	H201,	V205,	W238T,	G251S,	M252V).	As	in	HheC2360,	the	majority	of	the	
less	 frequently	 occurring	 mutations	 in	 HheC2656	 are	 positioned	 in	 or	 flank	






as	 HheC.	 After	 purification	 of	 the	 enzymes,	 yielding	 samples	 that	 gave	 single	
bands	on	SDS‐PAGE,	catalytic	activities	 for	dehalogenation	and	cyanolysis	were	
measured.	 Most	 data	 were	 compared	 with	 those	 for	 the	 variant	 HheC‐C153S,	
which	is	wild‐type	HheC	containing	a	single	mutation	that	makes	the	enzyme	less	
susceptible	to	oxidative	damage,	but	otherwise	has	similar	properties[4,	8].	
The	 dehalogenation	 of	 the	 chloroalcohol	 ester	 (S)‐4,	 which	 yields	 the	
corresponding	 (S)‐5	as	 an	 intermediate,	 is	 the	 first	 HheC‐catalyzed	 reaction	 in	
the	production	of	(R)‐6.	The	catalytic	constants	for	this	dehalogenation	reaction	
with	 (R)‐	 and	 (S)‐4,	 as	 well	 as	 those	 with	 several	 other	 haloalcohols,	 were	
obtained	 by	 measuring	 initial	 halide	 release	 rates.	 Data	 were	 measured	 with	
both	mutants	 and	were	 compared	with	 data	 for	 HheC‐C153S	 (Table	 2‐1).	 The	
HheC‐C153S	 enzyme	 exhibited	 steady‐state	 parameters	 similar	 to	 previously	
determined	constants	for	the	wild‐type	enzyme.	The	kcat	values	were	in	the	range	
of	 2.7	 to	 35.1	 s−1	per	 active	 site	 for	 all	 tested	 substrates.	 For	 achiral	 1,3‐
dichloropropan‐2‐ol	 (7)	 and	 1,3‐dibromopropan‐2‐ol	 (8),	 as	 well	 as	 for	 (R)‐4,	
the	KM	values	 were	 lower	 than	 the	 lowest	 tested	 haloalcohol	 concentration	 of	
0.05	 mM.	 For	 the	 other	 haloalcohols,	 the	 KM	 values	 were	 in	 the	 0.16	 to	 4	
mM	range.	 Because	 of	 the	 very	 low	 KM	 values	 with	 the	 two	 achiral	
dihalopropanols	7	and	8	and	 with	 (R)‐4,	 the	 highest	 catalytic	 efficiencies	 were	
found	 with	 these	 substrates,	 whereas	 the	 lowest	 catalytic	 efficiency	 was	











 Table 2-1 Comparison of kinetic constants for halide release. 




















hydroxybutyrate [(R)-4] 4.0 ± 0.3 <0.05
[a] >80[a] 6.3 ± 0.2 2.8 ± 0.2 2.3 14.5 ± 0.3 2.5 ± 0.1 5.8 
ethyl (S)-4-chloro-3-
hydroxybutyrate [(S)-4] 2.68 ± 0.06 0.16 ± 0.01 16.8 8.3 ± 0.3 1.9 ± 0.2 4.4 16.2 ± 0.5 3.5 ± 0.3 4.6 
1,3-dichloro-2-propanol 
(7) 6.0 ± 0.3 <0.05
[a] >120[a] 4.8 ± 0.4 10.4 ± 1.9 0.5 13.5 ± 0.3 2.8 ± 0.2 4.8 
1,3-dibromo-2-propanol 
(8) 6.6 ± 0.3 <0.05
[a] >132[a] 7.8 ± 0.2 0.59 ± 0.05 13.2 22.9 ± 1.5 1.5 ± 0.2 15.3 
rac-1-chloro-2-propanol 
(rac-9) 18.2 ± 0.6 0.7 ± 0.1 26.0 0.30 ± 0.01 19.6 ± 1.3 0.02 1.23 ± 0.05 39.8 ± 3.4 0.03 
1-chloro-2-methyl-2-
propanol (10) 35.1 ± 0.5 0.53 ± 0.02 66.2 6.5 ± 0.1 16.5 ± 0.8 0.4 10.5 ± 0.3 8.0 ± 0.6 1.3 
rac-3-chloro-1,2-
propanediol (rac-11) 3.17 ± 0.05 4.0 ± 0.2 0.8 >0.2
[b] >>85.5[b] 0.002[b] 0.4 ± 0.1 58.0 ± 21.7 0.01 
rac-3-bromo-1,2-
propanediol (rac-12) 6.1 ± 0.1 0.16 ± 0.02 38.1 5.7 ± 0.2 22.6 ± 1.8 0.3 10.8 ± 0.3 57.4 ± 2.8 0.2 
rac-2-chloro-1-
phenylethanol (rac-13) 12.6 ± 0.3 1.3 ± 0.1 9.7 3.8 ± 0.4 5.3 ± 1.4 0.7 6.39 ± 0.08 3.6 ± 0.1 1.8 
 [a] The KM was lower than the lowest measured haloalcohol concentration. 












4	similar	 to	 those	 found	 with	 other	 tested	 haloalcohols	 [7,	8,	 and	rac‐3‐
bromopropane‐1,2‐diol	 (rac‐12)],	 the	kcat	values	 of	 which	 were	 little	 affected	
(0.8‐	 to	 1.2‐fold	 changes).	 For	rac‐1‐chloropropan‐2‐ol	 (rac‐9),	 1‐chloro‐2‐
methylpropan‐2‐ol	 (10),	 and	rac‐2‐chloro‐1‐phenylethanol	 (rac‐13)	 3.3‐	 to	 60‐
fold	drops	in	kcat	relative	to	HheC‐C153S	were	observed.	






was	 so	 high	 that	 no	 saturation	 according	 to	 Michaelis–Menten	 kinetics	 was	
observed,	 even	 at	 the	 highest	 substrate	 concentration	 tested	 (85.5	 mM).	 As	 a	
consequence,	 the	 catalytic	 efficiencies	 (kcat/KM)	 of	 mutant	 HheC2360	 for	 all	
haloalcohols	 tested	were	 lower	 than	 those	with	HheC‐C153S.	 The	 reduction	 in	
catalytic	efficiency	was	lowest,	however,	for	the	target	chloroalcohol	(S)‐4.	
Mutant	 HheC2656	 also	 showed	 increases	 in	 kcat	 values	 with	 most	





The	 enantiopreference	 of	 HheC‐C153S	 with	4	is	 in	 favor	 of	
the	R	enantiomer,	 with	 an	 apparent	 enantiomeric	 ratio	 of	ER>4.8.	 The	 mutant	
HheC2656	 hardly	 discriminated	 between	 the	 enantiomers	 of	4	(ER=1.3).	 In	
contrast,	 mutant	 HheC2360	 exhibited	 an	 enantiomeric	 ratio	 of	 ES=1.9,	
corresponding	 to	 a	 modest	 preference	 for	 (S)‐4	over	 (R)‐4.	 Even	 though	 the	
observed	 values	 are	 low,	 the	 enantiopreference	 of	 mutant	 HheC2360	 is	 the	
opposite	 of	 those	 of	 HheC‐C153S	 or	 mutant	 HheC2656.	 Enantiopreference	
towards	S‐configured	 haloalcohols	 and	 epoxides	 has	 not	 been	 observed	 in	
previous	 biochemical	 studies	 on	HheC	 and	 its	 variants,[8‐9]	 but	mutants	with	 a	
preference	for	S‐configured	substrates	were	found	in	mutants	of	Arthrobacter	sp.	
strain	AD2[29].	
The	 cyanolysis	 of	 epoxide	 ester	 (S)‐5	by	 a	 HheC	 mutant	 is	 the	 last	
enzymatic	step	in	the	production	of	(R)‐6.	Apparent	kinetic	constants	for	cyanide	
with	 fixed	 initial	 concentrations	 of	 (S)‐5	and	 several	 aliphatic	 epoxides	 were	
obtained	 for	 all	 three	 enzymes	 (Table	 2‐2).	 Enzyme	 HheC‐C153S	 displayed	
modest	 cyanolysis	apparent	kcat	values	 in	 the	 range	0.5	 to	4.8	 s−1.	 Interestingly,	
the	highest	rate	was	obtained	with	target	epoxide	(S)‐5.	The	apparent	KM	values	
for	 cyanide	 were	 in	 the	 0.3	 to	 1.8	 mM	range	 for	 all	 epoxides,	 so	 the	 catalytic	
efficiencies	did	not	exceed	3.7	s−1 mM−1.	Both	37‐fold	mutant	enzymes	displayed	
higher	 cyanolysis	 rates	 than	 HheC‐C153S	 for	 all	 epoxides	 tested.	 The	
apparent	KM	values	 for	 cyanide	 were	 also	 increased	 for	 all	 tested	 epoxides,	
except	for	mutant	HheC2656	converting	epoxide	(S)‐5.	
The	 apparent	kcat	values	 of	 epoxide	 cyanolysis	 observed	 with	 mutant	
HheC2360	were	ten	to	120	times	greater	than	those	observed	with	HheC‐C153S.	
Whereas	 the	 highest	 absolute	 rate	was	 110	 s−1	‐for	 chiral	 (S)‐1,2‐epoxybutane	










Table 2-2. Apparent kinetic constants for cyanide obtained with various epoxides in ring-opening reactions.[a] 




















epoxybutyrate [(S)-5] 4.8 ± 0.4 1.8 ± 0.4 2.7 46.6 ± 6.0 4.1 ± 1.1 11.4 17.5 ± 0.5 1.4 ± 0.1 12.5 
 rac-1,2-epoxybutane 
(rac-14) 1.1 ± 0.1 0.6 ± 0.1 1.8 91.7 ± 6.6 4.1 ± 0.7 22.4 63.9 ± 8.5 3.1 ± 0.9 20.6 
 (R)-1,2-epoxybutane 
[(R)-14] 1.1 ± 0.1 0.3 ± 0.1 3.7 88.6 ± 9.1 5.2 ± 1.1 17.0 52.6 ± 2.1 2.1 ± 0.2 25.0 
 (S)-1,2-epoxybutane 
[(S)-14] 1.3 ± 0.1 0.5 ± 0.1 2.6 110.3 ± 5.4 5.4 ± 0.6 20.4 33.4 ± 2.6 2.4 ± 0.4 13.9 
 rac-1,2-epoxy-2-
methylbutane (rac-15) 2.5 ± 0.2 0.9 ± 0.2 2.8 57.5 ± 5.8 11.0 ± 1.8 5.3 31.3 ± 2.5 1.7 ± 0.4 18.4 
 rac-1,2-epoxyhexane 
(rac-16) 0.51 ± 0.03 1.4 ± 0.2 0.4 62.0 ± 7.1 3.1 ± 0.8 20.0 19.0 ± 0.8 1.7 ± 0.2 11.2 
 [a] All kinetic constants for the cyanolysis reaction were determined using a fixed starting concentration (20 mM) of epoxide. 
	
Mutant	 HheC2656	 showed	 apparent	kcat	values	 3.6	 to	 58	 times	 higher	
than	 those	 obtained	 for	 HheC‐C153S.	 The	 apparent	KM	values	with	 the	mutant	
HheC2656	 and	rac‐14	to	rac‐16	were	 1.2	 to	 7.0	 times	 higher	 than	 those	 with	
HheC‐C153S.	 For	 target	 epoxide	 (S)‐5,	 a	 slightly	 reduced	 apparent	KM	(1.3‐fold	
lower)	 was	 even	 observed.	 Variant	 HheC2656	 displays	 higher	 affinities	 than	
mutant	 HheC2360	 towards	 all	 tested	 epoxides;	 this	 seems	 to	 come	 at	 the	
expense	of	catalytic	rates,	which	are	higher	for	HheC2360.	
To	 explore	 the	 enantiopreferences	 of	 all	 three	 enzymes,	 catalytic	
efficiencies	 of	 cyanolysis	 reactions	 were	 determined	 with	 (R)‐	 and	 (S)‐14.	
Mutant	 HheC2360	 shows	 an	 apparent	ES	of	 1.2,	 indicating	 a	 very	 small	
preference	 for	S‐configured	14.	 In	 contrast,	 the	 determined	 apparent	
enantiomeric	 ratios	 of	ER=1.4	 and	ER=1.8	 indicated	 slight	 preferences	 for	 (R)‐
14	for	HheC‐C153S	and	HheC2656,	respectively.	The	directed	evolution	of	HheC‐
C153S	 towards	 HheC2360	 thus	 also	 inverted	 the	 enantiopreference	 in	
cyanolysis,	 whereas	 both	 HheC‐C153S	 and	 HheC2656	 exhibit	






giving	 higher	 dehalogenation	 rates	 than	 HheC2360.	 Although	 the	 cyanolysis	
rates	 of	mutant	HheC2656	were	 not	 as	 high	 as	 those	 observed	 for	HheC2360,	
HheC2656	 is	still	a	good	catalyst	 for	various	cyanolysis	reactions,	as	 illustrated	
by	 the	 low	 apparent	KM	values	 for	 cyanide.	 In	 contrast,	 mutant	 HheC2360	
displayed	 significantly	 higher	 cyanolysis	 activities	 and	 exhibited	 an	
enantiopreference	 for	S‐configured	molecules	 both	 for	 the	 dehalogenation	 and	
for	 the	 cyanolysis	 reactions.	 In	 the	 statin	 side	 chain	 production	 process	
described	 above,	 the	 chirality	 of	 (S)‐5	is	 introduced	 by	 reduction	 of	3	to	 (S)‐
4	with	 an	 S‐selective	 ketoreductase[19,	 21a].	 This	 reaction	 is	 followed	 by	
dehalogenation	 of	 (S)‐4	to	 yield	 (S)‐5	with	 the	 HheC2360	 mutant	 halohydrin	
dehalogenase,	which	 displays	 catalytic	 efficiency	 for	 (S)‐4	about	 twice	 that	 for	
(R)‐4.	 Because	 the	kcat	and	kcat/KM	values	 of	 mutant	 HheC2360	 in	 cyanolysis	 of	
(S)‐5	to	 (R)‐6	are	more	 than	 5.6	 and	 2.6	 times	 higher	 than	 the	 corresponding	
values	 for	 the	 conversion	 of	 (S)‐4to	 epoxide	 (S)‐5,	 the	 epoxide	 intermediate	
should	be	efficiently	removed	from	a	chloroalcohol/epoxide	reaction	mixture	by	
rapid	conversion	to	the	desired	product	(R)‐6.	The	better	S	activity	and	a	higher	
rate	 of	 cyanolysis	 that	 come	 from	 the	 combination	 of	 an	S‐selective	
ketoreductase	 variant	 and	 the	 HheC	 variant	 HheC2360	 thus	 allow	 three	
enzymatic	 reaction	 steps	 that	 lead	 to	 formation	 of	 (R)‐6	from	
prochiral	3	(Scheme	 2‐2).	 In	 view	 of	 its	 better	 catalytic	 properties,	 HheC2360	
was	selected	for	structural	analysis.	
Crystal	structure	of	HheC2360	
To	 explain	 the	 greatly	 enhanced	 epoxide	 cyanolysis	 rates	 and	 the	 observed	
inversion	of	enantiopreference,	structures	of	mutant	HheC2360	were	solved	by	
X‐ray	 crystallography	 (Table	 2‐3).	 Three	 structures	 of	 the	 enzyme	 were	
obtained:	HheC2360	with	chloride	bound	(PDB	 ID:	4IY1),	HheC2360	with	both	
epoxide	 (S)‐5	and	 chloride	 bound	 (PDB	 ID:	 4IXW),	 and	 HheC2360	 with	
hydroxynitrile	(R)‐6	bound	in	the	active	site	(PDB	ID:	4IXT).	The	structures	were	
compared	with	wild‐type	HheC	crystal	structures.	
The	 structures	 of	 the	 three	 mutant	 tetrameric	 proteins	 were	
superimposed	on	that	of	wild‐type	HheC	(PDB	ID:	1PWX),	giving	RMSD	values	of	
less	 than	 0.7	 Å	 for	 the	 equivalent	 Cα	 atom	 positions.	 These	 low	 RMSD	 values	
indicate	 that	 the	 general	 structure	 of	 the	 tetrameric	 enzyme	 assembly	 is	







were	 only	 observed	 in	 the	 loops	 between	A83	 and	W86	 and	between	T134	 to	
W139	and	in	the	C‐terminal	loop,	including	the	last	C‐terminal	residues	visible	in	
the	 electron	 density.	 The	 three	mutant	 protein	 structures	were	 highly	 similar,	
with	 RMSD	 values	 for	 Cα	 atoms	 <0.3	 Å.	 A	 similarly	 high	 degree	 of	 similarity	
between	 structures	with	 substrate	 or	 product	 bound	was	 also	 observed	when	
comparing	 wild‐type	 enzyme	 with	 (R)‐styrene	 oxide	 [(R)‐17]	 and	 chloride	
bound	 (PDB	 ID:	 1PWZ)	 and	 with	 (R)‐p‐nitrophenyl‐2‐azidoethanol	 [(R)‐18]	
bound	in	the	active	site	(PDB	ID:	1PX0)[6].	
The	 HheC2360	 structure	 with	 hydroxynitrile	 (R)‐6	shows	 for	 the	 first	
time	 how	 a	 cyano	 moiety	 is	 bound	 in	 the	 active	 site	 of	 a	 halohydrin	
dehalogenase.	The	cyanide	binding	mode	in	the	mutant	is	very	similar	to	that	of	
the	azido	moiety	of	(R)‐18	in	the	wild‐type	enzyme	(PDB	ID:	1PX0)	and	also	to	
the	 chloride	 binding	mode	 in	 HheC	 (PDB	 ID:	 1PWZ).	 The	 nitrogen	 of	 the	 (R)‐
6	cyano	 group	 is	 thus	 at	 the	 same	 location	 as	 a	 chloride	 ion	 in	 the	 wild‐type	
anion	binding	site.	Furthermore,	a	water	molecule	that	interacts	with	the	halide	
in	 the	wild‐type	 is	at	 the	same	position	 in	 the	HheC2360	structure,	where	 it	 is	
involved	in	a	hydrogen‐bonding	interaction	(2.9	Å)	with	the	nitrogen	atom	of	the	
cyano	group.	Such	equivalence	was	suggested	 in	previous	studies,[6,	10a]	but	 the	




mutant	 and	wild‐type	 enzyme	 structures	 showed	 no	 differences	 in	 their	 side‐
chain	 orientations	 (RMSD<0.2	 Å).	 The	 active‐site	 cavity	 of	 HheC	 can	 be	
subdivided	into	three	sites:	1)	the	site	that	interacts	with	the	substrate	hydroxy	
group	(or	epoxide	oxygen),	2)	the	binding	site	for	the	anionic	leaving	group	(or	
incoming	nucleophile),	 and	3)	 the	binding	 site	 for	 the	epoxide	 ring	 substituent	
(e.g.,	phenyl	in	Figure	2‐1A).	Whereas	only	minor	structural	changes	occur	in	the	
epoxide	oxygen	and	anion	binding	sites	(1	and	2),	 the	epoxide	ring‐substituent	
binding	region	 (3)	has	undergone	 significant	 changes	 in	 the	HheC2360	mutant	
structure.	
The	 shape	 of	 the	 HheC2360	 active	 site	 is	 altered	 by	 a	 combination	 of	
several,	 sometimes	 coupled,	 mutations	 (Figure	 2‐1B).	 This	 change	 is	 largely	
caused	by	mutation	P84V	(see	below)	and	concomitant	backbone	changes	 that	
sterically	hinder	binding	of	the	epoxide	ring	substituent.	Furthermore,	mutation	





highest	 relative	 increase	 in	 catalytic	 efficiency	was	 found	 for	 the	 cyanolysis	 of	
the	 longest	 tested	 linear	 aliphatic	 epoxide	16	(50‐fold);	 this	 suggests	 that	 the	
mutations	 create	 an	 active	 site	 geometry	 optimized	 for	 longer	 aliphatic	
substrates.	
	
Table 2-3. Data collection and refinement statistics for HheC2360 




Beam line (ESRF) ID 23-2 ID 14-4 ID 14-4 
Resolution (Å) 40.4-2.10 (2.21-2.1) 63.51-2.47 (2.61-2.47) 73.36-2.47 (2.61-2.47)
Reflections 194915 (28224) 128124 (18553) 187079 (27496) 
Space group P432121 P432121 P432121 
Cell dimensions (Å) 104.91, 104.91, 121.33 105.13, 105.13, 122.17 103.74, 103.74, 120.93
Rsym  0.10 (0.58) 0.07 (0.267) 0.09 (0.20) 
Wavelength (Å) 0,8726 0,9395 0,9395 
I ⁄ σ (I) 8.5 (2.4) 14.1 (4.9) 14.3 7.7 
Completeness (%) 98.7 (98.7) 98.5 (99.7) 100 (100) 
Redundancy 4.9 (5.0) 5.2 (5.2) 5.9 (6.0) 
 
Refinement    
Resolution (Å) 40.4-2.10 63.51-2.47 73.36-2.47 
Number reflections 37428 23346 22989 
Rwork/Rfree (%) 0.21/0.26 0.21/0.28 0.19/0.26 
 
Number of atoms    
Number of residues 604 528 563 
Total 3966 3901 3930 
 
RMS deviations    
Bond lengths (Å) 0.023 0.019 0.019 
Bond angles (°) 1.961 1.857 1.841 
Ramachandran 
Favored/outliers (%) 94.5/1.0 93.5/1.4 94.7/1.2 




(Figure	 2‐1B)	 that	 the	 cavity	 can	 now	 bind	 (S)‐5	in	 a	 catalytically	 productive	
mode,	with	the	epoxide	ring	oxygen	oriented	towards	the	catalytic	triad	residues	







(S)‐19	was	 oriented	 away	 from	 the	 catalytic	 triad	 residues,	 due	 to	 inverted	
positions	of	the	epoxide	oxygen	and	the	terminal	carbon	of	the	substrate	relative	
to	 the	 (R)‐19	binding	mode.	This	explained	why	 the	wild‐type	enzyme	exhibits	













Active	 site	of	HheC2360	with	 (S)‐5	(orange)	 and	 chloride	 (PDB	 ID:	4IXW).	The	
most	 important	 changes	 in	 the	 active	 sites	 are	 a	 rotation	 of	 W139	 and	 the	
intrusion	of	residue	84	into	the	active	site.		
The	 only	 mutation	 that	 affects	 the	 epoxide	 ring	 oxygen	 binding	 region	
(site	1)	 is	T134A,	which	 is	present	 in	both	mutants.	 In	wild‐type	HheC,	residue	
T134	 forms	a	hydrogen	bond	with	 the	catalytic	 triad	 residue	S132.	The	role	of	
S132	 is	 to	 provide	 a	 hydrogen	 bonding	 interaction	 with	 the	 oxygen	 of	 the	
substrate	 hydroxy	 group,	 which	 must	 be	 deprotonated	 by	 Y145	 during	 the	





Because	 this	 is	 the	most	 frequently	 observed	 substitution,	 it	 is	 presumably	 of	
high	importance	for	the	evolved	target	activity.	
Lastly,	 in	 mutant	 HheC2360	 the	 anion	 binding	 site	 (2)	 is	 also	 slightly	
modified.	 In	 the	wild‐type	 structure,	 anions	 are	 stabilized	by	 interactions	with	
the	backbone	amide	groups	of	Y177	and	L178,	the	side	chains	of	P175	and	L178,	
the	 slightly	 positive	 edges	 of	 the	 aromatic	 rings	 of	 F12,	 F186,	 and	 Y187,	 and	
through	 a	 bound	 water	 molecule[6].	 The	 loop	 between	 residues	 P175	 to	 Y185	
forms	 part	 of	 the	 spacious	 halide‐binding	 loop.	 The	 L178V	mutation	 increases	
the	 available	 space	 in	 the	 anion‐binding	 site.	 This	 allows	 the	 position	 of	 the	
chloride	 to	be	shifted	by	0.8	 to	1.1	Å	relative	 to	HheC	structures	with	bromide	





with	 cyanide.	 Similar	 distances,	 in	 the	 3.5	 to	 4.5	 Å	 range,	 were	 observed	 in	
quantum	 chemical	models	 for	 cyanolysis	 and	 azidolysis	 reactions	 catalyzed	 by	





structures.	When	 the	cis‐peptide	 bond	was	 discovered	 upon	 elucidation	 of	 the	
wild‐type	enzyme	structure,	the	authors	proposed	that	it	has	a	stabilizing	role	on	
the	 anion	 binding	 architecture.	 In	 the	 wild	 type,	 the	cis‐peptide	 bond	 is	 only	
stabilized	 by	 a	 single	 hydrogen	 bond	 with	 the	 backbone	 amide	 of	 F12[6].	 The	
substitution	 F186Y	 further	 stabilizes	 this	cis‐peptide	 bond	 by	 introducing	 an	
extra	 hydrogen	 bond	 between	 the	 hydroxy	 group	 of	 Y186	 and	 the	 backbone	
amide	 group	 of	 F82A.	 The	 mutation	 F186Y	 was	 the	 second	 most	 frequently	
observed	 substitution	 in	 the	 mutant	 sequence	 population	 (89 %),[21b]	which	
highlights	 the	 importance	 of	 this	cis‐peptide	 bond	 stabilization	 for	 the	 evolved	
target	activity.	
From	inspection	of	the	structure	it	is	clear	that	substitutions	flanking	the	
active	 site	 pocket	 are	 likely	 to	 contribute	 to	 the	 observed	 changes	 in	 catalytic	
properties,	 such	 as	 the	 more	 than	 80‐	 and	 120‐fold	 enhanced	 activities	 with	
epoxides	rac‐14	and	rac‐16,	respectively,	and	the	inversion	of	enantioselectivity	
with	 chloroalcohol	4.	 Such	 replacements	 around	 active	 site	 residues	 are	 often	





activities	or	expansion	of	 substrate	scope,[30]	and	have	 in	 fact	been	reported	 in	
most	 structural	 investigations	 of	 highly	 mutated	 proteins[22,	 25‐27].	 For	 this	
reason,	 efficient	 directed	 evolution	 protocols	 such	 as	 iterative	 saturation	
mutagenesis	selectively	target	residues	close	to	the	active	site.[31]	Mutations	of	a	
few	 key	 residues	 close	 to	 an	 active	 site	 can	 drastically	 alter	 substrate	
specificities.	 A	 carboxylesterase	 [25]	 and	 an	N‐acetylneuramic	 acid	 lyase,[32]	 for	
example,	required	only	mutations	of	a	few	key	residues	to	produce	variants	that	
hydrolyze	 an	 artificial	 dimeric	 substrate	 or	 condense	 non‐natural	 substrates,	
respectively.	
Improved	thermal	stability	
As	well	 as	 shifts	 in	 catalytic	 activity,	 the	 HheC	mutants	were	 also	 reported	 to	
show	 enhanced	 stabilities.	 Indeed,	 mutant	 HheC2360	 displayed	 an	 increased	







different	 temperatures.	 HheC‐C153S	 (open	 diamonds)	 and	 mutant	 HheC2360	
(closed	 squares)	 exhibited	 initial	 activities	 at	 30 °C	 (100 %)	of	 0.26	U mg−1	and	
0.11	U mg−1,	respectively.	
Thermal	 unfolding	 was	 monitored	 by	 determining	 changes	 in	
fluorescence	upon	heating	in	the	presence	of	the	fluorophore	SYPRO	Orange.[33]	
The	maximum	change	in	fluorescence	is	a	measure	of	the	apparent	unfolding	or	







SYPRO	 Orange	 to	 hydrophobic	 parts	 of	 HheC‐C153S	 (black)	 and	 mutant	
HheC2360	(gray)	due	to	thermal	unfolding	in	a	temperature	gradient	from	30	to	
90 °C.	
The	 tetrameric	 assembly	 of	 HheC	 is	 stabilized	 by	 a	 large	 hydrophobic	
surface	area	that	 is	buried	upon	formation	of	the	oligomer.	This	buried	surface	
was	 calculated	 to	 be	 17 840	Å2	for	 the	wild	 type	 and	18 340	Å2	for	 the	mutant	
(Table	 2‐4).	 The	 surface	 area	 buried	 upon	 formation	 of	 the	 tetramer	 is	 thus	
increased	 by	 500	 Å2	in	 mutant	 HheC2360,	 which	 is	 predicted	 to	 cause	 an	
increase	 in	 the	 dissociation	 energy	 of	 8	 kcal mol−1.	 It	 is	 known	 that	 such	 an	
increase	 in	 buried	 surface	 area	 can	 stabilize	 a	 protein.	 An	 increase	 in	 buried	
surface	 area	was	 found	 to	 lead,	 for	 example,	 to	 a	 6 °C	 increase	 in	 the	melting	
temperature	of	cocaine	esterase	mutants	from	Rhodococcus	sp.	strain	MB1.[34]	An	
increase	 in	 buried	 surface	 area	was	 also	 found	 to	 be	 responsible	 for	 the	 40°C	
difference	 in	 melting	 temperature	 between	 a	 mesostable	 and	 thermostable	
homologue	of	a	Rhodococcus	sp.	naphthalene	1,2‐dioxygenase.[35]	
	
Table 2-4. A comparison of the buried surface area, free energy gain upon formation of the assembly 
(ΔGint) and free energy of assembly dissociation (ΔGdiss) as calculate by the webserver PISA.[36]  
Structure Ligand Surface area (Å2) Buried surface area (Å2) ΔGint  (kcal mol-1) 
ΔGdiss  
(kcal mol-1) 
1PWX Bromide 30870 17840 -126 87 
4IY1 Chloride 32430 18340 -185 95 
	
Another	contribution	to	the	increased	stability	comes	from	intra‐subunit	
van	 der	 Waals	 interactions.	 A	 new	 intra‐subunit	 van	 der	 Waals	 interaction	 is	
created	by	the	relocation	of	residue	F136	induced	by	the	nearby	P135S	mutation.	
This	mutation	shifts	the	position	of	the	phenyalanine	side	chain	by	more	than	11	







reasoned	 that	 this	mutation	 stabilizes	 the	 tetrameric	 ensemble	 by	 creating	 an	





(magenta)	 relative	 to	wild‐type	HheC	 (cyan).	A)	 The	 relocation	of	F136,	which	
leads	to	an	increase	of	330	Å2	in	buried	surface	area.	B)	The	enlarged	aromatic	
network	 in	 HheC2360	 contains	 five	 tryptophan	 residues	 from	 two	 different	














interact	 in	 this	 cluster	 located	 at	 the	 inter‐subunit	 interface.	 Earlier	 research	
showed	that	residue	W192	is	essential	for	the	formation	of	the	tetramer	and	that	
the	 W192F	 mutation	 leads	 to	 inactive,	 monomeric	 or	 dimeric	 enzyme.[5a]	 In	
HheC2360,	 the	 tryptophan	 residues	 W192,	 W86,	 W139,	 W201,	 and	 W249′	
(protruding	 into	 the	 active	 site	 from	 the	 opposite	 monomer)	 participate	 in	
multiple	 tryptophan–tryptophan	 interactions.	 Whereas	 in	 the	 wild‐type	




the	 shape	 of	 the	 active	 site	 and	 stabilizes	 the	 positioning	 of	 the	 C‐terminal	
extension	into	the	active	site	of	an	opposite	subunit,	thereby	stabilizing	a	region	
in	the	protein	that	is	involved	in	tetramer	formation.	
Inter‐subunit	 hydrogen	 bonds	 also	 contribute	 to	 the	 oligomeric	
stabilization	 of	 HheC2360	 by,	 for	 example,	 mutation	 V205Y.	 This	 interfacial	
mutation	creates	a	new	inter‐subunit	hydrogen	bond	with	residue	V205Y′	from	
the	opposite	monomer	(2.8	Å)	(Figure	2‐4C).	Furthermore,	the	aromatic	ring	of	
Y205	 participates	 in	 van	 der	Waals	 interactions	 with	 the	 hydrophobic	 carbon	
atoms	of	 the	K204	 side	 chain	 (3.6	Å),	 as	well	 as	 in	 an	 edge‐to‐face	 interaction	
with	W201	(3.8	Å).	Other	possibly	stabilizing	substitutions	 include	the	surface‐
exposed	mutation	Q87R,	which	 leads	 to	 an	additional	hydrogen	bond	with	 the	
peptide	 bond	 nitrogen	 of	 K91	 (Figure	 2‐5),	 and	 Y166H,	 which	 extends	 the	
existing	 hydrogen	 bonding	 network	 between	 E165	 and	 K140′	 from	 a	
neighboring	monomer	to	residue	K123	(Figure	2‐6).	
These	 results	 suggest	 that	 the	 stabilization	 of	 HheC	 is	 to	 a	 large	 extent	
governed	 by	 improved	 inter‐subunit	 interactions.	 Consequently,	 protein	
stabilization	experiments	might	profitably	focus,	in	cases	of	oligomeric	proteins,	
on	 improving	 hydrophobic	 and	 hydrogen‐bonding	 interactions	 between	
subunits.	 Improved	 interactions	 of	 this	 type	 have	 also	 been	 found	 in	 other	










B)	 HheC2360	 (Y166H).	 The	mutation	 creates	 an	 inter‐subunit	 hydrogen	 bond	
network	 between	 residues	 Y166,	 E165,	 K140	 and	 residue	 K123	 from	 another	
molecule.		
Other	 mutations	 in	 the	 HheC2360	 mutants	 suggest	 further	 stabilizing	
effects.	 Both	 mutation	 M245V	 and	 the	 previously	 found	 substitution	 C153S[4]	
remove	 oxidation‐prone	 sulfur‐containing	 residues	 from	 the	 protein.	 The	
majority	of	mutant	 sequences	generated	by	Fox	et	al.	 contain	 the	substitutions	
C153S	(87 %)	or	M245V	(82 %).[21b]	Removal	of	sulfoxidation‐susceptible	sites	is	
indeed	important	for	protein	stability.[39]	Introduction	of	charged	groups	on	the	
protein	 surface,	 causing	 formation	 of	 new	 surface	 salt	 bridges	 or	 extension	 of	
existing	 salt‐bridge	 networks,	 can	 also	 provide	 stabilization.[40]	 This	 was	
observed	 in,	 for	 example,	 the	 crystal	 structure	 of	 a	 thermostable	 variant	 of	B.	
subtilis	lipase	LipA.[23]	Formation	of	new	salt	bridges	does	not	appear	prominent	
from	 the	 HheC2360	 crystal	 structures,	 however,	 even	 though	 six	 surface	
mutations	influence	electrostatics	(Q37H,	K38Q,	Q78R,	G99D,	K121R,	K203R).	
Proline	mutations	
The	modifications	 of	 the	 HheC2360	 active	 site	 are	 not	 caused	merely	 by	 side	
chain	 substitutions,	 but	 also	 by	 protein	 backbone	 changes	 resulting	 from	 the	
introduction	or	 replacement	of	 proline	 residues.	 Proline	units	 stabilize	protein	
structures	 by	 decreasing	 the	 difference	 in	 entropy	 between	 the	 folded	 and	
unfolded	 state.	 The	 presence	 of	 proline	 residues	 also	 restricts	 the	 local	
backbone	ϕ	dihedrals	to	a	relatively	narrow	area	of	the	Ramachandran	plot.	This	
reduces	 rotational	 freedom	 and	 might	 restrict	 backbone	 conformations,	
including	 conformations	 that	 occur	 as	 early	 intermediates	 in	 an	 unfolding	
pathway.	Structures	of	evolved	enzymes	containing	mutations	involving	prolines	




variant[26]	and	 a	 glycine	 oxidase	 variant.[41]	 Because	 changes	 in	 backbone	




is	 removed	 (P84V	 and	 P135S).	 All	 three	 mutations	 produce	 significant	 local	
backbone	 changes	 relative	 to	 the	 wild	 type,	 whereas	 no	 large	 differences	 in	
backbone	structure	are	present	in	regions	that	do	not	contain	proline	mutations.	
The	 A83P	 and	 P84V	 mutations	 lead	 to	 Cα	 positional	 changes	 (relative	 to	 the	
wild‐type	enzyme)	of	up	to	2.5	Å	in	the	loop	between	A83	and	W86.	The	P135S	
mutation	 is	 accompanied	 by	 a	 drastic	 change	 in	 the	ϕ	dihedral	 of	 residue	 135	
from	−60°	to	−30°,	which	in	turn	results	in	a	3.4	Å	shift	of	the	position	of	Cα	of	
F136	 and	 an	 average	 shift	 of	 2.8	 Å	 in	 the	 position	 of	 the	 Cα	 atoms	 between	
T134A	and	W139.	The	altered	backbone	conformations	in	the	134	to	139	region	
are	 accompanied	 by	 a	 shift	 of	 the	 F136	 CZ	atom	 by	 11	 Å	 (Figure	 2‐4A).	 This	
relocation	of	the	side	chain	of	F136	enhances	the	inter‐subunit	interactions	and	
leads	 to	 an	 increase	 in	 buried	 surface	 area,	 which	 contributes	 to	 enhanced	
stability	as	discussed	above.	
Similar	 effects	 are	 caused	 by	 the	 A83P	 and	 P84V	mutations,	 which	 are	
located	 in	 a	 loop	 between	 residues	 A83	 and	W86,	 surrounding	 the	 active	 site.	
The	ψ	and	ϕ	dihedrals	 at	 the	 position	 of	 the	 introduced	 proline	 residue	 are	
changed	in	relation	to	the	wild‐type	enzyme,	which	results	in	different	backbone	
conformations	 between	 residues	 83	 and	 86,	 but	 wild‐type	 backbone	
conformations	are	re‐established	from	position	W86.	Apparently,	the	introduced	
proline	 locally	 modifies	 the	 backbone,	 but	 nearby	 strands	 and	 helices	 fix	 the	
backbone	 back	 to	 its	wild‐type	 conformation	 outside	 the	 affected	 loop.	 This	 is	
similar	 to	 what	 has	 been	 described	 for	 an	 evolved	p‐nitrobenzyl	 esterase	
variant.[26]	 Although	 not	 located	 in	 the	 active	 site,	 the	 A83P	 mutation	
significantly	 alters	 the	 shape	 of	 the	 active	 site	 by	 inducing	 backbone	 changes,	
which	 in	 turn	 cause	 a	 different	 orientation	 of	 the	 side	 chain	 of	 V84.	 This	
reorientation	makes	atoms	Cγ1	and	Cγ2	protrude	into	the	active	site	(Figure	2‐1),	
which	results	in	a	narrowing	of	the	binding	region	for	the	R	group	connected	to	
the	 epoxide	 ring.	 The	modified	 binding	 pocket	 is	more	 suitable	 for	 binding	 an	
aliphatic	 group	 than	 an	 aromatic	 ring.	 These	 results	 suggest	 that	 experiments	
directed	towards	changing	enzyme	activity	can	be	benefit	from	the	introduction	
of	 proline	 residues	 in	 loops	 that	 flank	 residues	 shaping	 active	 site.	 These	







The	structures	of	 the	HheC2360	enzyme	reveal	 several	coupled	mutations	 that	
mainly	 alleviate	 steric	 clashes	 that	 would	 result	 from	 some	 mutations	 when	
present	 individually.	 For	 example,	 the	 indole	 group	 introduced	by	 substitution	
H201W	 would	 sterically	 clash	 with	 the	 side	 chain	 of	 Y177	 (0.6	 Å).	 Mutation	
Y177G	 resolves	 this	 clash	 (Figure	 2‐7A).	 Another	 steric	 clash	 would	 occur	
between	 the	 Cγ2	atom	 of	 wild‐type	 I246	 and	 the	 side	 chain	 of	 P138	 (0.9	 Å),	
resulting	from	the	3	Å	backbone	shift	of	the	loop	between	residues	134	and	139,	
which	is	in	turn	caused	by	the	P135S	substitution	discussed	above.	This	clash	is	
resolved	 by	 the	 I246V	 mutation	 and	 associated	 backbone	 changes	 in	 the	 C‐
terminal	loop,	which	increase	the	distance	between	the	side	chains	of	P138	and	
the	Cγ2	atom	of	V246	to	3.4	Å.	Furthermore,	the	relocation	of	the	loop	harboring	
F136,	 caused	 by	 the	 P135S	 substitution	 discussed	 above,	would	 cause	 a	 steric	




Figure	 2‐7.	 Synergistic	 mutations	 in	 the	 evolved	 HheC2360	 enzyme.	 A)	 The	
synergistic	 mutations	 H201W	 and	 Y177G	 prevent	 a	 steric	 clash	 between	
residues	 W201	 and	 Y177.	 B)	 The	 substitution	 F82A	 creates	 a	 destabilizing	
hydrophobic	 cavity	 in	 the	protein,	which	 is	 filled	by	 the	methionine	 side	 chain	
introduced	by	the	A100M	mutation.	The	structures	of	HheC2360	are	in	magenta	
and	those	of	wild‐type	HheC	in	cyan.	
Another	 example	 of	 paired	 mutations	 is	 given	 by	 the	 F82A+A100M	
couple.	Mutation	F82A	removes	an	aromatic	ring	from	the	hydrophobic	interior	
of	 the	 protein,	 creating	 an	 unfavorable	 cavity.	 The	 substitution	 A100M	
compensates	for	this	detrimental	effect	by	positioning	the	new	large	methionine	
side	chain	into	this	cavity	(Figure	2‐7B).	
Whereas	 many	 directed	 evolution	 studies	 have	 targeted	 residues	





a	 combined	 fashion.	 Cooperative	 effects	 of	 mutations	 have	 been	 found	 to	 be	
responsible	for	large	changes	in	activity	in	a	p‐nitrobenzyl	esterase,[26]	in	glucose	
dehydrogenase,[42a]	 and	 in	 lipase	 [42b‐d]	 mutants.	 If	 synergistic	 mutations	 are	









(Table	 2‐5).	 When	 the	 ΔΔGFold	values	 were	 calculated	 for	 the	 pairwise	
combinations,	 however,	 the	 destabilizing	 effects	 were	 much	 smaller.	 The	
calculations	with	FoldX	predicted	that	the	effects	of	the	combined	mutations	on	
ΔΔGFold	are	 negligible	 when	 the	 error	 of	 the	 calculation	 method	 is	 taken	 into	
consideration.	 The	 calculations	 thus	 confirm	 that	 the	 F82A	 and	 A100M	
mutations	 act	 in	 a	 cooperative	 manner,	 as	 do	 the	 Y177G	 and	 H201W	
substitutions.	
	





Predicted ΔΔGFold [kJ mol-1] 









F82A+A100M 125 ±27 11 ±27 172 ±40 74 ±40 
Y117G+H201W 118 ±27 11 ±27 240±40 85 ±40 
P135S+I246V 72 ±27 72 ±27 53±40 52 ±40 




changes	 that	 accompany	 the	 differences	 in	 side	 chain	 structures	 and	
conformations	 (see	 above),	 which	 make	 predictions	 of	 the	 effect	 on	









Directed	 evolution	 experiments	 can	 yield	 highly	 evolved	 enzyme	variants	with	
dramatic	 improvements	 in	 stability	 and	 catalytic	 efficiency,	 without	 requiring	
much	insight	into	the	molecular	basis	of	the	target	properties.	The	investigation	
of	 the	highly	engineered	halohydrin	dehalogenase	variant	HheC2360	described	
here	 provides	 insight	 into	 the	 structural	 effects	 of	 the	 mutations	 that	 are	
introduced	during	directed	evolution.	We	show	that	the	increases,	of	up	to	100‐
fold,	in	rates	of	cyanide‐mediated	epoxide	ring	opening,	as	well	as	the	modified	
enantiopreference	 occurring	 in	 HheC2360,	 can	 be	 explained	 by	 inspection	 of	
crystal	 structures.	 Specifically,	 side	 chain	 substitutions	 that	 allow	 formation	
(F186Y)	or	removal	(T134A)	of	hydrogen	bonds	affect	essential	 features	of	 the	
HheC	active	site,	such	as	the	cis‐peptide	bond	in	the	anion	binding	loop	and	the	
hydrogen	 bonding	 pattern	 of	 the	 catalytic	 triad	 residue	 S132,	 respectively.	
Furthermore,	the	mutations	reshape	the	active	site	cavity	for	improved	binding	
of	S‐configured	 target	 substrates,	 not	 only	 through	 altered	 side	 chains	 (F86W,	
L178V),	 but	 also	 through	 backbone	 modifications	 that	 result	 from	 the	
introduction	 and	 removal	 of	 proline	 residues	 (A83P,	 P84V).	 The	 enhanced	
thermal	stability	of	the	evolved	dehalogenase	is	explained	by	several	mutations	
that	 improve	 oligomeric	 interface	 contacts	 (V205Y,	 H201W),	 and	 also	 by	 a	
substantial	increase	in	buried	surface	area	that	further	stabilizes	the	tetrameric	




From	 the	 structure–function	 analysis	 of	 HheC2360	 it	 can	 be	 concluded	
that	 backbone	 changes	 to	 loop	 regions	 caused	 by	mutations	 that	 introduce	 or	
remove	 proline	 residues	 give	 access	 to	 additional	 functional	 changes	 in	 active	
site	geometry,	relative	to	mutations	that	only	influence	side	chains.	Targeting	of	
proline	residues	can	thus	be	highly	useful	when	engineering	enzymes	to	obtain	
modified	 catalytic	 properties.	 Through	 cooperative	 and	 synergistic	 effects,	
combinations	 of	 mutations	 allow	 greater	 functional	 diversity	 than	 individual	
mutations.	 Simultaneous	 introduction	 of	 mutations	 at	 two,	 three,	 or	 four	
structurally	close	sites	in	libraries	can	increase	the	functional	diversity	explored	
in	directed	evolution	without	strongly	diluting	libraries	with	inactive	variants.	
The	 enantiopreference	 of	 HheC‐C153S	 with	4	is	 in	 favor	 of	
the	R	enantiomer,	 with	 an	 apparent	 enantiomeric	 ratio	 of	ER>4.8.	 The	 mutant	
HheC2656	 hardly	 discriminated	 between	 the	 enantiomers	 of	4	(ER=1.3).	 In	




corresponding	 to	 a	 modest	 preference	 for	 (S)‐4	over	 (R)‐4.	 Even	 though	 the	
observed	 values	 are	 low,	 the	 enantiopreference	 of	 mutant	 HheC2360	 is	 the	
opposite	 of	 those	 of	 HheC‐C153S	 or	 mutant	 HheC2656.	 Enantiopreference	
towards	S‐configured	 haloalcohols	 and	 epoxides	 has	 not	 been	 observed	 in	




Chemicals	 and	 commercially	 available	 enzymes:	 The	 hydroxynitrile	 ethyl	 (R)‐4‐cyano‐3‐
hydroxybutyrate	 [(R)‐6)],	 the	 haloalcohols	 ethyl	 (R)‐4‐chloro‐3‐hydroxybutyrate	 [(R)‐4],	 ethyl	
(S)‐4‐chloro‐3‐hydroxybutyrate	 [(S)‐4],	 1,3‐dichloropropan‐2‐ol	 (7),	 1,3‐dibromopropan‐2‐ol	
(8),	rac‐1‐chloropropan‐2‐ol	 (rac‐9),	 1‐chloro‐2‐methylpropan‐2‐ol	 (10),	rac‐3‐chloropropane‐
1,2‐diol	(rac‐11),	rac‐3‐bromopropane‐1,2‐diol	(rac‐12),	and	rac‐2‐chloro‐1‐phenylethanol	(rac‐
13),	 as	well	 as	 the	 epoxides	 ethyl	 (S)‐3,4‐epoxybutyrate	 [(S)‐5],	rac‐1,2‐epoxybutane	 (rac‐14),	
(R)‐1,2‐epoxybutane	[(R)‐14],	(S)‐1,2‐epoxybutane	[(S)‐14],	rac‐1,2‐epoxy‐2‐methylbutane	(rac‐
15),	 and	rac‐1,2‐epoxyhexane	 (rac‐17),	 were	 purchased	 in	 the	 highest	 available	 purity	 from	
Sigma–Aldrich	 (St.	 Louis,	 MO,	 USA).	 Restriction	 enzymes	 NdeI	 and	 XhoI	 and	 T4	 ligase	 were	
ordered	 from	New	England	Biolabs	(Ipswich,	MA,	USA).	SYPRO	Orange	was	obtained	 from	Life	
Technologies	(Carlsbad,	CA,	USA).	
Cloning,	expression,	and	enzyme	preparation:	 The	directed	 evolution	 study	 by	 Fox	 and	 co‐
workers	yielded	1422	HheC	variants,[21b]	a	multiple	sequence	alignment	of	which	was	prepared	
by	using	ClustalX	v2.1.[44]	After	removal	of	 identical	protein	sequences	 from	the	alignment,	 the	
observed	 mutations	 were	 inspected	 and	 mapped	 to	 the	 wild‐type	 crystal	 structure	 (PDB	 ID:	
1PWZ).	 Sequences	HheC2360	 and	HheC2656	were	 obtained	 as	 synthetic	DNA	 constructs	 from	
Geneart	AG	(Regensburg,	Germany).	Synthetic	genes	for	HheC2360	and	HheC2656	were	cloned	




in	 TEMG	 buffer	 [Tris SO4	(10	 mM),	 ethylenediaminetetraacetic	 acid	 (EDTA,	 1	 mM),	 β‐
mercaptoethanol	 (1	 mM),	 glycerol	 (10 %),	 pH	 7.5)].	 Protein	 concentrations	 were	 determined	
spectrophotometrically	after	staining	with	Coomassie	Brilliant	Blue.	
Dehalogenase	assays:	Dehalogenase	assays	were	performed	in	duplicate	by	monitoring	halide	
release	 by	 the	 colorimetric	 assay	 described	 by	 Bergmann	 and	 Sanik.[47]	 Briefly,	 initial	 halide	




volume	 of	 2	 mL)	 at	 30 °C.	 Reactions	 were	 initiated	 by	 addition	 of	 enzyme,	 and	 halide	
concentrations	were	monitored	over	time.	Kinetic	parameters	were	obtained	from	initial	rates	by	
use	of	the	SimFit	v6.2.3	package	(http://www.simfit.man.ac.uk/)	for	curve	fitting	by	Michaelis–








Ni2+	in	 aqueous	NH3	solution.[49]	 In	 detail,	 samples	 (150	μL)	were	mixed	with	NiCl2	(2	mM,	150	
μL)	in	an	aqueous	solution	of	NH3	(1 M),	and	the	absorbance	at	267	nm	was	read	in	96‐well	UV‐
Star	 microplates	 (Greiner	 Bio	 One,	 Frickenhausen,	 Germany).	 Standard	 assays	 for	 cyanide‐
mediated	 epoxide	 ring	opening	 contained	 epoxide	 (20	mM)	in	potassium	phosphate	 buffer	 (50	
mM,	pH	 8.0)	 and	 varying	 concentrations	 of	 sodium	 cyanide.	 The	 reactions	 were	 performed	 in	
duplicate	in	a	total	volume	of	2	mL	at	30 °C	after	addition	of	enzyme.	Apparent	kinetic	constants	
and	apparent	catalytic	efficiencies	were	obtained	as	described	for	the	dehalogenase	reactions.	
Stability	 assays:	 The	 thermal	 stabilities	 of	 variant	 HheC2360	 and	 wild‐type	 HheC	 were	
determined	by	measuring	 residual	dehalogenase	activity	after	10	min	 incubation	of	 enzyme	at	




were	 plotted	 as	 a	 function	 of	 the	 corresponding	 temperature.	 The	 reported	 residual	 activities	
thus	represent	TM,app	values	(that	 is,	 the	temperatures	at	which	50 %	of	the	activity	 is	 lost	upon	
10	min	of	incubation).		
In	 addition,	 thermal	 unfolding	 of	 enzyme	 was	 monitored	 by	 a	 fluorescence‐based	
thermal	unfolding	assay	 (thermofluor).[33]	This	method	 is	based	on	 fluorescence	 increase	upon	
binding	 of	 SYPRO	Orange	 to	 hydrophobic	 protein	 surfaces	 that	 become	 exposed	upon	 thermal	
protein	 unfolding	 or	 multimer	 dissociation.	 The	 fluorescence	 increase	 was	 monitored	 by	
excitation	 at	 490	 nm	 and	 recording	 of	 the	 emission	 at	 575	 nm	 with	 a	 MyiQ	 real‐time	 PCR	
machine	 (Bio‐Rad,	Hercules,	 CA,	USA)	while	 increasing	block	 temperature	 from	30	 to	90 °C	by	
1 °C min−1.	 In	 iQ	 96‐well	 real‐time	 PCR	 plates	 (Bio‐Rad),	 protein	 solutions	 containing	 300‐fold	
diluted	 SYPRO	Orange	 (7.5	 μL)	 in	MilliQ	water	 and	 purified	 protein	 (17.5	 μL,	 0.4	mg mL−1)	 in	
TEMG	buffer	were	prepared.	After	sealing	(iQ	96‐well	PCR	plate	seals,	Bio‐Rad),	the	temperature	
gradient	 was	 started.	 The	 first	 derivative	 of	 measured	 fluorescence	 versus	 temperature	 was	
calculated.	It	gives	the	apparent	melting	temperature	at	the	local	maximum.	
Crystallization	 and	 structure	determination	 of	HheC2360:	 The	 HheC2360	 mutant	 did	 not	
crystallize	under	wild‐type	conditions.[6,	9,	50] 	Instead,	HheC2360	crystals	were	obtained	by	sitting	
drop	vapor	diffusion	at	room	temperature.	Purified	protein	(1	μL,	14.7	mg mL−1	in	HEPES	buffer	
[4‐(2‐hydroxyethyl)‐1‐piperazineethanesulfonic	 acid,	 50	mM,	 pH	 8.0]	 supplemented	 with	 NaCl	
(300	mM))	was	mixed	with	reservoir	solution	[1	μL,	MgCl2	(200	mM),	Tris-Cl	(pH	8.5,	100	mM),	




product‐bound	 structures,	 either	 (S)‐5	or	 (R)‐6	(7	 mM)	 was	 added	 to	 the	 cryo	 solution,	 and	
crystals	were	soaked	for	30	min	prior	to	flash	freezing.	Diffraction	data	were	collected	at	beam	
lines	 ID4‐1	and	 ID4‐4	at	 the	ESRF	 in	Grenoble,	France.	The	diffraction	data	were	processed	by	
use	 of	 iMOSFLM[51]	and	 scaled	 by	 use	 of	 SCALA.[52]	 No	 phasing	was	 necessary,	 because	 a	 rigid	








Computational	 methods:	 Buried	 surface	 areas,	 free	 energy	 gains	 upon	 formation	 of	 the	
tetrameric	 assembly	 (ΔGint),	 and	 free	 energies	 of	 tetrameric	 assembly	 dissociation	 (ΔGdiss)	were	
calculated	by	use	of	the	PISA	webserver	at	PDBe	with	structures	4IXW	and	1ZMT.[36]	A	solvent‐
accessible	 surface	 area	 of	 <5	 A2	was	 used	 as	 a	 cut‐off	 to	 discriminate	 buried	 from	 solvent‐
accessible	residues	in	tetrameric	assemblies.	The	predicted	changes	in	folding	energies	(ΔΔGFold)	
were	 calculated	 both	with	 FoldX[56]	 and	with	 Rosetta.[57]	With	 Rosetta	 an	 established	 protocol	
that	employs	a	soft‐repulsion	packing	of	all	 side	chains	within	8	Å	of	 the	mutated	residue	was	
used.[58]	 FoldX	 has	 a	 standard	 error	 of	 3.4	 kJ mol−1	(excluding	 5 %	 outliers).	 For	 the	 Rosetta	
method,	no	standard	error	has	been	reported,	but	its	correlation	coefficient	versus	experimental	
data	(r=0.68)	was	reported	to	be	better	than	for	FoldX	(r=0.5),	so	assumption	of	an	error	of	≤5	
kJ mol−1appears	prudent.	Because	 these	errors	are	 for	 single	mutations	 in	monomeric	proteins,	
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The	 ability	 to	 engineer	 enzymes	 and	 other	 proteins	 to	 any	 desired	 stability	
would	have	wide‐ranging	applications.	Here,	we	demonstrate	that	computational	
design	 of	 a	 library	 with	 chemically	 diverse	 stabilizing	 mutations	 allows	 the	
engineering	 of	 drastically	 stabilized	 and	 fully	 functional	 variants	 of	 the	
mesostable	 enzyme	 limonene	 epoxide	 hydrolase.	 First,	 point	 mutations	 were	
selected	 if	 they	 significantly	 improved	 the	 predicted	 free	 energy	 of	 protein	
folding.	 Disulfide	 bonds	 were	 designed	 using	 sampling	 of	 backbone	
conformational	 space,	 which	 tripled	 the	 number	 of	 experimentally	 stabilizing	
disulfide	bridges.	Next,	orthogonal	in	silico	screening	steps	were	used	to	remove	
chemically	unreasonable	mutations	and	mutations	that	are	predicted	to	increase	
protein	 flexibility.	 The	 resulting	 library	 of	 64	 variants	 was	 experimentally	
screened,	 which	 revealed	 21	 (pairs	 of)	 stabilizing	 mutations	 located	 both	 in	
relatively	rigid	and	in	flexible	areas	of	the	enzyme.	Finally,	combining	10–12	of	
these	 confirmed	 mutations	 resulted	 in	 multi‐site	 mutants	 with	 an	 increase	 in	
apparent	 melting	 temperature	 from	 50	 to	 85°C,	 enhanced	 catalytic	 activity,	


















Metabolic	 engineering	 and	 industrial	 biocatalysis	 increasingly	 need	 protein	
engineering	of	enzymes	to	provide	the	desired	catalytic	properties,	such	as	regio‐	
and	 stereospecificity,	 resulting	 in	 high	 product	 yields	 and	 low	 losses	 to	 side	
products.	 For	 applied	 biocatalysis,	 an	 ideal	 enzyme	 has	 a	 long	 shelf	 life	 and	 is	
stable	 under	 practical	 process	 conditions,	 which	 often	 includes	 high	
temperatures	 that	 are	 needed	 to	 solubilize	 substrates	 and	 prevent	 microbial	
contamination.	Mutations	that	provide	a	gain	of	function	often	decrease	stability,	
and	more	than	a	few	of	such	mutations	in	a	mesostable	enzyme	result	in	the	loss	
of	 folding	 and	 expression	 [1].	 To	 improve	 protein	 function	 by	 mutagenesis,	
thermostable	starting	points	are	preferred,	but	these	are	often	not	available	from	
natural	 biodiversity.	 For	 these	 reasons,	 methods	 to	 improve	 the	 stability	 of	
enzymes	and	other	proteins	are	highly	relevant	[2].		
Unless	 thermostability	 is	 associated	 with	 reversible	 unfolding,	 it	 is	
difficult	to	stabilize	a	protein	by	site‐directed	mutagenesis.	For	proteins	that	do	
unfold	reversibly,	there	is	an	equilibrium	between	the	folded	and	unfolded	states	
and	 the	 effects	 of	mutations	 on	 stability	 can	be	modelled	 relatively	 accurately.	
Computational	 design	 can	 produce	 highly	 stabilized	 variants	 of	 such	 model	
proteins	 [3].	 However,	 for	most	 proteins	 inactivation	 is	 essentially	 irreversible,	
often	 triggered	 by	 an	 initial	 unfolding	 of	 a	 particular	 region	 of	 the	 protein	 [4].	
Also,	 due	 to	 the	 kinetically	 complicated	 mechanisms	 involved,	 the	 effects	 of	
mutations	 on	 stability	 are	 hard	 to	 predict	 [2b,	 5].	 For	 typical	 proteins,	 these	
complications	make	it	challenging	to	engineer	major	stability	increases.	
Existing	 protein	 stabilization	 strategies	 normally	 yield	 only	 2–15°C	
increase	in	thermostability	of	enzymes	[6],	which	is	very	modest	when	compared	
with	 the	 ranges	 of	 thermostability	 observed	 in	 natural	 enzymes.	 Directed	
evolution	 can	 be	 applied	 to	 improve	 the	 stability	 of	 enzymes	 by	 introducing	
(random)	mutations	 in	 the	 coding	 gene	 and	 screening	 large	 libraries	 (typically	
≥104	variants)	 to	 find	 the	 rare	mutations	 that	 improve	 thermostability	 [2c,	7].	 A	
serious	shortcoming	of	such	a	random	approach	is	that	it	can	only	be	applied	to	
enzymes	 for	 which	 high‐throughput	 expression	 and	 activity	 screens	 are	
available.	Other	methods	to	stabilize	enzymes	are	consensus	design	[2c,	8]	rational	
protein	engineering	[2b],	 the	creation	of	chimeric	enzymes	[9]	and	computational	
design	 [10].	 The	 number	 of	 stabilizing	mutations	 that	 are	 introduced	 is	 usually	
rather	 low	 and	 currently	 none	 of	 these	methods	work	well	 enough	 to	 reliably	
achieve	a	large	stability	increase	of	a	target	enzyme.	
Here,	 we	 present	 a	 strategy	 aimed	 at	 dramatically	 improving	 the	





more	 than	 a	 few	 stabilizing	 mutations.	 Thus,	 a	 more	 successful	 stabilization	
method	 should	 generate	 many	 stabilizing	 mutations	 in	 a	 short	 time.	 The	
developed	 stabilization	 procedure	 (Scheme	 3‐1)	 employs	 computational	
methods	 to	 predict	 a	 large	 number	 of	 independent	 stabilizing	 mutations.	
Subsequent	 in	 silico	screening	 steps	 eliminate	 chemically	 unreasonable	
mutations	as	well	 as	mutations	which	 increase	protein	 flexibility.	This	 reduces	
the	number	of	variants	that	need	to	be	screened	in	vitro.	The	selected	mutations	
are	 tested	 experimentally,	 and	 the	most	 stabilizing	mutations	 are	 combined	 to	





Scheme	 3‐1.	 FRESCO.	 In	 Step	 1,	 stabilizing	 mutations	 are	 generated	 with	
multiple	algorithms.	The	in	silico	screening	Steps	2	and	3	remove	false	positives.	
In	 Step	 2,	 variants	 are	 eliminated	 which	 have	 properties	 that	 are	 known	 to	
typically	 decrease	 thermostability,	 such	 as	 increased	 hydrophobic	 surface	
exposure	 to	 the	 water	 phase	 or	 an	 increased	 number	 of	 unsatisfied	 H‐bond	
donors	 and	 acceptors	 (for	 details,	 see	 the	 Materials	 section	 and	 the	 Results	






To	 explore	 this	 strategy,	 limonene	 epoxide	 hydrolase	 (LEH)	 from	
Rhodococcus	 erythropolis	DCL14	 was	 selected	 as	 it	 is	 a	 target	 for	 protein	
engineering,	 aimed	 at	 improving	 its	 applicability	 in	 the	 production	 of	 chiral	
building	 blocks[11].	 Further	 efforts	 to	 engineer	 the	 substrate	 specificity	 would	
benefit	from	the	availability	of	a	thermostable	enzyme	[1],	but	the	TM,app	of	wild‐
type	 (WT)	LEH	 is	only	50°C.	We	show	 that,	by	applying	 the	described	FRESCO	







predict	 the	 resulting	 change	 in	ΔG	of	 folding	 (ΔΔGFold).	 The	ΔΔGFold	values	were	
calculated	with	both	Rosettaddg	and	FoldX	since	the	underlying	algorithms	gave	
significantly	 different	 predictions,	 resulting	 in	 different	 selected	mutations.	 All	
residues	were	allowed	to	mutate,	except	those	 inside	or	near	the	active	site.	Of	
all	1634	evaluated	point	mutations,	248	were	selected	either	because	they	were	
predicted	 to	 decrease	 the	 ΔΔGFold	<−5	 kJ	 mol−1	or	 because	 they	 introduced	 a	
known	 type	 of	 stabilizing	 point	mutation,	 such	 as	 those	 introducing	 a	 proline	
(see	 the	Methods	 section	 for	 criteria).	Of	 these	 248	point	mutations,	 48%	was	
predicted	to	be	stabilizing	only	by	Rosettaddg,	26%	only	by	FoldX	and	25%	by	
both	algorithms.	
Disulfide	 bonds	 were	 designed	 employing	 the	 newly	 written	 DDD	
algorithm,	which	uses	MD	simulations	to	sample	backbone	conformational	space.	
Without	 this	 sampling	of	backbone	 conformational	 space	 (i.e.	using	only	 the	X‐
ray	 structure),	 seven	 disulfide	 bonds	 were	 predicted	 to	 be	 stabilizing.	 The	
sampling	of	 different	backbone	positions	by	 the	MD	 simulation	 resulted	 in	 the	
design	 algorithm	 recognizing	 an	 additional	 21	 possible	 disulfide	 bonds,	
providing	a	total	of	28	potentially	stabilizing	disulfide	bonds.	
In	 the	 second	 step	 (Scheme	3‐1),	 130	of	 the	point	mutants	 (52%)	were	
eliminated	 because	 structural	 inspection	 revealed	 features	 that	 are	 typically	
encountered	 with	 destabilizing	 mutations	 [12].	 A	 control	 experiment	 described	
below	confirmed	that	this	step	enriches	for	stabilizing	mutations.	Furthermore,	
such	 visual	 inspection	 to	 filter	 out	 the	 unreasonable	 variants	 is	 commonly	




eliminate	 point	 mutants	 were	 that	 a	 hydrophobic	 side	 chain	 became	 surface	
exposed	 (70%)	 or	 that	 an	 unsatisfied	 H‐bond	 donor	 or	 acceptor	 was	 created	
(20%).	 Furthermore,	 all	 16	 point	 mutations	 (12%)	 of	 Pro23	 were	 eliminated	
because	 it	 appeared	 that	 the	 calculations	 erroneously	 predicted	 Pro23	 to	 be	
unfavorable	 for	 folding.	 Other	 reasons	 to	 eliminate	 variants	 were	 because	 a	
proline	was	introduced	inside	an	α‐helix	(4%)	or	because	a	hydrophobic	protein	
cavity	was	 created	 (2%).	The	 sum	 is	 >100%	because	 for	8%	of	 the	 eliminated	
point	mutants	multiple	elimination	criteria	applied.	Of	 the	disulfide	bonds,	 five	
(18%)	were	eliminated	because	they	created	a	large	hydrophobic	cavity.	This	left	









3	 are	 plotted	 with	 different	 symbols	 as	 indicated	 in	 the	 inset.	 (A)	 The	 point	
mutations	 that	 were	 predicted	 to	 be	 stabilizing	 using	 Rosettaddg	 and	 also	







maximally	 one	 mutation	 per	 position	 (thus,	 only	 T85I	 with	 a	 ΔΔGFold	of	 −20	
kJ/mol,	not	T85V	with	ΔΔGFold	of	−14	kJ/mol).	
Table 3-1. Experimentally confirmed stabilizing disulfide bonds designed using crystal structures or 
conformations from an MD simulation 
Protein structureA Cysteine positions 
  3 4 5 40 44 48 112 17 17 89 
  102 82 84 72 68 126 142 92B 94B 91B 
1NWW + +   
1NU3 + + +   
500 ps + + +   
750 ps + + + +   
1000 ps + + + + + 
1250 ps + + +   
1500 ps + + + 
1750 ps + + + + +   
2000 ps + + + + +   
2250 ps + + + +   
2500 ps + +   
 
AThe first column indicates which X-ray structure (pdb entry) or MD simulation snapshot (ps 
after start of simulation) was used for the computational design of disulfide bonds. 
BInter-subunit disulfide bond. 
	
MD	 simulations	 on	 the	 surviving	 point	 mutations	 and	 disulfide	 bond	
variants	 (Scheme	 3‐1,	 third	 step)	 were	 used	 to	 select	 against	 variants	 with	
increased	 local	 flexibility	 relative	 to	 the	 WT,	 because	 regions	 of	 increased	
flexibility	 in	 a	 protein	 are	 more	 prone	 to	 (partial)	 unfolding	 leading	 to	




variants	 were	 eliminated,	 which	 reduced	 the	 number	 of	 variants	 that	 were	
predicted	 to	be	stabilized	 to	64.	This	 included	17	disulfide	bonds	and	47	point	
mutants	 of	which	 21	 originated	 from	FoldX,	 12	 from	Rosettaddg	 and	 14	 point	
mutations,	which	were	predicted	to	be	stabilizing	by	both	Rosettaddg	and	FoldX.	
When	 these	 64	 variants	 were	 experimentally	 screened	 (Scheme	 3‐1,	
fourth	 step);	 21	 variants	 had	 an	 improved	 TM,app		 (33%).	 Of	 the	 17	 tested	
disulfide	 bond	 variants,	 10	 had	 an	 increased	 TM,app,	 ranging	 from	+4	 to	 +15°C.	




backbone	 sampling	 by	MD	 simulation	 (Table	 3‐1,	 Figure	 3‐2).	 Of	 the	 47	 point	
mutations,	 11	were	 stabilizing	 (6	 from	FoldX,	 3	 from	Rosettaddg,	2	 from	both,	
Figure	 3‐1A	 and	B).	 Point	mutations	with	 a	ΔΔGFold	>	 −5	 kJ/mol	 had	 also	 been	
tested	but	none	of	these	15	were	experimentally	stabilizing	(Figure	3‐1A	and	B).	
Of	 the	 point	 mutations	 with	 a	 ΔΔGFold	<	 −5	 kJ/mol,	 34%	 was	 stabilizing.	 The	





based	 on	 the	 use	 of	 the	 orthogonal	in	 silico	screening	 steps	 (Steps	 2	 and	 3	 in	
Scheme	 3‐1)	 for	 eliminating	 false‐positive	 predictions.	 When	 using	 FoldX	








stabilizing	 (Figure	 3‐1C)	 and	 half	 were	 strongly	 destabilizing.	 Of	 the	 12	 false‐
positive	 predictions,	 9	 were	 eliminated	 at	 Step	 2	 of	 FRESCO.	 Of	 these	 nine	
variants,	 four	 were	 eliminated	 because	 a	 highly	 surface‐exposed	 hydrophobic	







at	 Step	 3	 of	 FRESCO	 because	 they	were	 predicted	 to	 have	 increased	 flexibility	
(E49P,	Y96W,	R9P).		
The	importance	of	eliminating	false‐positive	predictions	through	Steps	2	
and	 3	 of	 the	 screening	 is	 also	 apparent	 from	 protein	 expression	 levels,	where	
lack	of	soluble	expression	of	a	mutant	suggests	lack	of	stability.	Whereas	in	the	





screening	 steps	 serve	 to	 eliminate	 false‐positive	 predictions,	 improves	 the	
accuracy	 with	 which	 stabilizing	 mutations	 are	 predicted	 and	 allows	 the	
discovery	of	multiple	stabilizing	mutations	with	minimal	experimental	screening.	
Origins	of	stabilization	
The	 modeled	 3D	 structures	 of	 the	 improved	 variants	 were	 analyzed	 to	
investigate	 the	 structural	 basis	 for	 the	 stabilizing	 effects.	 The	 beneficial	
mutations	 appear	 to	 introduce	 better	 H‐bonds	 that	 stabilize	 the	 local	 protein	
structure	 (A19K,	 N92K),	 improved	 surface	 charge–charge	 interactions	 (A19K,	
E45K,	 T76K,	 N92K,	 N92R),	 improved	 hydrophobic	 interactions	 (T85I,	 T85V,	
T85L,	 Y96F,	 Figure	 3‐3)	 and	 entropic	 stabilization	 (S15P	 and	 all	 disulfide	
variants).	 All	 of	 the	 stabilizing	mutations	 are	 located	 at	 or	 near	 the	 surface	 of	
LEH.	 Furthermore,	 the	most	 successful	mutations	 appear	 to	 be	 predominantly	





protein	 than	 the	 stabilizing	mutations.	 These	 observations	 indicate	 that	 the	N‐







Figure	3‐3.	Example	 of	 the	 predicted	 structure	 for	 a	 stabilizing	mutation.	 The	
substitution	 T85V	 (ΔTM,app	 =	 +7°C)	 removes	 a	 hydroxyl	 group	 in	 an	 apolar	
environment,	and	replaces	it	with	a	more	hydrophobic	methyl	group.	The	polar	
side‐chain	 atoms	 of	 Thr97	 and	 Arg99	 are	 >5	 Å	 from	 the	 hydroxyl	 oxygen	 of	




Figure	 3‐4.	 Distribution	 of	 stabilizing	 mutations	 over	 the	 protein	 (crystal	
structure	1NWW).	(A)	B‐factors	of	the	Cα	atoms	of	1NWW	(thickest	traces	with	
red	 color	 correspond	 to	 the	 highest	 B‐factors).	 (B)	 Location	 of	 all	 the	 point	
mutations	 shown	 with	 spheres	 for	 which	 the	 color	 reveals	 the	 level	 of	
stabilization.	
Design	of	combined	variants	
Aiming	 to	 obtain	 highly	 thermostable	 variants,	 the	 most	 stabilizing	 mutations	







increased	by	 improving	the	 local	stability	of	 the	N‐terminal	region	(see	above),	
different	 combinations	of	mutations	were	 screened	by	MD	simulation	 for	 their	
effect	on	the	flexibility	of	the	N‐terminus.	Disulfide	bonds	were	included	and	MD	
simulations	were	again	used	to	test	their	compatibility.	To	test	the	usefulness	of	
the	 flexibility	 predictions	 by	 MD	 simulations	 (third	 step	 of	 Scheme	 3‐1)	 for	
variants	 in	 which	 multiple	 mutations	 are	 combined,	 two	 combinations	 of	
disulfide	 bonds	were	 characterized,	 of	which	 one	 (S3C/I5C/E84C/V102C)	was	
predicted	 to	 rigidify	 the	 N‐terminus	 and	 thus	 be	 stabilizing,	 while	 the	 other	
combination	 (A40C/I44C/E68C/A72C)	was	predicted	 to	 increase	 the	 flexibility	
of	 the	 N‐terminal	 region	 of	 the	 enzyme,	 and	 thus	 be	 destabilizing.	 Indeed,	
S3C/I5C/E84C/V102C	 had	 a	 higher	TM,app	than	 its	 parents	 (66.8°C,	 ΔTM,app		=	
+15.8°C	 versus	 +13.5°C	 for	 I5C/E84C	 and	 +11.0°C	 for	 S3C/V102C),	 while	
A40C/I44C/E68C/A72C	had	a	lower	TM,app		than	its	parents	(54.8°C,	ΔTM,app		=	3.8	
versus	 +5.0°C	 for	 A40C/A72C	 and	 +5.5°C	 for	 44C/E68C).	 These	 experimental	
results	are	in	agreement	with	the	predictions	from	MD	simulation,	and	indicate	
that	 MD	 simulations	 can	 increase	 the	 chance	 of	 successfully	 combining	
mutations.	
The	 application	 of	 this	 method	 to	 combine	 multiple	 mutations	
simultaneously	resulted	in	the	final	variants	F1,	with	12	mutations,	and	F2	with	
10	mutations	(Figure	3‐2).	These	two	variants	combine	the	strongest	stabilizing	
mutations	 that	 were	 predicted	 by	 MD	 to	 rigidify	 the	 N‐terminus,	 whereas	
combinations	 that	 enhance	 local	 flexibility	were	 discarded.	 For	 example,	 S15P	
was	omitted	from	variant	F2	because	 in	combination	with	the	other	mutations,	
an	 increased	flexibility	of	 the	N‐terminal	 loop	was	predicted	by	MD	simulation.	
Furthermore,	the	highly	stabilizing	mutation	N92K	was	omitted	from	variant	F2	
because	 it	 cannot	 be	 combined	 with	 the	 A17C/N92C	 disulfide	 bonds.	 Also,	
maximally	 two	disulfide	bridges	per	enzyme	were	combined	 to	avoid	potential	
problems	with	the	kinetics	of	protein	folding.	
Table 3-2. Catalytic parameters of WT LEH and variants F1 and F2 
variant Wild type F1 F2 
temperature (°C) 30 50 30 80 30 70 
kcat (s-1) 13.9 ± 0.8 63 ± 4 8.9 ± 0.4 135 ± 6 8.2 ± 0.3 160 ± 7 
KM (mM) 0.3 ± 0.1 0.6 ± 0.1 < 0.25A 0.6 ± 0.1 < 0.25A 0.3 ± 0.1 
kcat/KM (s-1 M-1) 4.6 × 104 1.0 × 105    > 3.6 × 104 2.1 × 105   > 3.3 × 104 4.9× 105 
 
A The KM was below the detection limit of 0.25 mM. The kinetic parameters	 for the hydrolysis of (4R)-limonene 









min	 at	 the	 indicated	 temperatures.	 (D)	 The	 30°C	 increase	 in	 optimum	
temperature	 for	 catalytic	 activity	 of	 these	 variants	 and	 (E)	 the	 slower	 enzyme	
inactivation	 by	 incubation	 at	 55°C.	 (F)	 Retained	 regioselectivity	 of	 the	 final	
variants	 as	 determined	 by	 chiral	 GC.	 The	 elution	 profiles	 are	 those	 of	 the	
produced	 limonene	 diols.	 A	 reference	 sample	 contained	 both	 (1R,2R,4R)‐






When	 tested	 experimentally,	 variants	 F1	 and	 F2	 both	 exhibited	 a	 dramatically	
increased	TM,app	(ΔTM,app	=	 +34.6	 and	 35.5°C,	 Figure	 3‐5A).	 A	 variant	 P	 which	
lacked	 the	 disulfide	 bonds	 of	 F1	 still	 had	 a	 +20°C	 higher	 TM,app	than	 the	 WT	
(Figure	3‐2).	The	apparent	melting	temperatures	of	the	purified	WT	enzyme	and	
its	variants	F1	and	F2,	as	measured	by	differential	 scanning	calorimetry	 (DSC),	
were	 in	 agreement	 with	 results	 obtained	 by	 the	 thermofluor	 method	 (Figure	
3‐5A	and	B).	Thermal	inactivation	assays	also	demonstrated	that	the	variants	F1	
and	 F2	 are	 inactivated	 only	 above	 80°C	 (Figure	 3‐5C).	 Titration	with	 Ellman's	
reagent,	 the	 comparison	 of	 apparent	 melting	 temperature	 and	 the	






WT,	 F1	 and	 F2	 at	 55°C	was	 followed	 over	 time	 (Figure	 3‐5E).	 The	 fitted	 rates	
were	 0.31	 ±	 0.03,	 ≤80	 ×	 10−6	and	 (130	 ±	 40)	 ×	 10−6	min−1,	 respectively.	 This	
demonstrates	 that	 variants	 F1	 and	 F2	 are	 inactivated	 at	 least	 250	 times	more	






and	 F2	 variants	 under	 reducing	 (right	 side)	 and	 non‐reducing	 conditions	 (left	
side)	 on	 an	 SDS‐PAGE	 gel.	 The	 gel	 shows	 that	 there	 is	 a	 different	 migration	
pattern	 for	 F1	 and	 F2	 under	 reducing	 and	non‐reducing	 conditions,	 consistent	





Despite	 the	 10–12	 introduced	 mutations,	 the	 catalytic	 activities	 of	
variants	 F1	 and	 F2	 were	 retained.	 Both	 variants	 had	 a	 slightly	 reduced	kcat	at	
30°C	 (Table	 3‐2,	 Figure	 3‐7),	 but	 they	 were	 more	 than	 twice	 as	 catalytically	
active	 as	 the	WT	 at	 their	 respective	 optimum	 temperatures	 (Figure	 3‐5D	 and	
Figure	3‐7).	Moreover,	the	stereoconvergent	selectivity	of	the	WT	enzyme,	which	
produces	enantiopure	(1S,2S,4R)‐limonene	diol	from	a	diastereomeric	mixture	of	




Figure	 3‐7.	 Rate	 of	 (4R)‐limonene	 1,2‐epoxide	 conversion	 versus	 its	
concentration.	 Wild‐type	 LEH	 (grey	 dashed	 line),	 variant	 F1	 (black	 line)	 and	










rapid	 engineering	 of	 enzyme	 variants	 with	 a	 dramatically	 increased	
thermostability.	Essential	features	of	the	FRESCO	strategy	proposed	here	are	the	
use	of	computational	design	methods	to	create	a	library	of	potentially	stabilizing	
mutations,	 followed	 by	 a	 reduction	 of	 library	 size	 through	 orthogonal	in	
silico	screening	 aimed	 at	 removing	 false‐positive	 predictions.	 An	 experimental	
screening	 of	 the	 resulting	 library	 is	 then	 used	 to	 select	 the	 most	 stabilizing	





measurements,	 while	 catalytic	 activity	 and	 stereoselectivity	 were	 maintained.	
Natural	 thermostable	 enzymes	 are	 often	 far	 less	 catalytically	 active	 at	 lower	
temperatures	 than	 their	mesostable	 homologs	 [16].	 The	 results	 here	 show	 that	
even	a	35°C	increase	in	TM,app	is	not	necessarily	accompanied	by	loss	of	catalytic	
activity	at	lower	temperatures.	
The	 remarkable	 stabilization	 of	 LEH	 was	 achieved	 by	 experimental	
testing	 of	 <100	 variants	 in	 just	 two	 rounds	 of	mutagenesis.	 This	 is	 a	 very	 low	
number	when	compared	with	directed	evolution,	where	often	>104	variants	need	
to	 be	 screened	 to	 obtain	 a	 strong	 stabilization,	 since	 the	 vast	 majority	 of	 the	
tested	mutations	 are	neutral	 or	detrimental	 for	 stability	 [17].	 In	most	 cases,	 the	
screening	step	is	the	bottleneck	of	a	directed	evolution	project	[7a]	and	limits	its	
application.	Often	no	rapid	expression	systems	or	stability	assays	are	available.	
High‐throughput	 screening	 can	 be	 unfeasible	 if	 slow‐growing	 organisms	 are	
required	 for	protein	 expression	or	 if	 assays	 cannot	be	 scaled	down.	Therefore,	
the	protocols	presented	here	will	be	an	attractive	alternative	for	many	proteins.	
The	experimental	results	revealed	that	a	critical	region	for	stabilization	of	
LEH	 is	 located	 in	 the	 vicinity	 of	 the	 flexible	 N‐terminus	 (Figure	 3‐4B).	 This	
includes	both	the	interface	of	the	dimer	and	the	N‐terminus	itself	which	is	partly	
more	 remote	 from	 the	 interface.	 For	 example,	 both	 the	 G89C/S91C	 disulfide	
bond	 at	 the	 interface	 and	 the	 A5C/E84C	 disulfide	 bond	 at	 the	 N‐terminus	 are	
highly	stabilizing.	The	residues	of	the	N‐terminal	S3C‐V102C	disulfide	bond	are	
located	 >12	 Å	 away	 from	 the	 dimer	 interface,	 suggesting	 that	 its	 increased	
thermostability	can	be	unrelated	to	improved	stability	of	this	dimer	interface.	
Recent	 strategies	 for	 protein	 stabilization	 often	 only	 select	 the	 most	
flexible	 residues	 for	mutagenesis	 [7b,	10c,	18],	with	 the	 rationale	 that	 these	 should	
be	the	most	critical	residues.	However,	some	of	the	highly	stabilizing	mutations	
found	here	are	in	a	rigid	part	of	the	protein.	For	example,	T85V	(ΔTM,app	+7°C)	is	
close	 to	 the	 flexible	N‐terminus,	 even	 though	 the	mutated	 residue	 is	 in	 a	 rigid	
part	of	the	protein	as	judged	by	its	B‐factors	(13	Å2,	in	X‐ray	structure	1NWW),	
which	are	lower	than	average	(15	Å2	is	the	average	B‐factor	in	1NWW)	and	much	
lower	 than	 those	 of	 the	 flexible	 N‐terminus	 (Ile	 4,	 27	 Å2).	 Thus,	 the	
computational	methods	 generated	 stabilizing	mutations	 that	 would	 have	 been	
missed	if	only	highly	flexible	residues	had	been	selected	for	mutagenesis.	
An	 essential	 element	 of	 the	 FRESCO	 strategy	 is	 the	 elimination	 of	
mutations	that	are	suggested	by	the	computational	protocols,	but	lack	credibility	
when	 their	 predicted	 flexibility	 is	 taken	 into	 account	 or	 when	 their	 predicted	
structure	 is	 examined.	 Structural	 inspection	 showed	 that	 about	 50%	 of	 the	




probably	 false	 positives.	 They	were	 discarded	 in	 Step	 2	 (Scheme	 3‐1)	 because	
they	 introduce	 structural	 features	 that	 are	 expected	 to	 destabilize	 the	 protein,	
such	as	water‐exposed	hydrophobic	side	chains.	The	latter	 is	a	known	problem	
of	 computational	 design	 algorithms	 [19]	 and	 this	 justifies	 the	 use	 of	 rational	
criteria	to	remove	false	positives	that	result	from	imperfect	energy	functions	and	
sampling	 in	the	design	algorithms	 [20].	 It	 is	common	in	computational	design	to	




be	as	 important	 for	enzyme	 inactivation	as	overall	 thermodynamic	 stability	 [7b,	
10c,	22],	 elimination	 of	 false	 positives	 was	 also	 based	 on	 MD	 simulations	 which	
predicted	 effects	 on	 local	 flexibility	 (Step	 3).	 It	 is	 well	 established	 that	 high	
flexibility	 can	 promote	 unfolding	 [14].	 Here,	 experimental	 characterization	 of	
mutants	 that	 were	 eliminated	 at	 the	 third	 step	 of	 FRESCO	 because	 of	 higher	
flexibility	 showed	 that	 the	 discarded	mutations	were	 not	 stabilizing	 and	 often	
were	even	strongly	destabilizing	(Figure	3‐1C).	
The	efficiency	of	FRESCO	as	a	strategy	is	confirmed	by	the	large	number	
of	 mechanistically	 different	 stabilizing	 mutations	 that	 were	 discovered.	 The	
point	mutations	appear	to	act	through	various	effects	that	can	stabilize	a	protein,	
including	 the	 removal	 of	 unsatisfied	H‐bond	 donors/acceptors,	 introduction	 of	
new	 H‐bonds,	 better	 charge	 distribution	 [10b,	23]	 less	 hydrophobic	 exposure	 to	
solvent	and	entropic	stabilization	[2b,	12].	Multiple	disulfide	bonds	per	protein,	like	
in	variants	F1	and	F2,	occur	naturally	in	the	proteomes	of	a	few	thermophiles	[24].	
The	 ability	 to	 obtain	 mechanistically	 diverse	 types	 of	 stabilizing	 mutations	 is	
likely	 to	become	essential	 if	 the	goal	 is	 to	engineer	 strongly	enhanced	stability	
into	any	target	protein.	
The	 developed	 computational	 strategy	 to	 stabilize	 an	 enzyme	 is	
reminiscent	 of	 directed	 evolution,	 in	 that	 a	 library	 of	 potentially	 stabilizing	
mutations	 is	 experimentally	 screened	 before	 combining	 the	 most	 successful	
mutations	to	final	variants.	A	more	common	approach	in	computational	design	of	
thermostability	 is	 to	 select	 the	 best	 set	 of	 mutations	 purely	in	 silico	and	 only	
characterize	the	final	combined	variants	[3,	10,	25].	The	results	in	Figure	3‐1B	show	
that	 such	 an	 approach	 would	 have	 missed	 highly	 stabilizing	 mutations	
(T85V/N92K).	 Another	 approach	 is	 to	 use	 the	 consensus	 approach	 in	
combination	with	computational	design.	Using	FoldX	for	the	computations,	such	





thermostabilizing	 mutations	 [22],	 which	 is	 in	 agreement	 with	 our	 results	 of	
finding	 false	positives	 in	 the	absence	of	orthogonal	screening	(Figure	3‐1C).	To	
allow	 for	 larger	 increases	 in	 thermostability,	 the	 FRESCO	 approach	 uses	 an	
experimental	screening	to	verify	that	the	mutations	indeed	stabilize	the	enzyme	
and	 spare	 catalytic	 activity	 before	 creating	 variants	 in	 which	 mutations	 are	
combined.	
The	 modeling	 of	 backbone	 flexibility	 is	 an	 important	 problem	 in	
computational	protein	design.	With	a	rigid	backbone,	many	beneficial	mutations	
will	 be	 sterically	 excluded.	 The	 unusually	 large	 number	 of	 stabilizing	 disulfide	
bonds	discovered	in	this	study	is	mainly	due	to	the	use	of	an	MD	simulation	that	
samples	 the	 natural	 backbone	 flexibility	 to	 generate	 different	 realistic	 starting	
structures	 for	 the	 design	 of	 disulfide	 bonds.	 Backbone	 sampling	 protocols	
normally	 do	 not	 incorporate	 explicit	 water	 molecules[27].	 The	 MD	 simulations	
include	 the	surrounding	water	hydrogen‐bonding	network,	which	should	make	
the	 sampling	 of	 energetically	 accessible	 conformations	 more	 accurate.	 This	
protocol	produced	7	out	of	the	10	successful	disulfide	bonds,	which	included	all	
three	 disulfide	 bonds	 that	 were	 combined	 in	 the	 final	 highly	 thermostable	
variants	(Table	3‐1,	Figure	3‐2).	We	are	not	aware	of	previous	reports	describing	
a	 similar	 large	number	of	 stabilizing	disulfide	bonds.	With	existing	methods	 to	
stabilize	enzymes,	 typically	one	or	 two	stabilizing	disulfide	bonds	are	 reported	
[28].	Such	numbers	are	similar	 to	the	 finding	of	 three	stabilizing	disulfide	bonds	
for	 LEH	 (Table	 3‐1)	 in	 the	 absence	 of	 backbone	 conformational	 sampling.	 The	




positions,	 where	 based	 on	 the	 X‐ray	 structure	 a	 disulfide	 bond	 would	 not	 be	
feasible	 because	 the	 backbone	 atoms	were	 too	 far	 away	 from	 each	 other.	 For	
example,	 in	 case	 of	 disulfide	 bonds	distances	 of	 3.6–7.2	Å	 occur	 between	 their	
respective	 Cα	atoms	 [29]	 in	 natural	 proteins,	 whereas	 the	 distance	 between	 the	
Cα	atoms	 of	 residues	 4	 and	 82	 (where	 a	 stabilizing	 disulfide	 bond	 could	 be	
formed,	Table	3‐1,	 Figure	3‐2)	 is	 at	 least	8.90	 in	 the	 available	X‐ray	 structures	
(1NWW,	1NU3).	During	the	MD	simulation,	the	distance	between	the	Cα	atoms	of	
residues	4	 and	82	decreased	 to	6.52	Å	 (results	not	 shown).	Without	backbone	
conformational	 sampling,	 the	 additional	 disulfide	 bonds	 obtained	 from	 MD	
simulation	could	only	have	been	discovered	if	the	geometric	criteria	would	have	








temperature	 when	 compared	 with	 WT.	 The	 only	 precaution	 adopted	 in	 the	
FRESCO	protocol	was	not	to	introduce	mutations	at	residues	close	to	the	active	
site.	 Regioselectivity	 of	 water	 attack	 on	 the	 diastereomeric	 substrate	 is	 fully	
retained,	 allowing	 enantioconvergent	 production	 of	 (1S,2R,4R)‐limonene	 diol.	
The	 resulting	 variants	 are	 suitable	 for	 use	 in	 protein	 engineering	 aimed	 at	
introducing	new	selectivities.	
In	 conclusion,	 we	 show	 that	 computational	 library	 design	 can	 identify	
many	mutations	with	different	stabilization	mechanisms	to	cumulatively	obtain	a	





Computational	 methods:	 The	 relative	 changes	 in	 folding	 free	 energy	 ΔΔGFold	due	 to	 point	
mutations	 and	 the	 3D	 structures	 of	 the	 corresponding	 mutant	 enzymes	 were	 predicted	 with	
FoldX	(foldx.crg.es)	[30]	and	with	Rosettaddg	(www.rosettacommons.org)	[20a]	on	the	basis	of	the	
known	LEH	X‐ray	 structure	 1NWW	 [31].	 The	 predicted	ΔΔGFold	equals	 the	ΔGFold	for	 the	 protein	
carrying	the	point	mutation	minus	the	ΔGFold	for	the	WT	protein.	For	FoldX,	the	standard	settings	
of	 the	 software,	 which	 had	 been	 optimized	 on	 a	 large	 test	 set,	 were	 used,	 except	 that	 the	
calculation	was	 repeated	 five	 times	 to	 obtain	 a	 better	 averaging.	 For	 Rosettaddg,	we	 used	 the	
algorithm	 described	 by	 Kellogg	 et	al.	 [20a]	which	 includes	 repacking	within	 8	 Å	 of	 the	mutated	
residue	 using	 a	 soft‐repulsion	 energy	 function	 (options	 –ddg::local_opt_only	 true	 –
ddg::opt_radius	 8.0	 –ddg::weight_file	 soft_rep_design	 ‐ddg::iterations	 50	 ‐ddg::min_cst	 false	 ‐
ddg::mean	 true	 ‐ddg::min	 false	 ‐ddg::sc_min_only	 false	 ‐ddg::ramp_repulsive	 false).	 To	 avoid	
mutations	that	are	likely	to	interfere	with	catalysis	or	substrate	binding,	only	residues	that	were	
>10	Å	away	from	the	active‐site‐bound	heptamide	ligand	in	1NWW	[31]were	allowed	to	mutate.	
Selection	 of	 potentially	 stabilizing	mutations	was	 based	 on	 the	 following	 two	 criteria.	
Any	substitution	would	be	selected	if	its	predicted	ΔΔGFoldwas	<−5	kJ	mol−1,	which	corresponds	
to	the	approximate	error	(3.3	kJ	mol−1	in	ΔΔGFold	predictions	with	FoldX	[30].	For	Rosettaddg,	no	
error	 was	 reported	 [20a],	 but	 since	 the	 correlation	 coefficients	 with	 experimental	 data	 were	











within	 7	 Å	 but	 more	 than	 15	 positions	 away	 in	 the	 primary	 sequence.	 If	 such	 a	 neighboring	
residue	 is	 found,	 the	 algorithm	 introduces	 multiple	 initial	 geometries	 of	 disulfide	 bonds	 with	
dihedrals	θ1	for	 both	 donor	 and	 acceptor	 cysteine	 of	 −60°,	 60°,	 and	 180°	 (thus	 nine	 different	
combinations).	These	starting	structures	are	energy	minimized	with	fixed	backbone	atoms,	and	







in	 a	 test	 set	 appeared	 to	 identify	 most	 of	 the	 existing	 disulfide	 bonds.	 For	 the	 developed	
algorithm,	12	out	of	the	14	disulfide	bonds	in	a	small	test	set	consisting	of	X‐ray	structures	1CC5,	
1CPO,	1CRN,	1HNF,	1HXN,	1QBA,	1RLR	and	2LBP	were	acceptable.	While	adopting	more	lenient	





the	 Results	 section.	 Simulations	 were	 carried	 out	 under	 Yasara	 with	 the	 Yamber3	 force	 field,	
which	 is	 an	 Amber	 ff99	 [34]	 derivative	 that	 has	 been	 specifically	 parameterized	 for	 increased	
structural	 accuracy	 [35].	 A	 rectangular	 simulation	 box	 was	 used	 (with	 periodic	 boundary	
conditions,	 extended	 7.5	 Å	 around	 the	 protein	 fully	 solvated	 in	 explicit	 water	 with	 sodium	
chloride	 counter	 ions	 added	 to	 a	 concentration	 of	 0.5%).	 Long‐range	 (>7.86	 Å)	 electrostatic	
interactions	were	modeled	with	a	particle	mesh	Ewald	algorithm	[36]	with	fourth	degree	B‐spline	
functions.	To	remove	clashes	and	conformational	strain,	an	energy	minimization	was	carried	out	




to	 298	 K	 in	 30	 ps.	 MD	 simulations	 were	 started	 with	 the	 original	 crystal	 water	 present.	 A	
Berendsen	thermostat	was	used	to	control	the	temperature	[37]	under	an	NPT	ensemble	(number	




different	 initial	 atom	 velocities	 [38]	 of	 100	 (for	 the	 individual	 mutants)	 or	 1000	 ps	 (for	 the	
combined	mutants)	were	carried	out.	The	predicted	flexibility	of	the	enzyme	by	MD	simulation	
depends	on	the	initial	velocities	assigned	at	the	start	of	the	MD	simulation;	if	different	velocities	
are	 assigned	 initially,	 a	 different	 trajectory	 is	 observed	 [38].	 This	 provides	 a	 better	 sampling	 of	
conformations	than	a	single	long	MD	simulation,	even	if	sub‐trajectories	are	only	100	ps	long	[38].	
The	 root	 mean	 square	 fluctuation	 (RMSF)	 obtained	 from	 5	 of	 such	 100	 ps	 MD	 simulations	
correlated	well	with	 those	 from	 the	 X‐ray	 structures	 [the	RMSF	 of	 the	 crystal	 structures	were	





they	could	more	easily	be	obtained	 from	structural	 inspection	of	 the	simulated	protein.	All	 the	
structural	 flexibility	 effects	 were	 analyzed	 by	 inspecting	 the	 effect	 of	 the	 mutations	 on	 the	
averaged	structures	obtained	from	the	five	different	trajectories	per	variant.	If	one	out	of	the	five	
MD	 simulations	 appeared	 to	 sample	 a	 very	 different	 part	 of	 the	 protein	 conformational	 space	
than	 the	 other	 four,	 it	 was	 ignored.	 Removing	 these	 outliers	 enabled	 to	 compare	 different	
variants	because	otherwise	a	protein	variant	that	had	such	an	outlier	appeared	to	be	much	more	
flexible.	For	example,	initially	such	an	outlier	in	the	simulation	of	the	WT	protein	made	it	appear	
during	 the	structural	 inspection	as	 if	almost	all	 the	mutants	were	significantly	more	 rigid	 than	
the	WT.	
Protein	production	and	purification:	 A	 plasmid	 containing	 the	 gene	 for	 the	 LEH	was	 kindly	












the	 thermofluor	 method	 was	 carried	 out	 essentially	 as	 reported	 elsewhere	 [40].	 The	 analyzed	
samples	consisted	of	either	purified	protein	or	cell‐free	extract	for	screening	of	point	mutations.	
For	measurements,	5	μl	100×	diluted	commercial	Sypro	Orange	solution	(Life	Technologies,	CA,	
USA)	 was	 added	 to	 a	 20	 μl	 protein	 sample.	 The	 apparent	 melting	 temperature	 (TM,app)	 was	
determined	by	heating	the	samples	from	25	to	90°C	at	1°C/min	in	a	MyiQ	real‐time	PCR	machine	
(Bio‐Rad,	Hercules,	CA,	USA)	while	recording	the	fluorescence	with	a	490	nm	excitation	filter	and	
a	575	nm	emission	 filter	 [40].	The	maximum	of	 the	relative	 fluorescence	change	with	respect	 to	
the	temperature	(dRFU/dT)	was	taken	as	the	apparent	melting	temperature	(TM,app).	
Detection	of	disulfide	bonds:	 The	presence	 of	 inter‐subunit	 disulfide	 bonds	was	 analyzed	by	
examining	 the	migration	 patterns	 of	 the	WT	 and	mutant	 proteins	 by	 sodium	 dodecyl	 sulfate–
polyacrylamide	 gel	 electrophoresis	 (SDS–PAGE),	 both	 under	 reducing	 and	 non‐reducing	
conditions,	 since	 reduction	 of	 disulfide	 bonds	 should	 cause	 a	 shift	 in	 migration	 behavior.	 To	
determine	both	 inter‐	 and	 intramolecular	disulfide	bonds,	 the	number	of	 free	 cysteines,	which	




1,2‐epoxide	 (mixture	 of	 (1R,2S,4R)	 and	 (1S,2R,4R)	 isomers)	 as	 the	 substrate.	 After	 different	
incubation	 times,	 the	 reaction	mixtures	were	 extracted	with	 ethyl	 acetate,	 centrifuged	 and	 the	
organic	layers	were	removed	and	dried	by	Na2SO4.	The	production	of	diasteromers	was	analyzed	
by	 chiral	 GC,	 using	 a	 Hydrodex	 β‐TBDAc	 column	 (Aurora	 Borealis,	 The	 Netherlands),	 with	 a	










using	 a	 peqSTAR	 gradient	 polymerase	 chain	 reaction	 heating	 block	 (Peqlab	 Biotechnologie	




project	 (KBBE‐2011‐5,	 289646)	 and	 the	Metaexplore	 project	 (KBBE‐2007‐3‐3‐








































































































































the	 haloalkane	 dehalogenase	 LinB.	 Energy	 calculations,	 disulfide	 bond	 design,	
molecular	 dynamics	 simulations,	 and	 rational	 inspection	 of	 mutant	 structures	
predicted	 many	 stabilizing	 mutations.	 Screening	 of	 these	 in	 small	 mutant	
libraries	 led	 to	 the	 discovery	 of	 seventeen	 point	 mutations	 and	 one	 disulfide	
bond	that	enhanced	thermostability.	Mutations	 located	 in	or	contacting	 flexible	
regions	of	the	protein	had	a	larger	stabilizing	effect	than	mutations	outside	such	
regions.	The	combined	introduction	of	twelve	stabilizing	mutations	resulted	in	a	
LinB	 mutant	 with	 a	 23°C	 increase	 in	 apparent	 melting	 temperature	 (Tm,app,	
72.5°C)	 and	 an	 over	 200‐fold	 longer	 half‐life	 at	 60°C.	 The	 most	 stable	 LinB	


















Although	 enzymes	 are	 very	 proficient	 catalysts	 and	 can	 combine	 high	
acceleration	 of	 chemical	 reactions	 with	 good	 selectivity[1],	 their	 application	 in	
industrial	processes	can	be	hampered	by	their	limited	stability[2].	For	example,	at	
high	temperatures	or	in	the	presence	of	organic	co‐solvents,	enzymes	often	lose	
activity	 due	 to	 unfolding	 and	 aggregation.	 Performing	 enzyme	 reactions	 at	
elevated	 temperatures	 has	 several	 benefits,	 such	 as	 improved	 solubility	 of	
reactants,	 higher	 conversion	 rates,	 and	 reduced	 risk	 of	 microbial	
contamination[1‐3].	Improving	intrinsic	enzyme	stability	therefore	contributes	to	
the	 applicability	 of	 enzymes	 under	 realistic	 process	 conditions.	 Furthermore,	
thermostable	enzymes	are	better	suited	than	mesostable	enzymes	for	improving	
catalytic	activity	by	mutagenesis[2c,	4].	
Effective	 methods	 for	 improving	 intrinsic	 enzyme	 stability	 include	
directed	evolution	(repeated	rounds	of	random	mutagenesis	and	screening)[2b,	5]	
and	 the	 introduction	 of	 consensus	 amino	 acids	 detected	 by	multiple	 sequence	
alignments[5b,	6].	Replacement	of	amino	acids	based	on	structural	inspection	and	
reconstruction	of	ancestral	sequences	has	also	been	used[2b,	5].	Directed	evolution	
usually	 requires	 the	 screening	 of	 thousands	 of	 variants,	 and	 thus	 depends	 on	
high‐throughput	expression	and	assay	methods,	which	are	not	always	available.	
Rationally	predicted	 stabilizing	mutations	 can	be	 found	with	 less	 experimental	
screening	 effort	 and	 have	 also	 been	 used[7].	 However,	 the	 design	 of	 individual	
stabilizing	 mutations	 is	 often	 complicated	 and	 time‐consuming[5c].	
Computational	 design	 has	 evolved	 from	 rational	 design	 and	 can	 predict	 many	
potentially	 stabilizing	 mutations	 based	 on	 free	 energy	 calculations,	 and	 can	
replace	 or	 complement	 chemical	 intuition.	 Computational	 methods	 led	 to	 an	




thermostability	 have	 been	 explored[8c].	 One	 method	 is	 calculation	 of	 the	
electrostatic	 contributions	 of	 surface	 charges	 to	 the	 overall	 stability	 of	 the	
protein,	 and	 subsequent	 removal	 of	 charges	 that	 have	 destabilizing	
contributions.	This	method	was	used	to	improve	the	Tm,app	of	an	acylphosphatase	
and	 GTPase	 by	 9°C[9].	 Another	 approach	 uses	 semi‐empirical	 force	 fields	 to	
compute	 the	 differences	 in	 folding	 energy	 (ΔΔGfold)	 between	 the	 wild‐type	
enzyme	 structure	 and	 the	 predicted	 mutant	 structures.	 Algorithms	 that	 can	
calculate	 such	 folding‐energy	 differences	 include	 PoPMuSiC[8e],	 FoldX[8d,	 10],	





the	 hydrophobic	 core	 of	 a	 protein,	 and	 this	 resulted	 in	 an	 18°C	 increase	 in	
melting	 temperature	 of	 a	 domain	 of	 methionine	 aminopeptidase[8b].	
Furthermore,	 the	 design	 of	 stabilizing	 disulfide	 bonds	 has	 been	 reported	 for	
several	 proteins[12].	 However,	 computational	 methods	 to	 design	 chemically	
different	types	of	stabilizing	mutation	in	a	single	computational	approach	remain	
a	 challenge[8c],	 It	 is	 also	 difficult	 to	 accurately	 predict	 the	 ΔΔGfold	 required	 to	
achieve	 a	 large	 increase	 in	 unfolding	 temperature[8c,	13]	 and	 to	 retain	 catalytic	
activity	at	low	temperature	in	mutants	with	increased	thermostability[2c,	8a].	
We	recently	proposed	a	computational	strategy	 for	enzyme	stabilization	
based	 on	 the	 calculation	 of	 folding	 energies	 for	 all	 possible	 substitutions,	 the	
integration	of	conformational	sampling	in	disulfide‐bond	designs,	and	the	use	of	
molecular	 dynamics	 as	 a	 fast	 screening/ranking	 tool	 (FRESCO,	 framework	 for	
rapid	enzyme	stabilization	by	computation)[8f].	The	FRESCO	strategy	is	not	based	
on	 finding	 just	 a	 single	 or	 a	 few	 effective	 mutations,	 but	 on	 discovering	 and	
combining	as	many	stabilizing	mutations	as	possible	each	of	which	might	have	
only	a	 small	 effect.	 Furthermore,	as	most	of	 the	 screening	 is	done	 in	 silico,	 the	
number	 of	 variants	 that	 needs	 to	 be	 produced	 and	 tested	 experimentally	 is	
significantly	 reduced.	 By	 using	 the	 FRESCO	 approach,	 the	 Tm,app	 of	 limonene	
epoxide	 hydrolase	was	 improved	 by	 32°C,	with	 a	 total	 screening	 effort	 of	 less	
than	 80	 variants.	 The	 stabilization	 arose	 from	 both	 computationally	 designed	
point	 mutations	 and	 introduced	 disulfide	 bonds.	 The	 constructed	 enzymes,	
which	contained	10‐12	mutations,	remained	active	at	30°C[8f].	
In	 this	 study,	we	 examined	 the	 use	 of	 FRESCO	 for	 the	 stabilization	 of	 a	
larger	 monomeric	 protein	 that	 catalyzes	 both	 the	 degradation	 of	 recalcitrant	
environmental	 pollutants	 and	 performs	 stereoselective	 biocatalysis[14],	 that	 is,	
haloalkane	 dehalogenase	 (LinB,	 EC	 3.8.1.5)	 from	 Sphingomonas	 paucimobilis	
UT26[14b,	 15].	 LinB	 is	 responsible	 for	 the	 hydrolytic	 dehalogenation	 of	 1,3,4,6‐
tetrachloro‐1,4‐cyclohexadiene,	 which	 is	 an	 intermediate	 in	 the	 degradation	






can	 be	 used	 for	 the	 enantioselective	 preparation	 α‐bromoamides[14c]	 	 and	
haloalcohols[14d].	 Its	 catalytic	 mechanism	 has	 been	 studied	 in	 depth	 by	
structural[17],	mutational[17b,	18]	 and	 quantum	mechanical	methods[19].	 However,	




stability,	 as	 was	 found	 when	 performing	 mutagenesis	 experiments	 aimed	 to	
improve	the	enzyme	selectivity	for	the	enantioselective	conversion	of	N‐benzyl‐
2‐bromohexanamide	(unpublished	results).	The	limited	stability	results	in	a	low	
tolerance	 of	 organic	 co‐solvents[20],	 thus	 restricting	 the	 use	 of	 co‐solvents	 to	
solubilize	hydrophobic	 substrates[14c].	 In	 this	paper,	we	demonstrate	 that,	 by	 a	





Previously,	 the	 FRESCO	 computational	 framework	was	 applied	 to	 improve	 the	
Tm,app	of	the	small	dimeric	protein	limonene	epoxide	hydrolase	by	32°C[8f].	Here	
we	 investigated	 whether	 this	 framework,	 which	 aims	 to	 reduce	 experimental	
screening	 to	 a	 minimum,	 is	 also	 applicable	 for	 the	 stabilization	 of	 the	 larger	
monomeric	haloalkane	dehalogenase	LinB.	We	compared	the	effects	on	stability	
and	 activity	 by	mutations	 close	 to	 the	 active	 site	 to	 those	 by	mutations	 away	
from	the	active	site.	In	a	previous	study,	several	mutations	close	to	the	active	site	
were	 found	 to	 stabilize	 the	 haloalkane	 dehalogenase	 DhaA[21],	 but	 such	
mutations	often	result	in	reduced	catalytic	activity.	For	the	stabilization	of	LinB,	
mutations	were	first	 introduced	more	than	9	Å	from	the	docked	substrate	tert‐
butyl‐2‐(2‐bromopropanamido)acetate.	 This	 afforded	 the	 substitution	 of	 233	
residues;	 63	 other	 residues	 were	 excluded	 because	 of	 their	 proximity	 to	 the	




to	 identify	 mutations	 which	 should	 stabilize	 LinB.	 Such	 point	 mutations	 can	
stabilize	 proteins	 by	 improving	 hydrophobic	 interactions	 in	 the	 interior,	 by	
removing	 unsatisfied	 hydrogen	 bonds,	 by	 improving	 surface	 electrostatic	
interactions,	 or	 by	 reducing	 the	 flexibility	 of	 areas	 that	 are	 rate	 limiting	 for	
kinetic	 unfolding.	 FoldX	 predicted	 150	 possible	 stabilizing	 mutations,	 and	
Rosetta	predicted	314	mutations	with	ΔΔGfold	higher	 than	3.5	kJmol‐1.	Of	 these,	
57	 were	 predicted	 by	 both	 methods,	 so	 a	 total	 of	 407	 unique	 stabilizing	
substitutions	 were	 expected.	 Previous	 work	 suggests	 that	 although	 FoldX	 and	
Rosetta	can	be	used	to	find	stabilizing	mutations,	these	programs	also	give	false‐
positive	 predictions[8f,	13,	22].	 Therefore,	 the	 predicted	 structures	 of	 the	mutants	






hydrophobic	 residues	 exposed	 at	 the	 surface,	 internal	 cavities,	 and	 missing	
hydrogen‐bond	 interactions.	 The	 criteria	 for	 this	 elimination	 process	 are	
described	 in	 the	 Experimental	 Section.	 By	 this	 visual	 inspection,	 219	 variants	
were	eliminated.	
To	 reduce	 the	 required	 experimental	 screening	 effort,	 a	 further	
computational	 screening	 step	 by	 molecular	 dynamics	 simulations	 was	
performed.	 This	 procedure	 identifies	 unfavorable	 interactions	 that	 are	 not	
evident	in	the	initial	structure	predicted	by	FoldX,	but	occur	dynamically	during	
MD	 simulations.	 Previous	 MD	 studies	 showed	 that	 several	 short	 parallel	 MD	
simulations	can	simulate	an	enzyme	as	well	as	one	long	simulation[23].	Therefore,	
five	 parallel	 MD	 simulations	 of	 100	 ps	 were	 performed	 for	 each	mutant	 with	
varying	 initial	 atom	 velocities	 to	 obtain	 different	 samplings	 of	 conformational	
space.	The	MD	screening	eliminated	79	of	the	188	variants.	The	majority	of	the	
mutations	 that	 were	 eliminated	 showed	 changes	 in	 the	 conformation	 of	 the	
introduced	 and	 surrounding	 residues	 during	 the	 simulation,	 compared	 to	 the	
structures	predicted	by	FoldX.	This	resulted	in	unsatisfied	hydrogen	bonds,	 the	
removal	of	α‐helix	capping	interactions,	or	the	breaking	of	a	salt	bridge.	Finally,	
109	 designed	 mutations	 that	 passed	 the	 MD	 screening	 were	 selected	 for	
experimental	analysis.		
Mutants	were	 constructed	 by	QuikChange	 reactions	 in	microtiter	 plates	
(MTPs).	Subsequently,	cells	producing	the	protein	of	interest	were	grown	in	MTP	
plates	 and,	 after	 lysis,	 the	 enzymes	were	 purified	 by	 affinity	 chromatography.	
With	this	procedure,	soluble	protein	was	obtained	from	Escherichia	coli	cells	for	
99	 of	 the	 109	 mutants.	 To	 verify	 the	 predicted	 stabilizing	 effects	 of	 these	












LinB.	 A)	 Sites	 of	 stabilizing	 mutations	 shown	 on	 the	 X‐ray	 structure	 of	 LinB.	
Residues	within	9	Å		of	the	substrate	tert‐butyl‐2‐(2‐bromopropanamido)acetate	
bound	 in	 the	 active	 site	 are	 shown	 in	 red.	 The	 thickness	 of	 the	 backbone	
represents	 the	 protein	 flexibility	 as	 determined	 by	 B‐factor.	 Colored	 spheres	
indicate	 the	 effect	 of	 the	 mutation	 on	 Tm,app.	 The	 introduced	 disulfide	 bond	
(yellow)	 is	 between	 two	purple	 spheres.	 Structure	 drawn	 from	1MJ5,	with	 the	
docked	 substrate	 shown	 in	 sticks.	 B)	 Values	 for	 ΔTm,app	 of	 the	 introduced	
mutations	 (○)	 and	 B‐factors	 (‐)	 against	 residue	 number.	 C)	 ΔTm,app	 of	 the	
introduced	mutations	(○)	and	RMSF	(‐)	against	residue	number.	D)	ΔTm,app	of	the	
introduced	 mutations	 (○)	 and	 Cα	 distances	 to	 the	 chloride	 ion	 bound	 in	 the	
active	site	(‐)	against	residue	number.	
The	obtained	Tm,app	values	were	compared	to	the	melting	temperature	of	
the	 wild	 type	 to	 obtain	 ΔTm,app.	 Mutations	 that	 gave	 a	 ΔTm,app	 at	 least	 twofold	
higher	 than	 the	 standard	deviation	of	 the	 assay	 (±0.96°C,	n=9)	were	 scored	 as	
stabilizing.	This	resulted	in	the	discovery	of	ten	stabilizing	mutations	(Table	4‐1)	
a	 success	 rate	 of	 10%	 (number	 of	 mutations	 experimentally	 found	 to	 be	
stabilizing	 divided	 by	 the	 number	 of	 predicted	 mutations).	 Different	 types	 of	
stabilizing	mutations	were	experimentally	observed	(Table	4‐1	and	Figure	4‐2):	












van	 der	 Waals	 interactions.	 B)	 Mutation	 E192K	 (ΔTm=+3°C);	 the	 introduced	




stability	 but	 reduces	 activity.	 The	 docked	 substrate	 tert‐butyl‐2‐(2‐
bromopropanamido)‐acetate	 is	 shown	 in	 sticks	 to	 highlight	 its	 proximity	 to	
D147.	 D)	 Predicted	 structure	 with	 the	 disulfide	 bond	 introduced	 between	
residues	 185	 (protein	 core)	 and	 5	 (close	 to	 the	 N	 terminus);	 ΔTm=+5°C.	 The	
flexibility	of	 the	wild‐type	protein,	as	observed	by	crystallographic	B‐factors,	 is	
represented	by	the	thickness	of	the	chain	(3‐35	Å2)	in	panels	C	and	D.	
To	 determine	 if	 the	 discovered	 stabilizing	 mutations	 affected	
dehalogenase	 activity,	 specific	 activities	 of	 the	 purified	 enzymes	 were	
determined	with	1‐bromopropane.	Nearly	all	variants	were	as	active	as	the	wild‐
type	 enzyme	 (Table	 4‐1),	 thus	 supporting	 the	 expectation	 that	 mutations	
stabilizing	LinB	away	from	the	active	site	do	not	reduce	its	activity.	The	majority	











mechanics	 energy.	 Disulfide	 bonds	 are	 known	 to	 stabilize	 proteins	 both	
thermodynamically	(reducing	the	entropy	of	the	unfolded	state)	and	kinetically	
(slowing	important	steps	in	protein	unfolding	pathways,	such	as	local	unfolding	




positions	 where	 disulfide‐forming	 cysteines	 could	 be	 introduced.	 Previous	
experiments	suggested	that	small	variations	in	the	positions	of	backbone	atoms	
can	 have	 a	 large	 effect	 on	 the	 distances,	 angles,	 and	 dihedrals	 of	 the	 designed	
disulfide	bonds,	and	 therefore	on	 the	predicted	molecular‐mechanics	energy	of	
disulfide	 bonds[8f].	 By	 using	 a	 set	 of	MD‐generated	 template	 structures	 for	 the	
predictions,	 an	 additional	 25	 pairs	 of	 cysteine	 positions	were	 discovered,	 thus	
raising	the	total	number	of	predicted	pairs	to	32.	
After	visual	inspection	of	the	mutants	(based	on	criteria	described	in	the	
Experimental	 Section)	 the	dynamic	behavior	of	mutants	 carrying	 the	predicted	
disulfide	bonds	were	analyzed	by	MD	simulations,	 in	order	 to	 identify	mutants	
with	destabilizing	features,	such	as	surface‐exposed	aromatic	residues	or	broken	
salt	 bridges.	 This	 analysis	 revealed	 that	 19	 of	 the	 32	 predicted	 disulfide	 bond	
mutations	likely	were	destabilizing,	and	therefore	they	were	eliminated.	
The	 remaining	 13	 disulfide	 bond	 designs	 were	 characterized	
experimentally,	with	enzymes	produced	in	both	E.	coli	TOP10	and	E.	coli	SHuffle	
(Table	 4‐2).	 The	 latter	 is	 optimized	 for	 the	 cytosolic	 formation	 of	 disulfide	
bonds[29].	This	analysis	revealed	that	only	one	of	the	13	tested	mutants	was	more	
stable.	It	carried	a	disulfide	bond	between	residues	5	and	185,	and	this	stabilized	
the	 protein	 by	 5°C	 (Table	 4‐1,	 Figure	 4‐1	 and	 4.2).	 The	 mutation	 was	 only	
stabilizing	 in	 its	 oxidized	 state	 (Table	 4‐2),	 thus	 indicating	 that	 the	 observed	
increase	 in	 Tm,app	 can	 be	 attributed	 to	 the	 introduced	 disulfide	 bond.	 The	






indicating	 that	 the	 stabilizing	 disulfide	 bond	 does	 not	 diminish	 activity.	 This	
stabilizing	 disulfide	 bond	 was	 predicted	 by	 methods	 based	 on	 both	 the	 X‐ray	
structure	and	structures	generated	by	MD	simulations.	
	
Table 4-1. Stabilizing mutations discovered in LinB. 









   LinB WT variants    
wild-type - 51.0 0.0 ± 
wild-type Rosetta -4.2 E15T 52.0 1.0 ± 
wild-type Rosetta -4.0 A53L 52.0 1.0 - 
wild-type Rosetta -4.0 A81K 52.0 1.0 ± 
wild-type Rosetta -9.2 D166K 53.5 2.5 + 
wild-type Rosetta -4.3 D166N 53.0 2.0 ND 
wild-type FoldX -3.7 E192K 54.0 3.0 ± 
wild-type FoldX -4.6 E192R 53.5 2.5 ND 
wild-type FoldX -4.0 A197P 52.5 1.5 + 
wild-type - - G229Q + E192R[a] 54.0 3.9 + 
wild-type Rosetta -5.0 D255A 51.5 0.5 ± 
wild-type DDD /MD - A5C/A185C 56.0 5.0 ± 
Wild-type Variant G1  
A5C+A185C+G229Q+ 62.0 11 ± D166K+E192K 
LinB G1 variants 
G1 Rosetta -15.9 D147H 65.0 3.0 -- 
G1 Rosetta -25.4 D147Y 67.5 5.5 --- 
G1 Rosetta -9.2 D147M 65.0 3.0 --- 
G1 Rosetta -15.8 D147L 66.0 4.0 ---- 
G1 Rosetta -5.8 F169V 64.0 2.0 + 
G1 FoldX -5.8 T249L 62.5 0.5 ± 
G1 FoldX -4.0 A247F 67.5 5.5 --- 
G1 Variant G3 - E15T+A53L+A81K+F169V +A197P+D255A+A247F 74.0 12/23
[c] -- 
[a] TM,app determined for the double mutant. [b] Symbols:  -, activity with 1-bromopropane reduced by 10-
25%; --, reduced by 25-50%; ---, reduced by 50-75%; ---- reduced by 75-100%, ±,  similar to the wild-type; +, 
improved by 10-25%; ND,  not determined. [c] As compared to the wild-type.  
	
Previously,	 a	 similar	 approach	 aimed	 at	 enhancing	 the	 stabilization	 of	
limonene	epoxide	hydrolase	yielded	thirteen	stabilizing	disulfide	bonds[8f].	Other	
computational	 design	 studies	 have	 found	 one[12b‐d]	 or	 two	 stabilizing	 disulfide	
bonds[12a].	 For	 LinB,	 only	 one	 disulfide	 bond	 was	 found,	 and	 this	 yielded	
moderate	stabilization.	Possibly,	local	kinetic	stabilization	arising	from	the	other	
examined	 disulfide	 bonds	 did	 not	 contribute	 to	 the	 overall	 stability	 of	 the	
protein.	The	stabilizing	A5C/A185C	disulfide	bond	was	in	the	flexible	N	terminus	




discovered	 at	 more	 rigid	 parts	 of	 the	 protein.	 The	 observed	 stabilization	 in	 a	
flexible	area	is	consistent	with	results	for	other	proteins[12a,	30].	
	
Table 4-2. The TM,app of all disulfide bond mutants constructed and analyzed in both the 
oxidized and reduced state, in both E. coli TOP10 and shuffle strains. 
  E. coli TOP10 E. coli shuffle 
Mutation TM,oxidized (°C) TM,oxidized (°C) TM,reduced (°C)A 
WT 51 49.0 49.0 
S2C/N47C 48 - - 
A5C/A185C 56 55.5 49.0 
R20C/D70C 50 - 45.5 
A22C/D68C 50 - 49.5 
S42C/A60C - - 47.5 
I48C/G283C 49 - - 
H51C/G283C 48.5 - 46.0 
S75C/E199C 48.5 - - 
V106C/G114C - 50.0 50.0 
V268C/S278C 48.5 - 46.0 
S75C/R79C 45.5 - 44.0 
S183C/E186C 47 - - 
A196C/A200C 48.5 46.0 48.5 
 
A Reduced by the addition of 10 mM DTT 
	
To	analyze	why	the	other	disulfide	bonds	were	not	stabilizing,	the	melting	
temperatures	 of	 all	 13	 disulfide‐bond	 variants	 were	 determined	 in	 both	 the	
reduced	and	oxidized	states.	Six	of	these	did	not	show	a	clear	melting	transition	
in	 their	 oxidized	 state	 (suggesting	misfolding),	 whereas	 such	 a	 transition	 was	
seen	when	reduced	(Table	4‐2).	This	reduction	resulted	in	proteins	with	clearly	
defined	 melting	 temperatures,	 thus	 indicating	 homogenous	 structures.	 These	
results	 suggest	 that	 unintended	 disulfide	 bonds	 were	 formed	 between	 the	
introduced	 and	 endogenous	 cysteine	 residues,	 as	 six	 of	 the	 13	 constructed	
disulfide	bonds	resulted	in	misfolded	protein	(Table	4‐2).	
Combining	stabilizing	mutations	
To	 investigate	 whether	 a	 highly	 thermostable	 variant	 could	 be	 obtained	 by	
combining	 confirmed	stabilizing	mutations,	we	 constructed	mutant	LinB‐G1,	 in	
which	 three	 stabilizing	 point	 mutations	 (G229Q,	 D166K,	 and	 E192K)	 and	 one	
disulfide	bond	(A5C/A185C)	were	combined.	The	Tm,app	of	this	variant	was	11°C	
higher	 than	 that	 of	 the	 wild‐type	 enzyme	 (Table	 4‐1,	 Figure	 4‐3A	 and	 B).	 Its	







the	 same	 as	 for	 the	 wild	 type	 (Table	 4‐4).	 This	 supports	 the	 hypothesis	 that	
stabilizing	 mutations	 away	 from	 the	 active	 site	 do	 not	 affect	 activity,	 and	
indicates	that	the	mutations	did	not	indirectly	disturb	the	active	site	or	parts	of	
the	enzyme	that	need	to	be	flexible	for	substrate	access	or	product	release.	The	





Figure	 4‐3.	 Thermostabilities	 of	 wild‐type	 LinB	 and	 variants	 G1	 and	 G3	
determined	by	 four	different	methods:	wild	 type	(black	 line),	G1	(dashed	 line),	
G3	(gray	line).	A)	Tm,app	measured	by	the	thermofluor	method	(in	the	absence	of	
cosolvent).	 B)	 Tm,app	 measured	 by	 DSC.	 C)	 Thermal	 inactivation	 constants	 at	
different	 temperatures.	 D)	 Specific	 activities	 for	 dehalogenation	 of	 1‐
bromopropane	 at	 different	 temperatures.	 Because	 of	 the	 experimental	 setup,	
activities	could	only	be	measured	up	to	55°C.	
The	 correlation	 between	 increased	 Tm,app	 and	 protein	 unfolding	 and	
activity	 at	 elevated	 temperatures	 was	 investigated	 by	 measuring	 inactivation	







enzyme	 reached	 optimum	 activity	 at	 40°C,	 whereas	 G1	 showed	 its	 highest	
activity	at	50°C.	At	the	optimum	temperatures,	G1	was	1.5‐fold	more	active	than	
wild	type	(Figure	4‐3D).	Thus,	the	11°C	improvement	in	the	Tm,app	of	variant	G1	
(Figure	4‐3A	and	B)	 reflects	 significantly	 improved	half‐life	 and	activity	at	 and	
above	44°C.	
	
Table 4-3. Kinetic parameters for the dehalogenation of 1-bromopropane by wild-type LinB and 
evolved variants G1 and G3 at 30°C and at their optimum temperatures of 40, 50 and 50°C. 
30°C Optimum temperature  
Variant kcat (s-1) KM (mM) 
kcat/KM  





Wild-type 4.5 ± 0.2 1.9 ± 0.1 2.3 6.1 ± 0.3 3.2 ± 0.3 1.9 40 
G1 4.7 ± 0.4 3.0 ± 0.2 1.6 6.7 ± 0.4 3.7 ± 0.1 1.8 50 
G3 2.4 ± 0.1 1.3 ± 0.1 1.9 4.3 ± 0.6 2.4 ± 0.2 1.8 50 
Mutations	close	to	the	active	site	
It	has	been	suggested	that	stabilization	of	flexible	areas	of	a	protein	contributes	
more	 to	 the	 overall	 stability	 than	 does	 stabilization	 of	 rigid	 areas[7b,	27,	31].	 For	
LinB,	 the	 region	 surrounding	 the	 active	 site	 is	 relatively	 flexible	 (Figure	 4‐1).	
Structural	 inspection	 and	 analysis	 of	 the	B‐factors	 of	 the	 protein	 revealed	 that	
the	most	 flexible	parts	of	 two	helixes	 (α4,	 residues	144‐148,	 and	α5,	169‐173)	
flank	the	active	site	(Figure	4‐1B).	The	crystallographic	B‐factors	of	this	area	are	
1.5‐fold	 higher	 than	 the	 average	 for	 the	 protein	 (9.1	 and	 5.6	 Å2,	 respectively).	
Furthermore,	 the	 root‐mean	 square	 fluctuation	 (RMSF)	 calculated	 from	 MD	
simulations	 of	 the	wild‐type	 enzyme	was	 1.5‐fold	 higher	 in	 helix	 α4	 (residues	
144‐148).	Indeed,	with	the	exception	of	the	N	and	C	termini,	helix	α4	is	the	most	
flexible	part	of	the	protein,	based	on	B‐factor	and	RMSF	(Figure	4‐1B	and	C).	The	
active	 site	 of	 LinB	 is	 buried	 in	 the	 protein,	 and	 substrates	 reach	 it	 through	 an	
access	tunnel.	It	was	reported	that	flexibility	of	residues	lining	this	tunnel	(169‐
173)	 is	 required	 for	 substrate	 access	 to	 the	 active	 site[32].	 Therefore,	 this	 area	
could	 be	 an	 interesting	 region	 for	 the	 introduction	 of	 stabilizing	 mutations,	
although	this	bears	the	risk	of	incurring	a	negative	effect	on	catalytic	activity.	
To	 investigate	whether	mutations	close	to	the	active	site	(<9	Å	from	the	
bound	 chloride)	 have	 a	 larger	 effect	 on	 overall	 stability,	 potentially	 stabilizing	
mutations	 were	 computationally	 designed	 by	 the	 above	 approach,	 including	









rate	 for	mutations	 introduced	 close	 to	 the	 active	 site	 (29%)	was	much	 higher	
than	 for	 mutations	 distant	 from	 the	 active	 site	 (10%).	 Five	 of	 the	 seven	
stabilizing	mutations	 improved	 packing	 of	 hydrophobic	 residues	 in	 the	 apolar	
interior	 of	 the	 protein	 close	 to	 the	 active	 site	 (D147M,	 D147L,	 F169V,	 A247F,	
T249L,	Figure	4‐2C).	Residues	247	and	249	are	in	a	loop	covering	the	active	site	
and	 interact	 with	 a	 flexible	 helix	 (residues	 139‐156).	 Residue	 147	 is	 at	 the	
beginning	of	a	very	flexible	stretch	of	this	helix.	All	mutations	that	replaced	this	




Table 4-4. Specific activities for the dehalogenation of several haloalkanes by wild-type 
LinB and variants G1 and G3 
Bromoalkanes A LinB wild-type (U/mg) LinB-G1 (U/mg) LinB-G3 (U/mg) 
1-bromohexane 1.2 ± 0.1 1.3 ± 0.2 0.8 ± 0.1 
1-bromocyclohexane 1.5 ± 0.1 1.3 ± 0.1 1.5 ± 0.1 
1-bromopropanen 6.3 ± 0.1 6.3 ± 0.1 2.7 ± 0.1 
1,2-dibromomethane 7.1 ± 0.6 8.1 ± 0.6 0.5 ± 0.1 
chloroalkanes[a] 
1-chloropropane 14 ± 0.3 12.2 ± 0.4 1.3 ± 0.1 
1-chloroheptane 1.7 ± 0.1 1.8 ± 0.1 0.1 ± 0.05 
1-chloropentane  1.5 ± 0.2 1.4 ± 0.1 0.9 ± 0.1 
1-chlorobutane 1.3 ± 0.1 1.1 ± 0.1 1.2 ± 0.1 
1,3-dichloropropane 0.9 ± 0.1 0.7 ± 0.1 0.3 ± 0.1 
1-chlorocyclohexane 0.2 ± 0.1 0.1 ± 0.05 0.2 ± 0.1 
iodoalkanes[a] 
1-iodopropane  4.7 ± 0.1 4.0 ± 0.1 2.7 ± 0.3 
 
A Specific activities in U/mg protein, determined at 30°C. 
	
Stabilizing	 mutations	 close	 to	 the	 active	 site	 had	 a	 more	 pronounced	
effect	on	overall	thermostability.	For	mutations	near	the	active	site,	66%	(16	of	
24)	 affected	 overall	 stability,	 whereas	 only	 44%	 of	 distal	mutations	 (44	 of	 99	
variants	characterized)	 influenced	stability,	even	though	the	design	procedures	
were	 very	 similar.	 Mutations	 that	 improved	 local	 folding	 interactions	 (e.g.,	 by	






electrostatics	 at	 the	 surface.	 This	 suggests	 that	 mutations	 that	 improve	 local	
folding	 interactions	 close	 to	 the	 active	 site	 contribute	 more	 to	 the	 overall	
stability	of	LinB.	
Assays	 were	 carried	 out	 with	 1‐bromopropane	 to	 analyze	 whether	
stabilizing	mutations	close	to	the	active	site	 influence	activity:	 five	of	the	seven	
stabilizing	 mutations	 significantly	 reduced	 the	 activity	 of	 the	 enzyme;	 only	
mutations	 F169V	 and	T249L	 increased	 stability	while	 retaining	 activity	 (Table	
4‐1).	 Thus,	 although	 29%	 of	 the	 mutations	 surrounding	 the	 active	 site	 were	






mutations	 E15T/A53L/A81K/A197P/D255A	 (distant	 from	 the	 active	 site)	 and	
F169V/A247F	 (close	 to	 the	 active	 site)	 were	 introduced	 into	 variant	 G1.	 The	
resulting	 variant	 (LinB‐G3)	 contained	 ten	 stabilizing	 point	 mutations	 and	 one	
disulfide	bond.	Its	Tm,app	was	measured	by	both	differential	scanning	calorimetry	
(DSC)	 and	 thermofluor	 assays:	Tm,app	was	 (74±0.5)°C,	 an	 increase	of	 23°C	 over	
wild	 type	 (Figure	 4‐3A	 and	 B).	 This	 resulted	 in	 improvements	 to	 other	
parameters	 relevant	 for	 biocatalysis,	 such	 as	 half‐life	 and	 activity	 at	 higher	
temperatures:	half‐life	was	200	min	at	60°C,	compared	to	just	1.0	min	at	55°C	for	
the	wild	type	(Figure	4‐3C).	
To	 determine	 activity	 at	 30°C,	 variant	 G3	 was	 assayed	 with	 1‐
bromopropane	and	several	other	chloroalkanes,	iodoalkanes,	and	bromoalkanes	
(Table	 4‐4).	 Most	 of	 the	 G3	 mutations	 did	 not	 reduce	 enzymatic	 activity	
individually	 (Table	 4‐1).	 However,	 activity	 at	 30°C	 was	 reduced	 when	 the	
mutations	were	combined:	kcat	for	1‐bromopropane	was	reduced	(46%),	Km	was	
also	 weaker	 (1.9	 vs.	 1.3	 mM),	 and	 there	 was	 a	 moderate	 reduction	 (19%)	 in	
catalytic	efficiency	(kcat/Km,	Table	4‐3).	The	activity	for	several	other	haloalkanes	
was	 also	 lower	 (Table	 4‐4).	 However,	 the	 improved	 thermal	 stability	 allowed	
variant	G3	to	perform	dehalogenation	reactions	at	55°C,	whereas	the	wild‐type	









than	 mesostable	 enzymes[6c,	21,	33].	 This	 is	 advantageous	 for	 the	 conversion	 of	
poorly	soluble	substrates	 in	water/co‐solvent	mixtures.	To	 investigate	whether	
the	higher	stabilities	of	the	LinB	variants	were	accompanied	by	higher	tolerance	
of	 co‐solvent,	 catalytic	 activity	was	 determined	 in	 buffer	 containing	 50%	 (v/v)	
DMSO	or	1,4‐dioxane	(Figure	4‐4A	and	B).	Tm,app	values	in	the	presence	of	DMSO	
or	 1,4‐dioxane	were	 also	 determined.	 G1	 and	 G3	were	 inactivated	much	more	
slowly,	while	their	Tm,app	values	in	the	presence	of	co‐solvents	were	significantly	
increased	 over	 that	 of	 wild	 type	 (Figure	 4‐4C	 and	 D).	 G3	 displayed	 some	
heterogeneity:	 a	 fraction	 of	 the	 enzyme	 initially	 unfolded	 but	 the	 rest	 of	 the	
protein	 retained	 activity	 over	 time	 (Figure	 4‐4B).	 These	 results	 clearly	
demonstrate	 that	 these	 thermostable	variants	 are	able	 to	 function	 significantly	
better	in	the	presence	of	these	co‐solvents.	
A	 unique	 property	 of	 LinB	 is	 its	 activity	 with	 the	 highly	 recalcitrant	 β‐
isomer	 of	 HCH[16].	 However,	 efficient	 conversion	 by	 LinB	 is	 hampered	 by	 the	
poor	 solubility	 of	 this	 compound[21].	 In	 water	 β‐HCH	 is	 soluble	 up	 to	 only	 17	
μM[16,	21],	 but	 higher	 concentrations	 can	be	 obtained	 in	 a	DMSO/water	mixture.	
To	further	improve	the	solubility	of	and	activity	towards	β‐HCH,	the	temperature	
was	raised	to	45°C.	Activity	assays	with	a	tenfold	higher	concentration	of	β‐HCH	
(180	 μM	 in	 a	 DMSO/buffer	 mixture)	 at	 45°C	 showed	 superior	 conversion	
compared	to	that	in	buffer	alone	(Figure	4‐5).	Degradation	of	β‐HCH	by	the	wild‐
type	 enzyme	 and	 variant	 G1	 in	 25%	 DMSO	 at	 45°C	 was	 compared:	 G1	 fully	
converted	180	μM	β‐HCH	within	 8h	 (99	%	 conversion),	whereas	 the	wild‐type	
enzyme	converted	only	26%	and	was	inactivated	within	30	min	(Figure	4‐5).	The	
concurrent	 increase	 in	 thermostability	and	solvent	 tolerance	 suggests	 that	 it	 is	
possible	 to	 enhance	 the	 performance	 of	 enzymes	 in	 organic	 solvents	 by	
engineering	their	stability[6c,	21,	33].	
To	 investigate	 the	 cause	 of	 the	 improved	 tolerance	 to	 co‐solvent,	Tm,app	
was	 investigated	 in	 the	 presence	 of	 solvent.	 These	 experiments	 showed	 that	
reduced	Tm,app	 as	 a	 function	 of	 co‐solvent	 concentration	was	 rather	 similar	 for	
wild‐type	 and	 G1	 and	 G3	 enzymes	 (Figure	 4‐4C	 and	 D).	 However,	 the	 higher	
melting	temperatures	of	the	thermostable	variants	without	co‐solvents	resulted	
in	 higher	Tm,app	 values	 in	 the	 presence	 of	 co‐solvent,	 even	 though	 the	melting	
temperatures	 were	 lower	 for	 both	 the	 wild‐type	 and	 mutant	 enzymes	 in	 the	
presence	 of	 co‐solvent	 (Figure	 4‐4C	 and	 D).	 When	 the	 addition	 of	 co‐solvent	
resulted	 in	melting	 temperatures	 close	 to	 ambient	 temperature,	 LinB	unfolded	










with	organic	 co‐solvent.	A)	Effect	of	 the	 incubation	 time	on	 the	activity	 for	 the	
dehalogenation	 of	 1‐bromopropane	 in	 the	 presence	 of	 50%	 DMSO.	 The	 initial	
activity	without	co‐solvent	was	set	 to	100%.	B)	As	above	with	25%	co‐solvent	
1,4‐dioxane.	 C)	 Observed	 Tm,app	 of	 the	 different	 variants	 in	 the	 presence	 of	
different	amounts	of	DMSO.	D)	As	above	with	1,4‐dioxane.	
Kinetic	resolution	
In	order	 to	 investigate	whether	 the	FRESCO	method	could	 improve	 the	solvent	
tolerance	of	LinB	while	retaining	enantioselectivity,	variant	G1	was	used	for	the	
kinetic	resolution	of	tert‐butyl‐2‐(2‐bromopropanamido)‐acetate	in	the	presence	
of	 co‐solvent.	 LinB	 is	 highly	 enantioselective	 in	 this	 conversion,	 but	 the	
compound	is	soluble	in	water	up	to	only	1500	μM[14c].	Variant	G1	was	used	as	it	







Figure	 4‐5.	 Conversion	 of	 180	 μM	 β‐HCH	 by	 wild‐type	 LinB	 (black	 line)	 and	
variant	G1	(dashed	line)	at	45°C	in	the	presence	of	25%	DMSO	(co‐solvent).	A)	β‐
HCH	 concentration	 against	 time.	 B)	 Concentration	 of	 the	 product	
pentachlorocyclohexanol	against	time,	as	determined	by	relative	GC	peak	areas.	
Table 4-5. Kinetic resolution of t-butyl-2-(2-bromopropanamido)-acetate by LinB wild-type 
and G1 in the presence of 10% THF at 30°C. 























0 0 < 1 0 0 0 
5 2 < 1 < 3 -[a] 12 < 1 < 3 -[a] 
24 0.3 < 1 < 3 -[a] 56 89 39 30 
48 0.2 < 1 < 3 -[a] 80 84 49 28 
72 0.6 < 1 < 3 -[a] 91 81 53 29 
 
A cannot be calculated due to the low conversion. 
	
To	 allow	 higher	 substrate	 concentrations,	 the	 kinetic	 resolution	 was	
examined	in	a	buffer	containing	10%	(v/v)	THF	at	30°C.	Under	these	conditions,	
a	three‐fold	higher	substrate	concentration	of	could	be	tested	(5	mM,	Table	4‐5);	
THF	 can	 easily	 be	 removed	 from	 the	 reaction	 mixture	 after	 extraction	 of	 the	
substrates	 and	 products.	 Chiral	 HPLC	 showed	 that	 mutant	 G1	 was	 active	 for	
more	than	72h	and	gave	a	substrate	conversion	of	53%	under	these	conditions,	
whereas	 the	 wild‐type	 enzyme	 was	 inactivated	 within	 5h	 and	 its	 substrate	
conversion	 was	 less	 than	 3%	 (Table	 4‐5).	 The	 enzyme	 remained	 moderately	
enantioselective	 in	 this	 reaction	 (E	 value	 28‐30;	 67	 for	 wild	 type	 without	 co‐
solvent)[14c].	 This	 demonstrates	 that	 it	 was	 possible	 to	 enhance	 the	 solvent	
tolerance	 of	 the	 enzyme	 while	 retaining	 most	 of	 the	 catalytic	 properties.	









We	 describe	 here	 the	 use	 of	 a	 rapid	 computational	 design	 protocol	 for	 the	
stabilization	 of	 the	 LinB	 haloalkane	 dehalogenase.	 Most	 of	 the	 laboratory	
construction	 of	 libraries	 and	 thermostability	 screening	 (typical	 for	 directed‐
evolution	projects)	were	replaced	by	 in	silico	methods.	Only	150	mutants	were	
experimentally	 tested:	 18	 stabilizing	 mutations	 were	 found,	 as	 well	 as	 a	




FRESCO	 protocol[8f]	 provides	 an	 attractive	 route	 for	 rapid	 and	 cost‐effective	
protein	stabilization.	Thermostabilization	methods	that	rely	on	the	experimental	
evaluation	 of	 large	 libraries	 of	 mutations	 usually	 require	 the	 screening	 of	
thousands	of	variants,	as	most	random	mutations	are	neutral	or	detrimental	to	
stability[2c],	even	when	more	 advanced	methods	 such	 as	 B‐fitter[34]	 are	 used	 to	
identify	target	positions	for	mutagenesis.	The	FRESCO	method,	as	demonstrated	
here	 for	 the	 stabilization	 of	 LinB	 and	 previously	 for	 limonene	 epoxide	
hydrolase[8f],	 aims	 to	eliminate	mutations	 that	do	not	 contribute	 to	 the	desired	
phenotype,	by	in	silico	methods	instead	of	laboratory	testing.	
The	increase	in	thermostability	of	the	best	LinB	variant	that	carries	three	
point	 mutations	 and	 a	 disulfide	 bond	 was	 accompanied	 by	 an	 increase	 in	 co‐
solvent	 tolerance.	 Similar	 correlations	 between	 thermostability	 and	 solvent	
tolerance	were	observed	for	haloalkane	dehalogenase[21],	an	aminopeptidase[33a],	
an	aldolase[33b],	an	ene‐reductase[33c]	and	an	esterase[6c]	and	other	enzymes[33d‐g]	





enzymes	 by	 breaking	 hydrogen	 bonds	 and	 by	 removing	 or	 replacing	 essential	
water	 molecules	 in	 the	 solvent	 shell	 surrounding	 the	 protein[33d,	 35].	 Apolar	
solvents,	 such	 as	 THF,	 can	 disrupt	 hydrophobic	 interactions	 in	 the	 protein	
interior;	 these	 are	 important	 for	 protein	 folding.	There	 are	 several	 biophysical	






of	 stabilizing	 interactions	 in	 flexible	 parts.	 The	 observed	 relationship	 between	
folding	energy,	thermostability,	and	solvent	tolerance	can	be	used	to	improve	the	
co‐solvent	 compatibility	 of	 enzymes	 more	 easily,	 as	 demonstrated	 here.	 The	
ability	 to	 improve	enzyme	stability	 in	 the	presence	of	hydrophobic	 co‐solvents	
(e.g.,	THF)	can	provide	great	benefits	for	downstream	processing	in	biocatalytic	
conversion,	such	as	facile	product	separation	and	recovery.	Furthermore,	solvent	
tolerance	 is	 often	 required	 for	 the	 use	 of	 hydrolytic	 enzymes	 in	 synthetic	
reactions[36],	and	contributes	to	applicability	in	pharmaceutical	synthesis[37]	and	
polymer	modification[38].	
Although	 the	 computational	 methods	 used	 in	 this	 work	 identified	
eighteen	 mutations	 that	 enhanced	 stability,	 a	 significant	 number	 of	 the	
mutations	 that	 were	 predicted	 to	 enhance	 stability	 appeared	 to	 lower	 LinB	
thermostability	 when	 tested	 experimentally.	 Incorrect	 predictions	 frequently	
involved	 the	 introduction	 of	 surface‐exposed	 hydrophobic	 residues.	 These	
mutations	 can	 be	 discarded	 by	 visual	 inspection	 because	 they	 lack	 sufficient	
interaction	with	other	hydrophobic	groups.	The	energy	calculations	of	FoldX	and	
Rosetta	favor	introduction	of	such	residues;	this	is	(partially)	in	agreement	with	
observations	 for	 small	 model	 proteins,	 where	 such	 mutations	 can	 be	
stabilizing[10,	11b].	 However,	 the	 introduction	 of	 hydrophobic	 side	 chains	 at	 the	
protein	 surface	 can	be	disadvantageous	 for	 the	Tm,app	 of	 larger	proteins,	which	
more	easily	aggregate[22].	A	recent	study	by	Jacak	et	al.	showed	that	adaptations	
to	 the	Rosetta	energy	 function	can	prevent	 the	 formation	of	 these	hydrophobic	
patches	 on	 the	 protein	 surface;	 these	 can	 be	 applied	 in	 future	 computational	
enzyme	stabilization[22].	
Partial	 unfolding	 of	 flexible	 areas	 of	 a	 protein	 can	 cause	 irreversible	
inactivation	by	aggregation[13].	Mutations	that	improve	the	stability	of	such	areas	
might	contribute	 to	enhancing	overall	protein	stability	more	 than	substitutions	
in	 less‐flexible	 regions[7b,	 27,	 31].	 The	 highly	 flexible	 regions	 that	 can	 serve	 as	
targets	 for	 stabilization	 can	 be	 detected	 by	 their	 high	 B‐factors	 in	 crystal	
structures[39]	 or	 by	 a	 high	 RMSF	 during	 MD	 simulations[40].	 During	 the	
engineering	of	LinB,	two	strongly	stabilizing	point	mutations	(ΔTm,app>4°C)	were	
discovered	 at	 residue	 147,	which	 is	 in	 a	 flexible	 helix	 (residues	 138‐150)	 that	
covers	 the	 active	 site	 (Table	 4‐1,	 Figure	 4‐1).	 Cα	 atoms	 in	 the	 loop	 between	
residues	138‐150	are	predicted	to	be	relatively	flexible,	as	was	evident	from	the	
fivefold	higher	B‐factors	(compared	to	the	average)	and	a	1.5‐fold	higher	RMSF	







bond	 incorporated	 near	 the	 flexible	N	 terminus	 of	 the	 protein.	 Therefore,	 it	 is	
likely	that	the	most	effective	mutations	enhance	overall	stability	by	reducing	the	
unfolding	 of	 the	 weakest	 parts	 of	 the	 protein	 and	 thereby	 reduce	 protein	
inactivation	rates	(Figure	4‐3C).	
By	 identifying	 flexible	regions	where	mutations	affect	 stability,	 the	sizes	
of	 libraries	 targeting	 enhanced	 stability	 can	 be	 significantly	 decreased[6b].	
However,	 simply	 introducing	 the	mutations	 at	 highly	 flexible	 residues	 (the	 B‐
fitter	 approach)	 might	 not	 always	 be	 the	 best	 option.	 For	 the	 stabilization	 of	
limonene	epoxide	hydrolase	by	FRESCO,	the	most	effective	point	mutations	were	
near	flexible	areas	rather	than	in	the	flexible	regions	themselves[8f].	 In	LinB	the	
mutations	 with	 the	 largest	 stabilizing	 effects	 were	 in	 flexible	 regions,	 but	 the	
majority	 of	 the	 moderately	 stabilizing	 mutations	 were	 not	 (Figure	 4‐1B);	 one	
highly	stabilizing	mutation	was	not	in	a	flexible	area	but	had	interactions	with	it.	
These	 mutations	 would	 have	 been	 missed	 if	 only	 highly	 flexible	 residues	 had	
been	targeted	for	mutagenesis.	
In	many	enzymes,	 the	active	 site	 is	one	of	 the	most	 flexible	parts	of	 the	
protein,	and	 introducing	stabilizing	mutations	 into	 this	region	bears	 the	risk	of	
reducing	 enzymatic	 activity,	 as	 has	 been	 observed	 in	 studies	 on	 lysozyme[41],	
barnase[42],	 ribonuclease[43],	 beta‐lactamase[44],	 protease[45],	 enolase[46]	 and	
citrate	 synthase[47].	 However,	 other	 studies	 have	 shown	 that	 stabilizing	
mutations	 near	 the	 active	 site	 do	 not	 necessarily	 affect	 catalytic	 activity.	
Mutations	 at	 the	 entrance	 of	 the	 tunnel	 to	 the	 active	 site	 of	 haloalkane	
dehalogenase	 from	Rhodococcus	rhodochrous	 stabilized	 the	enzyme	but	did	not	
decrease	catalytic	activity;[21]	similarly,	the	activity	and	stability	of	a	lipase	were	
improved	concurrently[48].	The	LinB	active	site	 is	buried	in	the	protein	and	can	
only	 be	 accessed	 after	 movements	 of	 the	 loops	 covering	 it[49].	 Therefore,	
flexibility	 of	 these	 loops	 is	 important	 for	 substrate	 entrance	 or	 product	
release[49b,	50].	We	 indeed	observed	a	 significant	reduction	 in	enzymatic	activity	
of	 LinB	 by	most	 stabilizing	mutations	 introduced	 close	 to	 the	 active	 site.	 Four	
stabilizing	 mutations	 introduced	 at	 position	 D147	 (Table	 4‐1,	 Figure	 4‐2C)	
caused	 a	 reduction	 in	 activity,	 likely	 due	 to	 stronger	 interactions	 between	 a	
flexible	 helix	 (residues	 145‐155)	 and	 a	 loop	 and	 helix	 covering	 the	 active	 site	
(residues	166‐178	and	244‐250);	 these	 increased	stability	but	 reduced	activity	
with	1‐bromopropane	(Table	4‐1).	






mutant	 enzyme.	 For	 variant	 G1	 (no	 mutations	 near	 the	 active	 site),	 the	




enzyme,	whereas	 the	 other	 eight	 substrates	were	 converted	 only	 two	 to	 three	
times	more	slowly	(or	at	a	similar	rate;	Table	4‐4).	
In	 conclusion,	 the	 work	 reported	 here	 demonstrates	 that	 the	
thermostability	 and	 solvent	 tolerance	 of	 haloalkane	 dehalogenase	 can	 be	
simultaneously	 increased	 by	 using	 the	 FRESCO	 method	 for	 computational	
enzyme	 stabilization.	 Mutations	 introduced	 close	 to	 the	 active	 site	 were	 most	
stabilizing,	 but	 these	 should	 be	 chosen	 with	 care	 because	 they	 have	 a	 high	
probability	of	resulting	 in	a	 loss	of	activity	by	 influencing	functional	movement	
around	the	active	site.	By	introducing	mutations	only	at	more	distant	positions,	it	
was	 possible	 to	 engineer	 a	 variant	 that	 displayed	 both	 improved	 stability	 and	
fully	preserved	catalytic	activity	for	all	tested	substrates.	The	increase	in	stability	







FoldX[10],	 with	 the	 crystal	 structure	 of	 wild‐type	 LinB[49a]	 as	 the	 template.	 The	 free	 energy	







in	 one	 of	 the	 following	 types	 of	 unfavorable	 interactions	 were	 excluded:	 1)	 steric	 clashes,	 2)	
internal	cavities,	3)	solvent‐exposed	aromatic	residues,	4)	solvent‐exposed	methionines[51],	5)	a	
hydrogen	 bond	 donor	 or	 acceptor	 that	 has	 fewer	 hydrogen	 bonding	 interactions	 than	 in	wild	
type,	6)	a	 large	hydrophobic	patch	on	the	protein	surface,	7)	uncompensated	removal	of	a	salt	
bridge,	 and	 8)	 destabilization	 of	 an	 α‐helix	 by	 removal	 of	 α‐helix	 capping[52].	 In	 the	 field	 of	
computational	 design,	 visual	 inspection	 to	 eliminate	 designed	 variants	 with	 such	 defects	 is	 a	
standard	step	and	is	required	because	of	 insufficient	conformational	sampling	and	inaccuracies	
in	 the	 energy	 functions[53].	 Mutations	 were	 treated	 in	 two	 categories	 for	 stability/activity	




bromopropanamido)acetate),	 and	 those	 outside	 this	 area.	 To	 determine	 these	 distances,	 the	
substrate	was	modeled	in	the	active	site	by	using	AutoDock	4[54].	
Positions	 suitable	 for	 the	 introduction	 of	 disulfide‐bond	 forming	 cysteines	 were	
predicted	 by	 the	 Dynamic	 Disulfide	 Discovery	 (DDD)	 algorithm[8f],	 for	 both	 the	 wild‐type	
structure	and	snapshots	of	MD	simulations	for	conformational	sampling.	Prediction	of	disulfide	




for	 equilibration,	 and	after	 entering	 the	production	phase,	 snapshots	were	 taken	every	250	ps	
between	500	and	2500	ps,	thus	yielding	45	snapshots	in	total.	From	this	ensemble	of	structures	
as	a	 template,	 the	DDD	algorithm	predicts	disulfide	bonds	based	on	geometric	constraints	 that	
are	 derived	 from	 the	 angles,	 dihedrals,	 and	 bond	 lengths	 of	 disulfide	 bonds	 in	 high‐resolution	





MD	 simulations	 were	 performed	 for	 each	 mutant.	 Each	 simulation	 started	 with	 a	 different	
random	 set	 of	 initial	 atom	velocities,	 assigned	 according	 to	 a	Maxwell‐Boltzmann	 distribution.	
The	temperature	was	increased	from	5	to	298	K	over	30	ps,	followed	by	equilibration	(20	ps)	and	
production	 (50	 ps).	 Snapshots	 were	 taken	 every	 5	 ps.	 For	 each	 variant,	 five	 independent	MD	





were	 selected	 for	 experimental	 verification	 if	 they	 did	 not	 exhibit	 clearly	 unfavorable	
interactions	during	MD	simulation.	
Construction	 of	 mutants:	 A	 pBAD	 plasmid	 containing	 the	 linB	 gene	 from	 Sphingomonas	
paucimobilis	UT26	(UniProt	accession	number	P51698)	attached	to	an	N‐terminal	hexahistidine	
sequence	 was	 used	 throughout	 this	 study[14c].	 Mutations	 to	 the	 linB	 gene	 were	 introduced	 by	
QuikChange	mutagenesis	 (Agilent	Technologies)	with	 the	PfuUltra	Hotstart	 PCR	Master	Mix	 as	
recommended	by	the	manufacturer.	QuikChange	PCR	products	were	transformed	into	chemically	
competent	E.	coli	TOP10	(Life	Technologies).	 Incorporation	of	 the	mutations	was	confirmed	by	
DNA	 sequencing.	 Successive	 rounds	 of	 mutagenesis	 were	 performed	 to	 construct	 variants	
containing	multiple	mutations.	As	E.	coli	often	has	difficulty	with	cytosolic	production	of	proteins	
containing	 disulfide	 bonds,	 the	 production	 of	 variants	 containing	 these	 bonds	 was	 also	
performed	in	E.	coli	SHuffle	(New	England	Biolabs).	This	strain	is	optimized	for	the	production	of	
cytosolic	proteins	containing	disulfide	bonds[29].	
Protein	 expression:	 Small‐scale	 production	 (1.2	 mL)	 of	 LinB	 was	 performed	 in	 deep‐well	
microtiter	 plates	 (MTPs).	 Large‐scale	 protein	 expression	 (1	 L)	was	performed	 in	 terrific	 broth	
(TB:	yeast	extract	(24	g	L‐1),	tryptone	(12	g	L‐1),	glycerol	(4	mL	L‐1),	KH2PO4	(17	mM),	K2HPO4	(72	
mM),	 pH	 7.0).	 The	medium	was	 inoculated	with	 1%	of	 an	 overnight	 culture	 and	 subsequently	









Small	 scale	 protein	 purification:	 Cells	 from	 a	 1.2	 mL	 culture	 were	 lysed	 by	 addition	 of	
FastBreak	 cell	 lysis	 reagent	 (50	 μL,	 Promega)	 followed	by	 incubation	 for	 15	min	 at	 30°C	with	
shaking	at	200	rpm.	To	prepare	cell‐free	extract,	the	lysate	was	centrifuged	(2000g,	45	min,	4°C)	
and	the	supernatant	was	transferred	to	a	clean	MTP	and	used	for	protein	purification.	To	purify	
proteins	 on	 a	 small	 scale,	 the	 MagneHis	 protein	 purification	 system	 (Promega)	 was	 used	
















Enzyme	 assays:	 Catalytic	 activity	 by	 LinB	 variants	 was	 quantified	 by	 dehalogenation	 of	 the	
model	substrate	1‐bromopropane.	Protein	sample	(20	μL,	0.2	mg	mL‐1	in	protein	storage	buffer)	
was	mixed	with	1‐bromopropane	 (285	μL,	30	mM	 in	Tris	SO4	 (50	mM,	pH	8.2))	 in	a	microtiter	
plate.	The	mixture	was	incubated	at	30°C.	Samples	(40	μL)	were	removed	at	regular	intervals	and	
mixed	with	 halide	 quantification	 reagent	 (160	 μL;	 NH4Fe(SO4)2	 (16	 μL,	 0.25	 M	 in	 HNO3	 (9M)),	
saturated	Hg(SCN)2	(16	μL	in	ethanol),	and	deionized	water	(128	μL)).	This	reagent	quenches	the	
dehalogenation	 reaction	 and	 allows	 quantitative	 determination	 of	 halide	 concentration[57].	 The	
samples	were	 incubated	 for	 5	min	 at	 20°C,	 and	 absorbance	 at	 460	nm	was	measured	with	 an	
Synergy	Mx	plate	reader	(BioTek,	Winooski,	VT).	A	calibration	curve	was	made	with	NaBr,	and	
the	 free	 bromide	 concentration	 was	 calculated.	 Where	 necessary,	 a	 calibration	 curve	 of	 free	
bromide	in	the	presence	of	co‐solvent	was	constructed	to	correct	for	the	effect	of	co‐solvent	on	
the	halide	assay.	A	 linear	fit	of	this	data	was	used	to	obtain	the	initial	rate.	Specific	activities	at	
different	 substrate	 concentrations	 were	 determined	 and	 fitted	 with	 the	 Michaelis‐Menten	
equation	to	obtain	kinetics	parameters.	Specific	activities	at	higher	temperatures	were	measured	
by	incubating	the	protein	sample	for	5	min	at	the	specified	temperature	and	measuring	specific	
activity	 at	 this	 temperature.	A	 unit	 of	 catalytic	 activity	 (U)	was	defined	 as	 the	 conversion	of	 1	
μmol	of	substrate	in	one	minute.	










1).	 For	 protein	 samples	 below	 1.0	 mL,	 concentration	 was	 determined	 with	 a	 NanoDrop	 1000	
spectrophotometer	(Thermo	Scientific).	
Dehalogenation	of	β‐HCH:	β‐HCH	(2.88	mg;	Sigma‐Aldrich)	was	dissolved	in	DMSO	(15	mL)	to	
obtain	 a	 660	μM	 solution.	An	 aliquot	 (3.75	mL)	 of	 this	was	mixed	 in	 a	 15	mL	Pyrex	 tube	with	
buffer	(11.3	mL,	potassium	phosphate	(50	mM,	pH	7.5)	with	glycerol	(10%))	and	LinB	(6.4	mg,	
190	nmol;	wild	type	or	variant	G1).	The	tube	was	incubated	at	45°C	with	shaking	at	200	rpm,	and	
samples	 (1	 mL)	 were	 removed	 at	 regular	 intervals.	 β‐HCH,	 pentachlorocyclohexanol,	 and	




β‐HCH	 (retention	 time	 (tR)	 10.7	min)	 and	 products	 (tetrachlorocyclohexanediol	 (tR=11.6	min)	
and	pentachlorocyclohexanol	 (tR=11.8	min))	were	measured.	To	quantify	substrate	conversion,	
the	 peak	 area	 of	 β‐HCH	was	 divided	 by	 the	 peak	 area	 of	 the	 internal	 standard.	 This	 response	
value	was	converted	to	absolute	concentration	by	using	a	calibration	curve.	
Kinetic	resolution:	The	substrate	tert‐butyl‐2‐(2‐bromopropanamido)‐acetate	was	synthesized	
as	 reported	 by	 Westerbeek	 et	 al.[14c]	 To	 follow	 its	 kinetic	 resolution,	 tert‐butyl‐2‐(2‐
bromopropanamido)‐acetate	(50	mM	in	THF)	was	diluted	(1:10)	in	Tris‐SO4	(50	mM,	pH	8.2)	to	
obtain	 a	 5	mM	 solution	 in	 a	 buffer/co‐solvent	mixture.	An	 aliquot	 (15	mL)	was	 incubated	 in	 a	
Pyrex	tube	in	a	water	bath	at	30°C	with	wild‐type	LinB	or	LinB‐G1	(0.5	mg	mL‐1).	Samples	(1	mL)	







Determination	 of	 apparent	 melting	 temperatures:	 The	 thermofluor	 assay	 was	 used	 to	
determine	Tm,app[24].	Sypro	Orange	(	μL,	100‐fold	diluted;	Life	Technologies)	was	added	to	purified	
enzyme	(20	μL,	0.2‐1.5	mg	mL‐1).	This	sample	was	transferred	to	a	iQ	PCR	96‐well	plate	(Bio‐rad,	
Hercules,	CA)	and	 sealed	with	 iQ	96‐well	PCR	Plate	 seal	 (Bio‐rad).	Fluorescence	 (RFU;	λex=490	
nm,	λem=575	nm)	was	monitored	while	the	sample	was	heated	from	20	to	99°C	(1.1°C	min‐1)	in	a	
CFX96	Q‐PCR	 device	 (Bio‐rad).	Tm,app	was	 defined	 as	 the	maximum	of	 dRFU/dT.	 To	 determine	
Tm,app	after	reduction	of	disulfide	bonds,	dithiothreitol	(DTT,	10	mM)	was	added,	and	the	mixture	
was	incubated	for	15	min	at	20°C	before	measurement.	
Differential	 scanning	 calorimetry:	 Apparent	 melting	 temperatures	 were	 measured	 by	 DSC.	
Protein	samples	were	dialyzed	for	16	h	against	Na‐HEPES	(50	mM,	pH	7.5)	to	remove	salts.	The	
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Framework	 for	 Rapid	 Enzyme	 Stabilization	 by	 Computation)	 is	 emerging	 as	 a	
powerful	 way	 of	 obtaining	 highly	 thermostable	 enzymes.	 Nevertheless,	
mutations	predicted	to	be	stabilizing	do	not	always	appear	effective	when	tested	
in	 the	 laboratory.	 To	 examine	 the	 accuracy	 of	 mutant	 structure	 predictions	
underlying	the	computational	methods,	crystal	structures	of	FRESCO‐generated	
thermostable	 limonene	 epoxide	 hydrolase	 variants	 were	 determined.  Three	
different	 effects	 accounted	 for	 the	 obtained	 stabilization:  (i)	 enhanced	
interactions	between	a	 flexible	 loop	close	to	the	N‐terminus	and	the	rest	of	the	
protein;	 (ii)	 improved	 interactions	 at	 the	 dimer	 interface;	 and	 (iii)	 removal	 of	
unsatisfied	 hydrogen	 bonding	 groups.	 The	 structures	 of	 an	 eightfold	 and	 a	
elevenfold	mutant	showed	that	most	mutations	indeed	introduced	the	intended	
stabilizing	 interactions	 and	 side‐chain	 conformations	were	 correctly	 predicted	
for	72%	of	the	point	mutations.	However,	mutations	that	introduced	a	disulfide	
bond	 in	 a	 flexible	 region	had	 a	 larger	 influence	on	 the	backbone	 conformation	
than	 predicted	 by	 the	 algorithms.	 The	 enzyme	 active	 sites	 were	 unaltered,	 in	
agreement	with	the	observed	preservation	of	catalytic	activities.	The	structures	
also	 revealed	 how	 a	 c‐Myc	 tag,	 which	 was	 introduced	 for	 facile	 detection	 and	
purification,	can	reduce	access	to	the	active	site	and	thereby	lower	the	catalytic	
activity.	 Finally,	 sequence	 analysis	 showed	 that	 the	 computational	 methods	













of	 the	 reduced	 catalyst	 inactivation,	 the	 increased	 solubility	 of	 substrates	 and	
products	 and	 the	 higher	 reaction	 rates	 that	 can	 be	 achieved	 at	 elevated	
temperatures	 or	 in	 the	 presence	 of	 cosolvents.	 We	 have	 recently	 explored	 a	
strategy	 termed	 FRESCO,	which	 uses	 computational	 library	 design,	 for	 rapidly	
increasing	 the	 thermostability	 of	 enzymes.	 It	 was	 applied	 to	 obtain	 highly	
thermostable	 multi‐site	 mutants	 of	 limonene	 epoxide	 hydrolase	 (LEH)[1]	 from	
Rhodococcus	 erythropolis	 DCL14[2],	 and	 to	 obtain	 thermostable	 and	 solvent‐
resistant	 mutants	 of	 a	 haloalkane	 dehalogenase[3].	 LEH	 catalyzes	 the	
enantioconvergent	 production	 of	 (1S,2S,4R)‐limonene‐1,2‐diol[2a,	 4]	 from	 (4R)‐
limonene‐1,2‐epoxide.	 Furthermore,	 the	 enzyme	 has	 been	 engineered	 for	 the	
enantioselective	 production	 of	 both	 enantiomers	 of	 several	 other	 industrially	






disulfide	 bonds	 resulted	 in	 a	 hyper‐stabilized	 variant,	 of	 which	 the	 apparent	
melting	temperature	was	increased	by	32°C[1].		
There	 is	a	need	 to	 further	 improve	 the	FRESCO	strategy	since	only	one‐





more	 than	 1	 Å)	 or	 unaccounted	 secondary	 effects	 such	 as	 the	 formation	 of	
cavities	 or	 disruption	 of	 salt‐bridges,	 will	 result	 in	 errors	 in	 the	 selection	 of	
mutations	 for	 inclusion	 in	 the	 library.	 In	 FRESCO,	 a	 structure	 is	 first	 predicted	
(stage‐1)	 by	 molecular	 mechanics	 based	 methods	 to	 discover	 stabilizing	
substitutions,	 using	 FoldX[7]	 or	 Rosetta[6]	 for	 point	 mutants	 and	 Dynamic	
Disulfide	 Discovery	 for	 disulfide	 bonds[1].	 After	 screening	 for	 chemical	
reasonability,	MD	simulations	are	performed	with	the	initial	model	structures	to	
increase	 reliability	 of	 the	 predicted	 structures	 and	 the	 resulting	 averaged	MD	
structures	 (stage‐2	 predictions)	 serve	 to	 examine	 protein	 flexibility	 and	 to	






structures	 of	 multi‐site	mutants	 are	 constructed	 and	 simulated	 to	 analyze	 the	
possibility	of	combining	mutations	(stage‐3	structure	predictions).		
The	 elucidation	 of	 crystal	 structures	 of	 enzyme	 variants	 obtained	 by	
computational	methods	 can	 reveal	 possible	 flaws	 in	 structure	 predictions	 and	
may	help	 to	 improve	 the	design	protocols.	 Furthermore,	 crystal	 structures	 can	
confirm	the	validity	of	computation‐based	prediction	of	mutants	sequences	and	
also	reveal	unintended	structural	changes	that	affect	protein	stability[8].	Previous	
studies	 with	 computationally	 designed	 enzymes	 have	 shown	 that	 unforeseen	
effects	 indeed	can	occur[9].	For	example,	a	catalytic	 lysine	residue	of	a	designed	
Kemp‐eliminase	 made	 unintended	 hydrogen	 bonds	 in	 the	 active	 site	 that	
reduced	 catalytic	 activity[8a].	 Furthermore,	 the	 active	 site	 of	 a	 retro‐aldolase	
became	 more	 flexible	 after	 computational	 design,	 resulting	 in	 low	 catalytic	
activity[8b].	 In	another	study,	 the	crystal	structure	of	a	redesigned	mononuclear	
zinc	metalloenzyme	revealed	that	although	most	of	the	elucidated	structure	was	
similar	 to	 the	 designed	 structure,	 two	 loops	 surrounding	 the	 active	 site	 were	
displaced	by	2	Å.	One	of	these	loops	also	became	more	flexible,	which	resulted	in	
a	 lower	 enzymatic	 activity[8c].	 Finally,	 the	 crystal	 structure	 of	 a	 redesigned	
arabinose	 binding	 protein	 was	 very	 similar	 to	 the	 designed	 structure,	 even	
though	 the	protein	was	unable	 to	bind	 the	 target	 ligand.[8d]	This	demonstrated	
that	 the	 computationally	 designed	 substrate‐ligand	 interactions	 were	 not	
correct.	 In	 conclusion,	 computationally	 redesigned	 variants	 may	 harbor	
conformational	changes	not	predicted	by	the	design	approach.	
To	examine	the	accuracy	of	the	structure	predictions	used	in	the	FRESCO	
approach,	 we	 elucidated	 and	 analyzed	 the	 crystal	 structures	 of	 two	 highly	
thermostable	 variants	 of	 LEH[1].	 Furthermore,	 a	 comparison	 of	 structures	with	
(LEH‐F1b,	 eleven	 mutations)	 and	 without	 two	 disulfide	 bonds	 (LEH‐P,	 seven	
mutations)	was	used	 to	 analyze	 effects	 on	 local	 and	global	 protein	 folding.	We	
demonstrate	 that	 the	 conformations	 generated	 by	 MD	 simulations	 accurately	
mimicked	 the	 crystal	 structures	 of	 regions	 in	 the	 enzyme	 carrying	 stabilizing	
point	 mutations.	 Furthermore,	 the	 structures	 reveal	 that	 several	 stabilizing	
mutations	either	enhance	interactions	at	the	dimer	interface	or	between	the	core	
of	the	protein	and	a	flexible	loop	near	the	N‐terminus.	Mutations	predicted	by	B‐










structure	 predictions	 obtained	 and	 used	 by	 the	 FRESCO	 approach[1],	 3D	
structures	 of	 the	 two	 highly	 thermostable	 LEH	 variants,	 LEH‐P	 and	 LEH‐F1b,	
were	 determined	 by	 X‐ray	 crystallography.	 Variant	 LEH‐P	 carries	 eight	 point	
mutations	(S15P,	A19K,	E45K,	T76K,	T85V,	N92K,	Y96F,	E124D),	which	together	





S91C’),	which	when	combined	with	 seven	substitutions	of	LEH‐P	 increased	 the	
apparent	melting	 temperature	 by	 32°C	 to	 82°C[1].	 This	 variant	 lacks	 the	 E45K	
mutation,	 since	 omitting	 it	 resulted	 in	 higher	 protein	 production	 by	 E.	 coli	
without	influencing	LEH	stability.	
	
Figure	 5‐1.	 Positions	 of	 the	 twelve	 stabilizing	 mutations	 as	 revealed	 by	 the	
crystal	 structure	 of	 the	 LEH‐F1b	 and	 P	 dimers.	Mutations	 introducing	 surface‐
located	 positively	 charged	 residues	 are	 indicated	 in	 blue,	 surface‐located	
negative	 charges	 are	 shown	 in	 red,	 and	 buried	 hydrophobic	 residues	 in	 black.	
Proline	residues	in	loops	are	in	purple	and	disulfide	bonds	in	yellow.	Mutations	
are	indicated	once	per	dimer.	
The	 mutant	 enzymes	 crystallized	 in	 space	 group	 P32	 21	 with	 three	
molecules	per	asymmetric	unit,	which	is	different	from	that	of	wild‐type	enzyme	
(P212121	 with	 two	 molecules	 per	 asymmetric	 unit)[2b].	 Gel	 filtration	
chromatography	 indicated	 that	 wild‐type	 enzyme	 as	 well	 as	 the	 P	 and	 F1b	






superimposed	with	 low	RMSDs	on	 the	A/B	dimer	and	on	 the	dimer	 formed	by	
chain	C	and	a	symmetry‐related	chain	C	(C’),	we	conclude	that	the	A/B	and	C/C’	
dimers	are	representative	of	 the	dimer	 in	 solution.	A	PISA	analysis[12]	 revealed	




structures	 revealed	 that	 the	 backbone	 conformations	 are	 very	 similar,	 with	
RMSDs	of	0.4‐0.6	Å.	Differences	in	Cα	atom	positions	larger	than	1.0	Å	were	only	
observed	 for	 three	 small	 regions,	 i.e.	 the	 first	 seven	 N‐terminal	 residues,	 a	
surface	 loop	 containing	 residues	 12‐18,	 and	 the	 C‐terminal	 helical	 c‐Myc‐tag	
(residues	 149‐161).	 These	 regions	 are	 intrinsically	 flexible	 (see	 below),	 and	
therefore	these	conformational	differences	are	not	considered	to	be	significant.	
Strong	conservation	of	backbone	conformation	was	also	observed	in	structures	
of	 other	 multi‐site	 mutants	 obtained	 by	 directed	 evolution,	 such	 as	 a	 27‐fold	
mutant	 of	 a	 halohydrin	 dehalogenase[13],	 a	 sevenfold	 mutant	 of	 simvastatin	
synthase[14],	 a	 sixfold	mutant	 of	 a	 6‐aminohexanoate‐dimer	 hydrolase[15]	 and	 a	
sixfold	mutant	of	a	 lipase[16].	 In	contrast,	a	 study	on	a	sevenfold	mutant	of	a	p‐




the	 electron	density	 compared	 to	 the	wild‐type	 structure	 (residues	149‐159	of	
chain	 B	 and	 149‐164	 of	 chain	 C,	 Figure	 5‐2).	 They	 originate	 from	 the	 human	
transcription	 factor	 c‐Myc[18]	and	were	 included	 to	aid	protein	purification	and	
detection	 using	 Western	 blotting[19].	 The	 helical	 c‐Myc	 tag	 of	 monomer	 B	
interacts	 with	 the	 symmetry‐related	 c‐Myc	 tag	 of	 monomer	 C.	 The	 tag	 in	
monomer	A	is	not	visible	in	the	electron	density,	probably	because	it	cannot	have	
these	 helix‐helix	 interactions	 and	 therefore	 is	 more	 flexible.	 The	 secondary	
structure	 of	 the	 tag	 as	 present	 in	monomers	 B	 and	 C	 is	 stabilized	 by	 van	 der	
Waals	interaction	between	residues	P153,	L157	and	interactions	with	the	carbon	
atoms	of	the	side	chains	of	K156,	K158,	E160.	The	average	difference	in	position	









Figure	 5‐2.	 Structures	 comparing	 the	 interaction	 between	 two	 c‐Myc	 tags	 of	
LEH‐P	(shown	in	red)	to	two	monomers	of	the	native	c‐Myc	protein	(in	orange,	
pdb	id	1A93).		
The	helical	conformation	of	 the	tag	observed	 in	 the	crystal	structures	of	
LEH	is	very	similar	to	its	conformation	in	the	human	c‐Myc	protein	from	which	
the	 tag	 is	 derived[20]	 (pdb	 id	 1A93,	 Figure	 5‐2).	 A	 search	 in	 the	 pdb	 revealed	
thirteen	 other	 crystal	 structures	 containing	 this	 tag.	 Only	 in	 one	 of	 these	
structures	 the	 tag	was	visible	 in	 the	electron	density,	but	with	a	very	different	
secondary	 structure	 consisting	 of	 a	 partial	 ‐strand	 followed	 by	 a	 small	 helix	
(pdb	id	2J6P)[21].	In	most	structures,	the	tag	seems	to	be	too	flexible	to	be	visible	
in	the	electron	density.	However,	in	the	crystal	structure	of	the	LEH‐P	mutant	the	
tag	 is	stabilized	by	several	 interactions	with	surrounding	residues,	reducing	 its	
flexibility.		
The	presence	 of	 the	 tag	might	 affect	 the	 activity	 of	 the	 enzyme,	 since	 it	
blocks	part	of	the	entrance	to	the	active	site	and	thereby	could	impede	substrate	
binding	or	product	release.	Indeed,	the	specific	activity	of	wild‐type	LEH	with	c‐
Myc	 tag	 is	 half	 that	 of	 the	 enzyme	without	 it	 (Table	 5‐1).	 The	 tag	 thus	 has	 an	
effect	 beyond	 what	 was	 intended,	 indicating	 that	 care	 has	 to	 be	 taken	 when	
introducing	 a	 tag	 since	 it	 may	 influence	 catalytic	 activity	 even	 if	 the	 point	 of	




from	 stage	 1	 to	 3	 were	 compared	 to	 the	 crystal	 structures.	 This	 includes	 a	







occurred	 beyond	 the	 substituted	 residues,	 with	 the	 exception	 of	 backbone	
changes	in	residues	flanking	position	K92,	adjacent	to	the	disulfide	bridge	C89‐
C91’,	 and	 next	 to	 residue	 5.	 For	 positions	 in	 the	 crystal	 structures	 an	 error	
margin	 of	 0.4	 Å	 was	 used,	 since	 this	 is	 twice	 the	 RMSD	 when	 comparing	 the	
different	monomers	of	LEH‐P	or	F1b.		
	
Table 5-1. Occurrence of mutations discovered by FRESCO in a multiple sequence alignment 
containing closely and distantly related sequences.   
  Close relatives (36 sequences)A Superfamily (6100 sequences) 
Mutation RankB Same mutation (%) 
Same category 
(%) Rank




S15P NCC NCC 
A19K NCC NCC 
E45K 7 2.6 2.6D 3 11.7  21.3D 
T76K 6 2.6 7.9D 7 9 5.1D 
T85V 3 23.7 60.5E 2 17 69.9E 
T85I 2 28.9 60.5E 1 36.8 69.9E 
T85L 4 7.9 60.5E 3 13 69.9E 
N92K - 0 0D 11 2.5 4.7D 
N92R - 0 0D 13 1 4.7D 
Y96F 2 23.7 52.6E 11 2.7 23.1E 
E124D 1 50 71.1F 5 8.6 18.5F 
 
A These sequences all belong to one protein family according to the 3DM classification system. 
BThe rank of the frequency of occurrence of the introduced residue among all 20 possible 
residues in homologous proteins. C Residue located in a non-conserved area of the protein.D 
Category defined as positively charged residues containing K or R.E Defined as hydrophobic 
residues containing F or V or I or L.F Defined as negatively charged residues mutations 
containing D or E. 
 
The	 comparison	 showed	 that	 the	 stage‐1	 structures	 generated	by	FoldX	
gave	a	correct	prediction	for	five	of	the	eight	cases	(Table	5‐2).	The	accuracy	of	
structure	 predictions	 in	 the	 Dynamic	 Disulfide	 Discovery	 protocol	was	 correct	
for	three	of	the	four	cysteines.	The	correctness	of	the	structures	produced	by	MD	
simulations	(stage‐2)	was	rather	similar	 to	stage‐1	predictions	(Table	5‐2).	For	




the	 conformations	 of	 eight	 out	 of	 eleven	 mutated	 residues	 in	 LEH‐P	 and	 F1b	
correctly,	 including	 the	 effects	 of	 the	 mutations	 A19K	 and	 E45K.	 The	 RMSDs	
between	the	stage‐3	structures	and	the	crystal	structures	were	0.7	and	0.5	Å	for	








eight	 point	 mutations	 and	 two	 disulfide	 bonds	 could	 be	 grouped	 into	 four	
different	 categories:	 i)	 mutations	 removing	 unsatisfied	 hydrogen	 bonds;	 ii)	
substitutions	 introducing	 surface‐located	 charged	 groups;	 iii)	 mutations	
introducing	 proline	 residues	 in	 loops;	 and	 iv)	 mutations	 introducing	 disulfide	
bonds.	 The	 structural	 changes	 associated	 with	 these	 mutations	 are	 discussed	
below.	
	
Table 5-2. Accuracy of the prediction of point mutations in different stages of design   
    Stage-1 (FoldX predictions) Stage-2 (single-site short MD) 






differenceB Correct rotamer predicted 
Cα differenceB Correct rotamer 
predicted 
Cα 
differenceB Correct rotamer 
predicted (Å) (Å) (Å) 
S15P 1 1.9/2.8 N/ND 1.3/1.0 N/ND 1.5/1.1 N/ND 
A19K 2.5 0.4/0.6 Y/N 0.6/0.4 N/N 0.2/0.1 Y/Y 
E45K 2 0.1/0.4 N/N 0.8/0.8 N/N 0.8/0.4 Y/Y 
T76K 1.5 0.1/0.2 Y/Y 0.7/0.3 Y/Y 0.5/0.5 Y/Y 
T85V 6.8 0.1/0.2 Y/Y 0.4/0.2 Y/Y 0.4/0.2 Y/Y 
N92K 7.3 2.4/3.0 N/N 4.2/3.3 N/N 2.9/2.8 N/N 
Y96F 2.8 0.3/0.4 Y/Y 0.3/0.4 Y/Y 0.5/0.4 Y/Y 
E124D 1.3 0.8/0.8 Y/Y 1.2/1.0 Y/Y 1.1/1.0 Y/Y 
I5CE 13.5 - - - - - - 
E84C 0.4/0.7 Y/Y 0.4/1.1 Y/Y 0.2/0.1 Y/Y 
G89C 15 0.3/0.5 Y/Y 0.2/0.3 Y/Y 0.1/0.2 Y/Y 
S91C 0.3/0.5 Y/Y 0.3/0.2 Y/Y 0.3/0.4 Y/Y 
 
A Difference in melting temperature between the single mutants and the wild-type[1]. B Difference in Cα position 
between predicted and observed structure, values given for chains A/B. CWhether the design predicted the same side-
chain orientation as observed in the crystal structure, Y(es) or N(o), values given for chains A/B. D Both rotamers of the 
proline are close in energy and therefore interchange easily in solution. E Too little density to analyze the geometry of 
the residue in more detail. 
	
Effects	of	unsatisfied	hydrogen	bonds	on	stability	–	Mutations	T85V	and	
Y96F	 lead	 to	 loss	 of	 a	 buried	 hydroxyl	 group.	 Normally,	 hydroxyl	 and	 amide	




hydrogen‐bonding	 interactions.	Without	 such	 interactions	 a	 hydrogen‐bonding	
group	 can	 destabilize	 a	 protein,	 the	 exact	 extent	 of	 which	 is	 under	 debate.	
Fleming	 and	 coworkers	 suggest	 5‐6	 kcal/mol[23]	 per	 unsatisfied	 hydrogen‐







the	 enzyme	 and	 have	 only	 one	 hydrogen‐bonding	 interaction	 each,	 to	 a	water	
molecule	 (Figure	 5‐3A).	 Their	 hydrogen‐bonding	 potential	 is	 thus	 not	 fully	
fulfilled.	 Indeed,	 replacing	 the	 hydroxyl	 by	 an	 apolar	 group	 by	 the	 mutations	




water	 molecule	 hydrogen‐bonded	 to	 the	 T85	 hydroxyl	 group	 in	 wild‐type	
enzyme,	is	released.	The	conformations	of	residue	96	in	wild‐type	and	LEH‐P	are	
also	 indistinguishable,	 and	 a	 similar	 release	 of	 a	 hydrogen‐bonded	 water	
molecule	has	occurred.	The	expulsion	of	a	bound	water	molecule	can	stabilize	an	
enzyme	 by	 roughly	 2	 kcal/mol[25]	 because	 it	 reduces	 the	 entropy	 difference	
between	the	folded	and	unfolded	state.	However,	this	release	may	also	have	been	
caused	by	the	N92K	mutation,	since	in	wild‐type	enzyme	both	the	Y96	and	N92	
side	 chains	 are	 hydrogen	 bonded	 to	 this	 water	 molecule.	 As	 a	 result	 of	 the	
release	 of	 the	water	molecule	 and/or	 the	N92K/Y96F	mutations	 the	‐turn	 of	
residues	 91‐93	 has	 shifted	 by	 up	 to	 ~2	 Å.	 This	 change	 in	 conformation	 is	
discussed	in	more	detail	below.	Taken	together,	our	results	show	that	removing	
hydroxyl	 groups	 with	 unsatisfied	 hydrogen‐bonding	 potential	 increased	 LEH	
stability.	 A	 comparison	 between	 the	 elucidated	 and	 predicted	 structures	 of	
mutant	 enzyme	 LEH‐P	 demonstrated	 that	 that	 the	 conformations	 of	 the	
introduced	residues	F96	and	V85	were,	within	error,	correctly	predicted	both	by	
FoldX	in	stage‐1	and	by	MD	simulations	performed	in	stages	2	and	3	(Table	5‐2).	
Modification	of	 surface‐located	 charged	groups	–	 The	 introduction	 of	
positively	charged	lysine	residues	on	the	surface	of	the	enzyme	(A19K,	E45K	and	
T76K,	 Figure	 5‐3B)	 increases	 the	 TM,app	 by	 1.5‐2.5°C	 for	 each	 of	 the	 mutants.	
Surprisingly,	the	introduced	lysines	are	not	involved	in	direct	hydrogen‐bonding	
or	salt‐bridge	interactions	with	protein	residues	(except	for	K92	in	monomer	B	
of	 the	elevenfold	mutant	LEH‐F1b).	The	decrease	of	 the	net	negative	 charge	of	
the	protein	or	a	change	 in	 long‐range	electrostatic	 interactions	could	 favorably	
affect	the	stability	of	the	enzyme	dimer.	Electrostatic	interactions	can	have	large	
effects	 on	 enzyme	 stability[26].	 Excess	 charges	 can	 destabilize	 a	 protein	 by	









site	 mutants	 yielded	 different	 side‐chain	 orientations	 of	 K19	 and	 K45	 that	
differed	 from	 the	 crystal	 structures.	 Possibly,	 the	 longer	 time	 for	 equilibration	





(black)	 structures	of	LEH‐P.	A)	The	 substitution	T85V	 (ΔTM=	6.8°C)	 removes	a	
hydroxyl	 group	with	 only	 one	 hydrogen	 bonding	 interaction.	B)	The	mutation	







LEH‐P	 mutant	 structure	 the	 lysine	 side	 chain	 points	 away	 from	 the	 dimer	
interface,	 probably	 because	 there	 is	 insufficient	 space	 in	 the	 dimer	 interface.	
Nevertheless,	 water‐mediated	 dimer	 contacts	 are	 maintained.	 In	 contrast,	 in	
monomer	 B	 of	 the	 LEH‐F1b	 structure,	 the	 N	 atom	 of	 K92	 may	 have	 direct	
intermolecular	hydrogen‐bonding	 interactions	with	O	of	S21	and	 the	carbonyl	







enzyme	 by	 stabilizing	 the	 dimer	 interface[28],	 and	 may	 lie	 at	 the	 basis	 of	 the	
observed	stabilization.	Both	 the	MD	simulations	(stage‐2	and	3	structures)	and	
FoldX	 (stage‐1)	predicted	 the	occurrence	of	additional	 inter‐subunit	hydrogen‐




apparent	melting	 temperature	of	LEH	by	1.0°C.	 It	 introduces	a	proline	 into	 the	
flexible	N‐terminal	loop	of	the	protein,	restricting	conformational	freedom	of	the	
main	 chain	 in	 this	 region[13].	 The	 stabilization	 can	 be	 explained	 both	 by	





in	 backbone	 position	 was	 not	 predicted	 correctly	 during	 all	 stages	 of	 design.	
However,	the	simulated	structures	of	stage‐2	and	3	had	smaller	differences	in	C	
position	 compared	 to	 the	 FoldX	 structure	 of	 stage‐1,	 indicating	 that	 the	 MD	





in	 LEH‐F1b.	 Electron	 densities	 are	 shown	 in	 orange.	 	 A)	 Comparison	 of	 the	
conformations	 of	 the	 predicted	 (in	 black)	 and	 observed	 (grey)	 intra‐molecular	








disulfide	 bonds	 I5C‐E84C	 (TM	 =	 13.5°C)	 and	 G89C‐S91C’	 (TM	 =	 15.0°C).	 The	
mutations	I5C‐E84C	introduce	a	covalent	interaction	between	the	rather	flexible	
residue	 of	 the	 wild‐type	 at	 position	 5,	 which	 is	 located	 in	 a	 loop	 near	 the	 N‐
terminus,	and	the	well‐defined	residue	at	position	84,	located	in	a	β‐sheet	of	the	
protein	 core	 (Figure	 5‐4A).	 Comparison	 of	 the	 structures	 of	 the	 elevenfold	
mutant	LEH‐F1b	(with	disulfide	bonds)	and	the	eightfold	mutant	LEH‐P	(without	
disulfide	 bonds)	 revealed	 a	 3.2	 Å	 positional	 shift	 of	 residue	 5	 to	 bring	 it	 in	
proximity	to	residue	84	(Figure	5‐4A),	while	the	Cα	position	of	residue	84,	which	
is	 part	 of	 a	 ‐strand,	 had	 shifted	 by	 only	 0.5	 Å.	 The	 flexible	 surface	 loop	
harboring	 residue	5	has	only	 few	 interactions	with	 the	 rest	of	 the	protein,	 and	




covalent	 links	 between	 the	 monomers	 which	 reduces	 unfolding	 caused	 by	
dissociation	 into	 subunits,	 which	 can	 be	 an	 important	 factor	 in	 protein	
instability[28d,	30].	 The	 structure	 confirms	 that	 these	 cysteines	 form	 a	 disulfide	
bond.	However,	C89	and	C91	in	monomers	A	and	B	have	a	dual	conformation.	In	
one	 conformation	 the	 Cys	 side	 chains	 form	 an	 inter‐subunit	 disulfide	 bond	
between	 residues	 89	 and	 91',	while	 in	 the	 other	 conformation	 the	 thiol	 group	
adopts	a	different	 rotamer	and	 the	disulfide	bond	 is	not	 formed	 (Figure	5‐4B).	
Thermal	denaturation	experiments	confirmed	that	multiple	forms	of	the	protein	
that	 differ	 in	 TM,app	 are	 present	 in	 solution.	 This	 is	 in	 agreement	 with	 the	
presence	of	varying	numbers	of	inter‐subunit	disulfide	bonds	per	dimer	(Figure	
5‐5).	
For	 the	 intermolecular	 disulfide	 bond	 (C89‐C91’),	 the	 well‐defined	
positions	of	 the	Cα	atoms	of	neighboring	residues	C89,	S90	and	C91	are	shifted	
by	 respectively	0.6,	 1.1	 and	0.9	Å	when	 comparing	 the	 structure	of	 LEH‐P	 and	
wild‐type.	The	 side	 chains	 of	 the	 introduced	 residues	 push	 the	 two	monomers	
further	apart	 to	accommodate	 the	 larger	Cys	side	chains	 (compared	 to	Gly	and	
Ser)	 at	 the	 interface.	 These	 changes	 increase	 the	 C‐Cdistance	 between	 the	
two	 residues	 from	 4.7‐4.8	 Å	 to	 5.8	 Å.	 The	 MD	 simulations	 in	 stage	 2	 and	 3	
predicted	the	required	main‐chain	changes	correctly.	Thus,	 the	use	of	a	flexible	











F1b	directly	 after	purification,	 indicating	 the	presence	of	multiple	 forms	of	 the	
protein.	 The	 final	 form	 of	 the	 protein	 in	 solution	 (continuous	 line)	 has	 an	
apparent	melting	temperature	of	85	°C.	This	form	was	obtained	after	incubating	
the	protein	for	72	h	at	20	°C.		
Table 5-3. Specific activities of selected LEH variants for the hydrolysis of (4R)-limonene 
epoxide at 30°C. 
LEH Variant specific activity (μmol/mg/min) Reference 
Wild-type  85 [2a] 
Wild-type c-Myc 44 [1] 
P (c-Myc) 55 A 
F1b (c-Myc) 28 [1] 
 
A Chapter 6 of this thesis. 
	
Comparison	of	active	 site	residues	 ‐	 The	 stabilization	 of	 enzymes	 should	 not	
reduce	 their	 catalytic	 activity.	 To	 investigate	 if	 the	 mutations	 introduced	 by	
FRESCO	influenced	the	active	site	structure,	the	positions	of	all	122	atoms	within	
10	Å	from	the	position	of	the	ligand	heptaneamide	in	the	wild‐type	LEH	structure	
were	 compared	 between	 the	 structures	 of	 LEH‐P	 and	 the	 wild‐type[2b].	 This	
selection	 included	 the	 catalytic	 residues	R99,	D101	and	D132.	The	 comparison	
revealed	that	the	active	sites	are	fully	superimposable,	with	RMSDs	of	only	0.19	
Å,	 as	 are	 the	 catalytic	 water	 molecules.	 The	 positions	 and	 orientations	 of	 the	
catalytic	 residues	 Y53,	 N55,	 R99,	 D101	 and	 D132	 are	 completely	 preserved	





LEH‐P	 and	wild‐type	 LEH	 (with	 c‐Myc	 tag)	was	 similar	 for	 the	 substrate	 (4R)‐
limonene‐1,2‐epoxide	 (Table	 5‐3).	 These	 results	 demonstrate	 that	 the	 strategy	
not	 to	mutate	 residues	 close	 to	 the	 active	 site	was	 successful	 for	 the	design	of	
fully	active,	 thermostable	LEH‐P	variants.	Similarly,	stabilizing	mutations	 in	the	
dehalogenase	 LinB	 only	 reduced	 enzyme	 activity	 when	 they	 were	 introduced	
close	 to	 the	 active	 site[3].	 This	 strategy	 could	 be	 a	 simple	 but	 effective	way	 to	




A)	 Overlay	 of	 the	 structures	 of	 LEH‐P	 (light	 grey)	 and	 wild‐type	 LEH	 (pdb	 id	
1NWW,	dark	grey).	The	proposed	ligand	2‐hydroxyhexylamide	bound	to	LEH‐P	




Identification	 of	 ligand	 ‐	 The	 electron	 density	 of	 LEH‐P	 revealed	 that	 an	
unexpected	 ligand	 was	 bound	 in	 the	 active	 site	 of	 the	 enzyme	 (Figure	 5‐6B),	
which	 was	 not	 related	 to	 any	 compound	 added	 during	 the	 crystallization	
experiments.	Arand	 and	 coworkers	 also	observed	 an	 endogenous	 ligand	 in	 the	
wild‐type	 structure[2b].	 This	 ligand	was	proposed	 to	be	 valpromide,	 although	 it	












protein	 sample	 containing	 the	 ligand.	 This	 suggested	 that	 the	 compound	 is	 2‐
hydroxyhexanamide	by	molecular	mass	and	fragmentation	pattern	(Figure	5‐7),	
although	it	could	not	be	unambiguously	assigned.	Amides	are	known	to	be	low‐Ki	
non‐covalent	 inhibitors	 of	 epoxide	 hydrolases[32].	 Trace	 amounts	 of	 this	
compound	 could	 be	 present	 in	 the	 solutions	 used	 for	 growth,	 purification	 or	
crystallization	 or	 produced	 by	 E.	coli	cells,	 similar	 as	 observed	 by	 Arand	 and	
coworkers	when	crystalizing	wild‐type	LEH[2b].		
	
Figure	 5‐7.	 MS	 data	 on	 the	 composition	 of	 the	 unknown	 ligand	 in	 LEH‐P	

















consensus	 approach[10a,	 11]	 and	 the	 B‐FIT	 method[10].	 Accordingly,	 the	 3DM	
superfamily	 database[34]	 was	 used	 to	 predict	 the	 consensus	 residue	 at	 each	
position	where	FRESCO	suggested	a	stabilizing	mutation	(Table	5‐1).	A	mutation	
was	considered	to	be	towards	consensus	if	the	introduced	amino	acid	was	one	of	
the	 two	 most	 frequently	 occurring	 residues	 at	 that	 position	 in	 a	 multiple	
sequence	alignment	of	6,100	proteins	homologous	 to	LEH.	The	highly	effective	





However,	 the	 consensus	 method	 revealed	 no	 preference	 for	 lysine	 or	
arginine	residues	at	positions	45,	76	or	92,	while	FRESCO	introduced	stabilizing	





explain	 why	 the	 consensus	 method	 did	 not	 predict	 these	 mutations.	
Furthermore,	 the	 consensus	method	was	unable	 to	predict	mutations	 in	highly	





is	 a	 higher	 chance	 of	 finding	 stabilizing	 mutations	 when	 mutating	 the	 most	
flexible	 residues	 of	 the	 protein.	 The	method	 selects	 twenty	 positions	with	 the	
highest	B‐factor	and	targets	them	by	site‐saturation	mutagenesis.	Both	FRESCO	
and	the	B‐FIT	method	predict	that	substitutions	at	positions	5,	15	and	92	have	a	
large	 chance	 to	 improve	 thermostability.	 Unlike	 B‐FIT,	 FRESCO	 also	 yielded	











generating	 substitution	 and	 the	 S15P	 mutation	 may	 indicate	 that	 kinetic	 or	
thermodynamic	 stabilization	 of	 the	 N‐terminal	 loop	 (residues	 9‐21)	 is	 an	
important	 stabilizing	 mechanism.	 Disulfide	 bonds	 can	 stabilize	 a	 protein	 by	
reducing	 entropy	 gain	 upon	 unfolding	 and/or	 by	 preventing	 local	 unfolding	
starting	 at	 a	 flexible	 region[29,	36].	 Local	 unfolding	 can	 lead	 to	 aggregation	 and	
irreversible	inactivation[29]	and	several	studies	have	indicated	that	reducing	the	
flexibility	of	 the	peptide	chain	 termini	can	stabilize	enzymes	 [37].	 In	view	of	 the	
irreversibility	of	LEH	unfolding,	suppression	of	denaturation	starting	at	an	early	
unfolding	region	may	be	most	important	for	the	obtained	stabilization[10c,	38].		
Another	 important	 protein	 stabilization	mechanism	 is	 the	 improvement	
of	 intersubunit	 interactions.	 The	 disulfide	 bond	 G89C‐S91C'	 enhances	
interactions	 between	 the	 monomers	 and	 increases	 the	 energy	 required	 to	
dissociate	 the	dimer[28d,	30].	Other	 frequently	reported	stabilization	mechanisms	
such	as	the	removal	of	oxidation‐prone	residues	or	the	filling	of	internal	cavities	
are	 not	 observed	 in	 the	 structures	 of	 LEH‐P	 and	 F1b[39].	 In	 conclusion,	 three	
mechanisms	seem	to	be	responsible	for	the	majority	of	the	obtained	stabilization	
interactions:	(i)	enhanced	interactions	between	the	flexible	 loop	close	to	the	N‐
terminus	 and	 the	 rest	 of	 the	 protein;	 (ii)	 improved	 interactions	 at	 the	 dimer	
interface;	and	(iii)	removal	of	unsatisfied	hydrogen	bonding	groups.		
Implications	 for	 FRESCO	 and	 computational	 library	 design	 ‐	 Accurate	
prediction	of	mutant	 structures	 is	of	key	 importance	 for	 computational	design.	
Computation	 of	 the	 stabilizing	 effect	 of	 mutations	 requires	 that	 backbone	
positions	and	rotamers	are	correctly	predicted.	The	present	study	revealed	that	




crystal	 structure.	Therefore,	 the	position	observed	 in	 the	crystal	 structure	may	
be	 of	 minor	 relevance	 to	 the	 solution	 structure	 and	 to	 enzyme	 stability.	
Furthermore,	 changes	 in	 the	 positions	 of	 the	 backbone	 atoms	 of	 residue	 124,	
located	 in	a	 flexible	 loop,	were	also	not	predicted	correctly.	On	the	other	hand,	
the	backbone	shifts	in	the	region	89‐91,	which	create	space	for	the	disulfide	bond	





FRESCO	 uses	 a	 set	 of	 MD‐generated	 backbones.	 Overall,	 the	 quality	 of	 the	
structures	generated	in	the	longer	MD	simulations	in	stage‐3	appears	sufficiently	
high	to	be	used	for	computational	library	design	(Table	5‐2).	
The	 current	 study	 suggests	 that	 computational	 enzyme	 stabilization	
methods	 can	 be	 further	 improved	 by	 introducing	 or	 improving	 stabilizing	
interactions	 in	 labile	 areas.	 Better	modeling	 of	 intrinsic	 protein	 flexibility	 and	
improved	 conformational	 sampling	 for	 mutant	 structure	 prediction	 probably	
also	 can	 increase	 predictive	 quality.	 The	 identification	 of	 labile	 areas	 may	 be	
done	by	a	variety	of	techniques	such	as	electron	density	analysis,	conformational	
plasticity	 analysis	 of	 homologous	 structures,	 B‐factor	 analysis[10],	 flexibility	
analysis	 by	 hydrogen	 deuterium	 exchange	 mass	 spectrometry[28d,	 40]	 or	 MD	
simulations[41].	 An	 approach	 that	more	 selectively	 stabilizes	 flexible	 areas	 and	
that	 takes	 into	 account	 backbone	 changes	 is	 expected	 to	 further	 improve	 the	
quality	of	mutant	libraries	obtained	by	computational	design.		
Conclusions	
In	 this	 study,	 the	 structural	 predictions	 generated	 and	 used	 in	 the	 FRESCO	
approach	for	computational	enzyme	stabilization	have	been	validated	by	protein	





mutations	 that	 were	 not	 predicted	 by	 the	 consensus	 approach	 or	 the	 B‐FIT	
method	for	thermostabilization.		
Materials	and	methods	
Protein	 production	 and	 purification:	 Escherichia	 coli	 TOP10	 cells,	 harboring	 the	 limA	gene	
(UniProt	accession	code	Q9ZAG3)	with	the	desired	mutations	 in	a	pBAD	plasmid,	were	used	to	
produce	 the	 limonene	 epoxide	hydrolase	mutants[1].	 The	 genes	 contained	an	 extra	 3'	 segment,	






with	 1	 tablet	 of	 complete	 protease	 inhibitor	 cocktail	 [Roche,	 Switzerland].	 Subsequently,	 cells	
were	lysed	using	sonication	(10’	total	time,	cycles	of	10”	on,	30”	off,	60	watt,	20	kHz,	4°C).	Cell	







LEH	 was	 purified	 by	 affinity	 chromatography	 using	 an	 Äkta	 FPLC	 (GE	 Healthcare)	
connected	 to	a	5	mL	Ni‐NTA	column	(HisTrap	HP,	GE	Healthcare).	Cell‐free	extract	was	 loaded	
onto	 the	 column	and	 it	was	washed	with	100	mL	buffer	TN	 to	 remove	unbound	proteins.	The	
column	was	subsequently	washed	with	25	mL	buffer	TN	containing	50	mM	imidazole	to	remove	
most	bound	contaminants.	Epoxide	hydrolase	was	eluted	with	50	mL	buffer	TN	containing	300	


















of	6.1	mg/mL.	The	disulfide	bonds	 in	 the	 freshly	purified	variant	were	not	 completely	 formed,	
but	matured	in	one	week	at	4°C	(Figure	5‐5).	After	maturation,	the	protein	was	crystallized	using	
a	 similar	 set	 up	 as	 for	 variant	 LEH‐P.	 As	 precipitant,	 1.44	 M	 tri‐sodium	 citrate,	 pH	 6.4,	
supplemented	with	50	mM	sodium	tartrate	dihydrate	was	used.	After	5	days,	needle‐like	crystals	
were	obtained	(30	× 50	× 200	μm),	which	were	suitable	for	diffraction	studies.		
Data	 collection,	processing	 and	molecular	 replacement:	 Diffraction	 data	 were	 collected	 at	
beam	lines	ID29	and	ID23	of	the	ESRF	(Grenoble,	France).	The	diffraction	data	were	processed	
using	 XDS[42],	 converted	 using	 COMBAT[43]	 and	 scaled	 using	 SCALA[44].	 Molecular	 replacement	
was	performed	with	PHASER[45],	 using	pdb	 id	 1NWW[2b]	 as	 search	model.	 The	 obtained	model	
was	refined	using	REFMAC5[46].	Manual	rebuilding	of	the	structure	using	COOT[47]	was	alternated	
with	 refinement	 using	REFMAC5	until	 convergence	was	 reached.	 Finally,	MOLPROBITY[48]	was	
used	for	structure	validation	and	PYMOL	(www.pymol.org)	for	structure	visualization.		
Mass	spectrometry:	To	determine	 the	 identity	of	 the	 compound	bound	 in	 the	active	 site,	ESI‐
MS/MS	 was	 performed	 on	 purified	 protein	 from	 the	 same	 sample	 as	 used	 for	 crystallization.	
Protein	 (20	 mg/mL)	 was	 dialyzed	 against	 milliQ	 water	 to	 remove	 buffer	 and	 salts.	 After	
denaturation	(10	min	incubation	at	99°C),	the	protein	was	centrifuged	(10	min	at	13,000	x	g)	and	
the	supernatant	was	filtered	to	remove	remaining	protein	(Amicon	filter,	10	kDa	cut	off).	Formic	









Table 5-4. Details on data collection and structure refinement. 
Data collection LEH-P LEH-F1b 
PBD identifier 4R9K 4R9L 
Beam line (ESRF) ID 29 ID 23-1 
Resolution (Å) 44.7-1.5 (1.53-1.45) 44.3-1.8 (1.9-1.8) 
Unique Reflections 87,794 (12,648) 45,204 (6,552) 
Space group P 32 2 1 P 32 2 1 
Cell dimensions (Å) 88.0, 88.0, 110.2 87.7, 87.7, 108.9 
Angles (°) 90, 90, 120 90, 90, 120 
Rsym 0.024 (0.296) 0.042 (0.313) 
Wavelength (Å) 0.976 0.999 
I ⁄ σ (I) 18.0 (2.9) 10 (2.3) 
Completeness (%) 99.9 (99.6) 99.5 (99.9) 
Redundancy 9.9 (10.0) 3.5 (3.6) 
Refinement 
Resolution (Å) 76.2-1.5 44.2-1.80 
Number of reflections 75,382 42,884 
Rwork/Rfree (%) 14.1/16.5 16.3/20.7 
Number of atoms 
Protein 3623 3622 
Ligand/Ion 58 27 
Water 369 209 
RMS deviations 
Bond lengths (Å) 0.024 0.020 
Bond angles (°) 2.3 2.0 
Ramachandran Favored/outliers (%) 99.6/0  98.9/0.45 
Both the overall values and those for the highest resolution shell are indicated, the latter between 
brackets.  
	
Comparison	 to	 predicted	 structures:	 Structures	 predicted	 by	 FoldX[7],	 Dynamic	 Disulfide	
Discovery[1]	(stage‐1	structures)	and	MD	simulations	(stage‐2)		were	identical	to	the	ones	used	in	
the	 FRESCO	 workflow	 to	 select	 (combinations	 of)	 potentially	 stabilizing	 mutations	 for	
experimental	 characterization[1].	 MD	 simulations	 were	 carried	 out	 using	 LEH	 dimers,	 with	
explicit	water	and	counter	ions	present	as	described	in	detail	by	Wijma	et	al.	[1].	MD	simulations	
for	 stage‐2	 structures	 lasted	 for	 100	 ps.	 	 Snapshots	 from	 the	 last	 50	 ps	 of	 five	 independent	
trajectories	 were	 averaged	 to	 obtain	 the	 modeled	 structures.	 For	 stage‐3	 predictions	 MD	
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Computational	 enzyme	 design	 can	 provide	 new	 or	 improved	 biocatalysts	 for	
synthetic	 chemistry.	 However,	 current	 computational	 tools	 are	 not	 sufficiently	
accurate	to	control	substrate	binding	and	orientation	in	catalytic	sites	with	the	level	
of	 precision	 required	 for	 rapid	 and	 selective	 catalysis.	 Here,	we	 report	 a	 strategy	
that	 uses	 computational	 design	 and	 molecular	 dynamics	 simulations	 to	 produce	
divergent	enzyme	variants	that	position	a	meso	substrate	in	predefined	orientations	
required	 for	 enantioselective	 conversions.	 We	 applied	 this	 strategy	 to	 develop	
enantio‐complementary	 epoxide	 hydrolases	 in	 which	 the	 target	 substrate	
cyclopentene	oxide	 is	 oriented	 such	 that	 ring	opening	proceeds	predominantly	by	
attack	at	either	the	(R)‐	or	(S)‐carbon	atom,	producing	highly	enantio‐enriched	(S,S)‐
diol	 or	 (R,R)‐diol,	 respectively.	 Key	 features	 of	 this	 strategy	 (CASCO,	 catalytic	
selectivity	 by	 computational	 design	 and	 MD	 screening	 for	 optimal	 substrate	
positioning)	are	the	use	of	RosettaDesign	to	design	mutations	that	favor	binding	of	
the	 substrate	 in	 a	 predefined	 orientation,	 the	 introduction	 of	 steric	 hindrance	 to	
prevent	 unwanted	 substrate	 binding	 modes,	 and	 an	 in	 silico	 ranking	 of	 initial	
designs	by	high‐throughput	molecular	dynamics	simulations.	The	scoring	procedure	
















to	design	enzymes	with	activities	not	 found	 in	nature	and	 to	 improve	activities	of	
existing	 enzymes.	 Examples	 of	 the	de	novo	 designed	 enzymes	 include	 esterases[1],	
Kemp	eliminases[2],	retro‐aldolases[3]	and	Diels‐Alderases[4].	Modification	of	enzyme	
selectivity	by	 computational	methods	was	 reported	 for	 several	 enzymes	 including	
homing	 endonucleases[5],	 deaminases[6],	 a	 peptidase[7],	 a	 phosphorylase[8],	




stabilize	 that	 geometry.	 In	 case	 of	 prochiral	 and	meso	 substrates	 this	 could	 yield	
enzymes	 that	 form	 a	 single	 product	 enantiomer	 due	 to	 regioselective	 or	
facioselective	 reactivity.	 A	 protein	 sequence	 forming	 such	 redesigned	 active	 sites	
can	 be	 generated	by	 CPD	methods	 such	 as	 implemented	 in	 RosettaDesign[11]	 and	
described	 in	several	reviews[12].	Protein	engineering	efforts	on	enzymes	catalyzing	
enantioselective	 substitution	 reactions	 on	 prochiral	 and	 meso	 compounds	 have	
been	 reported,	 including	 directed	 evolution	 to	 produce	 enantio‐complementary	
enzyme	pairs	 that	 allow	 formation	 of	 both	product	 enantiomers[13].	 The	 approach	
included	 rational	 design	 and	 optimized	 directed	 evolution	 strategies,	 but	 in	most	
cases	 large	mutant	 libraries	had	 to	be	used[13].	Whereas	computational	design	can	
be	used	to	obtain	highly	efficient	mutant	libraries	for	enhancing	thermostability[14],	
it	 remains	 to	 be	 explored	 if	 similar	 methods	 can	 be	 applied	 to	 produce	
complementary	enantioselective	biocatalysts	for	desymmetrization	reactions.	
An	 important	 shortcoming	 of	 enzymes	 obtained	 by	 de	novo	 computational	
design	is	that	their	catalytic	activity	tends	to	be	orders	of	magnitude	lower	than	that	
of	 natural	 enzymes[1‐4,	15].	 A	 main	 cause	 was	 revealed	 by	 MD	 simulations,	 which	
indicated	 that	 the	designed	enzymes	bind	 their	 substrate	 in	multiple	 orientations,	
most	of	which	are	unsuitable	for	catalysis.	This	differs	from	the	more	homogeneous	
substrate	 orientations	 observed	 in	 natural	 enzymes	 and	 in	 enzymes	 improved	 by	
directed	 evolution[15b,	 16].	 The	 abundance	 of	 undesired	 binding	 orientations	 in	
designed	 enzymes	was	 confirmed	 by	 crystal	 structures,	which	 showed	 binding	 of	
















the	CPD.	 In	 this	 study	we	examine	 the	use	of	MD	 simulations	 to	predict	 substrate	
positioning	 for	 enantioselective	 catalysis.	 While	 MD	 simulations	 are	 capable	 of	
predicting	 behavior	 of	 enzyme‐substrate	 complexes,	 the	 computational	 costs	 are	
usually	 too	 high	 to	 cover	 functionally	 relevant	 timescales	 or	 to	 rank	more	 than	 a	
dozen	 of	 computationally	 designed	 variants.	 We	 recently	 described	 a	
computationally	 inexpensive	 MD	 protocol	 for	 predicting	 substrate	 orientations	
through	simulating	enzyme‐substrate	interactions	using	a	large	number	(e.g.	20)	of	
short	 (10	 –	 100	 ps)	 and	 differently	 initialized	MD	 simulations.	 It	 turned	 out	 that	
several	of	such	short	independent	MD	simulations	sampled	a	much	wider	diversity	
of	substrate	orientations	than	a	single	long	MD	simulation	(e.g.	20	ns).	This	allowed	
a	 more	 complete	 sampling	 of	 possible	 substrate	 orientations,	 which	 resulted	 in	
better	 prediction	 of	 the	 enantioselectivity	 of	 existing	 enzymes[18]	 than	 the	 use	 of	
standard	 single	 long	 MD	 simulations	 at	 a	 100‐fold	 lower	 computational	 cost.	We	
refer	 to	 this	protocol	as	HTMI‐MD	(high‐throughput	multiple	 independent	MD)[18].	






















To	 obtain	 enantioselective	 variants,	 we	 redesigned	 the	 limonene	 epoxide	








Arg‐Asp	 catalytic	 triad	 (Scheme	 6‐2)[19‐20].	 The	 Asp	 132‐Arg	 99	 pair	 abstracts	 a	
proton	 from	 a	 water	 molecule,	 triggering	 nucleophilic	 attack,	 and	 the	 epoxide	
oxygen	leaving	group	is	protonated	by	Asp	101.	We	call	this	pro‐RR	attack	(Scheme	
6‐1)	 if	 nucleophilic	 displacement	 occurs	 on	 the	 (S)‐configured	 carbon	 atom	 of	
epoxide	1a,	which	leads	to	the	(R,R)	diol	1b	by	inversion	of	stereo‐configuration	at	
the	 reacting	 carbon	 atom[19a,	 20].	 Vice	 versa,	 pro‐SS	 attack	 occurs	 on	 the	 (R)‐
configured	carbon	atom	and	produces	(S,S)‐diol.	The	orientation	of	the	substrate	in	




Scheme	 6‐3.	 CASCO	 framework	 for	 redesign	 of	 catalytic	 selectivity	 by	
computational	protocols.	 In	 the	 current	work,	 the	 adjustment	of	 the	CPD	protocol	
encompassed	 the	 introduction	 of	 steric	 hindrance	 to	 prevent	 unwanted	 substrate	
binding	modes.	
In	this	study,	we	describe	an	approach	we	term	CASCO	(Catalytic	selectivity	
by	 computational	 design	 and	 MD	 screening	 for	 substrate	 positioning)	 for	
engineering	enzyme	stereoselectivity.	This	strategy	(Scheme	6‐3)	combines	the	use	
of	 RosettaDesign	 for	 obtaining	 initial	 designs	 that	 can	 bind	 the	 substrate	 in	 the	
desired	 orientation	 with	 HTMI‐MD	 to	 predict	 substrate	 binding	 modes	 and	
selectivities.	 Subsequently,	 the	 most	 promising	 variants	 can	 be	 produced	 for	






1b	 or	 (S,S)‐1b	 would	 be	 formed.	 Therefore,	 the	 CPD	 protocol	 was	 modified	 to	
explicitly	 prevent	 the	 formation	 of	 the	 unwanted	 product.	 This	 was	 achieved	 by	
designing	 steric	 clashes	between	 the	protein	 and	 the	undesired	orientation	of	 the	
substrate.	Variants	obtained	using	 this	modified	procedure	were	predicted	by	MD	
simulation	 to	 have	 more	 defined	 substrate	 orientations,	 in	 which	 the	 substrate	
selectively	bound	in	either	the	pro‐SS	or	pro‐RR	nucleophilic	attack	orientation.	The	
37	 most	 promising	 variants	 were	 experimentally	 constructed	 and	 the	 formed	
products	were	 analyzed	 by	 chiral	 gas	 chromatography,	which	 revealed	 that	 33	 of	




Prediction	 of	 LEH	 enantioselectivity	 by	HTMI‐MD	 –	 The	 use	 of	 HTMI‐MD	 for	
predicting	enantioselectivity	in	the	conversion	of	substrate	enantiomers	by	existing	
haloalkane	dehalogenases	was	recently	explored[18,	21].	To	examine	if	HTMI‐MD	can	
also	be	used	 to	predict	 the	enantioselectivity	of	 cyclopentene	oxide	 conversion	by	
LEH	variants,	which	is	based	on	regioselectivity	of	water	attack[19‐20],	we	performed	
MD	 simulations	 using	 data	 from	 LEH	 mutants	 that	 were	 obtained	 by	 directed	







simulations	 can	 be	 used	 to	 predict	 enzyme	 enantioselectivity[18,	 21].	 The	 NAC	
geometries	 for	 pro‐RR	 and	 pro‐SS	 attack	 (Scheme	 6‐2)	 were	 based	 on	 earlier	
published	quantum	mechanical	modeling	 [19a,	23].	 	Based	on	the	relative	frequencies	
of	pro‐RR	 and	pro‐SS	NACs	during	MD	 simulation,	 the	 enantiomeric	 excess	 (ee)	of	
product	enantiomers	as	given	by	Eq.1	can	be	predicted	by	Eq.	2.	
eeோோ									 	ൌ ሾሺோ,ோሻି૚܊ሿ	ି	ሾሺௌ,ௌሻି૚܊ሿሾሺோ,ோሻି૚܊ሿ	ା	ሾሺௌ,ௌሻି૚܊ሿ       (1) 
 





To	 investigate	 of	 the	 accuracy	 of	 the	 method,	 differences	 in	 activation	




correlations	 (Figure	 6‐1)	with	 experimental	 data	were	 obtained	 both	with	 20	MD	
simulations	of	10	ps	and	10	longer	simulations	100	ps.	The	accuracy	was	similar	to	
those	of	QM/MM	calculations[19b].	 The	high	quality	 of	 the	HTMI‐MD	predictions	 is	
consistent	 with	 the	 notion	 that	 MD	 simulations	 can	 model	 steric	 interactions	



















Computational	 design	 of	 substrate	 positioning	 –	 Asymmetric	 enzymatic	
synthesis	of	1b	requires	an	active	site	geometry	that	selectively	positions	substrate	
1a	 for	either	pro‐RR	 or	pro‐SS	hydrolysis[13b,	19‐20].	Therefore	 the	design	procedure	
aimed	 to	 identify	a	 set	of	mutations	 that	 creates	an	active	site	 cavity	 in	which	 the	
substrate	is	positioned	selectively	in	one	of	the	two	catalytic	orientations.	To	fulfill	
this	requirement,	we	used	RosettaDesign[11]	 to	design	 limonene	epoxide	hydrolase	
variants	 that	 have	 shape	 complementarity	 to	 the	 substrate	 in	 the	 desired	




The	 substrate	was	 docked	 in	 the	 crystal	 structure	 of	 limonene	 epoxide	 hydrolase	
either	 in	 a	 pro‐RR	 or	 a	 pro‐SS	 attack	 position,	 and	 RosettaDesign[11,	 24]	 searched	
within	 the	 sequence‐conformational	 space	 for	 substrate‐bound	 active‐site	
conformations	with	a	low	energy,	as	defined	by	the	RosettaDesign	energy	function.	
The	 use	 of	 search	 algorithms	 to	 find	 the	 low	 energy	 conformations	 within	 the	









16b,	17,	26].	 Therefore,	 the	 CASCO	 approach	 used	 HTMI‐MD	 to	 predict	 which	 of	 the	
designed	variants	were	best	at	selectively	binding	the	substrate	either	in	a	pro‐RR	or	
pro‐SS	 attack	 orientation.	 This	 analysis	 indicated	 that	 the	 initially	 designed	 LEH	
variants	 would	 indeed	 catalyze	 the	 desired	 reaction,	 but	 without	 displaying	 the	
exclusive	 pro‐RR	 or	 pro‐SS	 regioselectivity	 required	 for	 enantioselective	 product	
formation	 (Figure	 6‐2A).	 While	 there	 are	 a	 few	 variants	 for	 which	 a	 high	 ee	 is	
predicted	 (Figure	 6‐2A),	 these	 variants	 occur	 as	 infrequently	 as	 that	 the	 non‐
selective	 wild‐type	 enzyme	 is	 predicted	 to	 have	 high	 ee.	 The	 prediction	 that	 the	
substrate	will	be	bound	aspecifically	by	the	initial	designs	concurs	with	studies	that	





orientations[15b,	16b,	17,	26].	 Inspection	 of	 MD	 simulation	 trajectories	 of	 the	 designed	
LEH	 variants	 indicated	 that	 there	 was	 too	 much	 space	 around	 the	 (1R,2S)‐
cyclopentene	oxide,	which	enabled	the	substrate	to	move	both	into	pro‐RR	and	pro‐
SS	orientations.		
Improved	CPD	procedure	by	 incorporating	steric	restraints	–	To	 improve	 the	
CPD	procedure,	we	decided	to	specifically	introduce	steric	hindrance	to	prevent	the	
undesired	 substrate‐binding	 binding	 modes.	 Thus,	 pro‐RR	 designs	 should	
specifically	hinder	the	pro‐SS	substrate	orientation	and	vice	versa.	In	this	approach,	
we	 first	 analyzed	 the	 effect	 of	 introducing	 bulky	 residues	 (W,	 F,	 or	 also	 Y	 if	 the	
original	 residue	was	an	F)	 for	each	of	 the	11	 target	 residues	 lining	 the	active	site.	
This	 was	 done	 by	 computationally	 predicting	 at	 which	 positions	 the	 rotamers	 of	
these	bulky	side	chains	could	sterically	clash	with	1a	docked	in	a	pro‐RR	or	a	pro‐SS	
attack	 position.	 This	 procedure	 indicated	 that	 the	mutations	 F134W/Y,	 I116F/W,	
L103F/W,	and	L114F/W	could	sterically	hinder	pro‐RR	attack,	while	the	mutations	
I80F/W,	 L103F/W,	 L35F/W,	 L74F/W,	 and	 M78F/W	 could	 prevent	 pro‐SS	 attack.	
The	 targeted	 introduction	 of	 these	 mutations	 was	 necessary,	 since	 these	
substitutions	 only	 occurred	 in	 low	 frequencies	 amongst	 the	 initial	 designs,	 and	
increasing	 the	 energy	 of	 unwanted	 substrate	 orientations	 is	 not	 part	 of	 the	
RosettaDesign	algorithm.	Algorithms	to	automatically	carry	out	such	tasks	are	still	
under	development,	and	will	aid	future	design	projects[27].	After	the	introduction	of	
single	 mutations	 to	 enforce	 steric	 hindrance,	 the	 other	 ten	 residues	 were	
computationally	redesigned,	which	resulted	in	945	pro‐RR	and	931	pro‐SS	designs.	
The	 sequence	 profile	 of	 this	 set	 of	 variants	 differs	 from	 the	 set	 of	 initial	 designs	
obtained	without	steric	restraints.		
A	 much	 larger	 fraction	 of	 the	 designs	 with	 enforced	 steric	 hindrance	
produced	 the	desired	enantioselectivity	 in	HTMI‐MD	simulations	 (Figure	6‐2B).	Of	
the	designs	without	any	enforced	steric	hindrance,	1.6%	had	an	eepred	of	over	90%,	
while	 over	 20%	 of	 the	 designs	 with	 the	 enforced	 mutation	 L103F/W	 has	 a	 high	
eepred	 for	 pro‐RR	 attack.	 Furthermore,	 substitutions	 L35F/W,	M78W,	 and	 I80F/W	
increased	the	eepred	for	pro‐SS	attack	to	10	to	20%	of	the	designs.	Only	a	minority	of	
the	 enforced	 mutations	 significantly	 increased	 the	 overall	 folding	 energy	 of	 the	









for	 pro‐RR	 attack	 obtained	 by	 computational	 design	 without	 enforcing	 selective	





this,	 the	 10	 designs	 with	 the	 highest	 predicted	 pro‐RR	 selectivity	 and	 27	 pro‐SS	
designs	were	selected.	Both	designs	that	 featured	clear	steric	hindrance	(pro‐RR‐4	
























pro-RR-1 M32L_L35M_M78I_F134W 54.5 1.96 5.6 (R,R) 68.0 
pro-RR-2 M32L_M78F_I80V_L103W 54.3 0.028 3.3 (R,R) 69.5 
pro-RR-3 M32L_M78L_F134W_F139L 54.5 1.55 9.7 (R,R) 71.0 
pro-RR-4 M32L_M78G_L103F_I116V_F139L 3.49 0.00 49.1 (S,S) 67.0 
pro-RR-5 M32L_M78G_L103F_F139M 1.43 0.00 14.4 (R,R) 60.0 
pro-RR-6 M32A_M78G_L103F_F139L 0.86 0.00 10.4 (R,R) 59.0 
pro-RR-7 M32L_L74I_I80V_L103F_F139W 0.65 0.00 54.4 (R,R) 60.5 
pro-RR-8 M32L_L74I_I80V_L103F_F139L 5.95 0.00 84.5 (R,R) 66.0 
pro-RR-9 M78I_I80V_L103F 0.58 0.01 73.2 (R,R) 57.5 
pro-RR-10 M32L_L74I_L103F_F139W 4.51 0.11 47.1 (R,R) 62.0 
pro-SS-1 M32L_M78L_I80F_L103I_I116V_F139L 0.43 57.3 77.6(S,S) 78.5 
pro-SS-2 M32L_L35W_L74F_M78F_I80A_L103I_F139L 1.86 55.5 63.8(S,S) 63.5 
pro-SS-3 M32L_L35M_L74I_M78L_I80F_V83I_L103I_I116V_F139L 1.24 51.0 81.4(S,S) 77.0 
pro-SS-4 M32L_L35M_L74I_M78L_I80F_L103I_I116V_F139L 1.35 46.0 56.8(S,S) 76.5 
pro-SS-5 M32L_L35W_M78L_I80A_I116V_F139W 3.38 45.5 70.1(S,S) NOC 
pro-SS-6 M78W_F139W 0.01 18.7 32.1(R,R) 62.0 
pro-SS-7 M32L_L35M_L74I_M78I_I80F_V83I_L103V_I116V_F139L 0.01 1.20 62.8 (S,S) 75.0 
pro-SS-8 M32L_I80W_L103I_I116V_F139W 0.04 5.25 NPB 76.5 
pro-SS-9 M32L_L35M_L74F_I80F_V83I_L103I_I116V_F139L 0.24 33.16 78.8 (S,S) 71.0 
pro-SS-10 M32L_L35W_L74W_M78A_I80A_L103I_I116V_F139L 0.17 20.30 62.4 (S,S) 60.0 
pro-SS-11 M32L_L35M_L74I_M78V_I80F_V83G_L103V_F139L 0.02 2.65 13.9 (R,R) NO 
pro-SS-12 M32L_M78I_I80F_L103I_I116V_F139L 0.18 16.2 74.7 (S,S) 76.5 
pro-SS-13 M32L_L74F_I80F_L103I_I116V_F139L 0.04 3.42 78.3 (S,S) 72.5 
pro-SS-14 M32L_L35A_M78L_I80W_L103I_I116V_F139L 0.64 48.1 62.0 (S,S) 72.0 
pro-SS-15 M32A_L35M_M78L_I80W_L103V_I116V_F139W 0.42 31.1 1.5 (R,R) 61.0 
pro-SS-16 M32L_L35W_L74F_M78F_I80A_I116V_F139L 0.69 48.1 90.3 (S,S) 68.0 
pro-SS-17 M78L_I80F_I116V_F139W 0.30 14.8 60.3 (S,S) 63.0 
pro-SS-18 M32L_M78L_I80F_I116V_F139W 0.30 14.6 57.3 (S,S) 70.0 
pro-SS-19 M32A_L35W_M78I_I80A_V83A_I116V 0.89 39.8 NP 48.5 
pro-SS-20 M32L_L35W_M78L_I80V_L103I_F139W 0.00 4.90 44.6 (R,R) NO 
pro-SS-21 M32L_M78I_I80W_L103I_I116V_F139L 0.00 0.05 NP 80.0 
pro-SS-22 M32L_L35M_M78L_I80W_V83I_L103I_I116V_F139W 0.20 32.6 NP 75.5 
pro-SS-23 L74I_I80F_I116V_F139W 0.29 20.2 43.2 (S,S) 62.0 
pro-SS-24 M32L_L35W_L103I_I116V_F139W 0.05 2.96 21.2 (S,S) NO 
pro-SS-25 M32L_L35W_M78I_I80A_L103I_I116V_F139L 0.22 9.70 71.4 (S,S) 64.5 
pro-SS-26 M32L_L35M_M78L_I80F_L103I_I116V_F139L 0.25 10.7 64.8 (S,S) 75.5 
pro-SS-27 M32L_L74F_M78A_I80F_L103I_I116V_F139L 0.21 8.94 78.6 (S,S) 71.0 
WT (LEH-P) None   23.5 (R,R) 68.5 
	
The	 designed	 variants	 were	 constructed	 in	 a	 previously	 engineered	
thermostable	variant	of	LEH‐P	because	use	of	a	thermostable	template	increases	the	
chance	that	mutations	are	tolerated	without	formation	of	misfolded	protein[28].	This	






Conversion	 assays	 with	 the	 purified	 mutant	 enzymes	 with	 analysis	 by	 chiral	 GC	
revealed	that	33	of	the	37	variants	were	catalytically	active	of	which	28	(85	%)	had	
the	designed	chiral	selectivity	(pro‐RR	or	pro‐SS)	(Table	6‐1).	Of	these	28	variants,	
nine	 (33	%)	were	 highly	 selective,	 producing	 the	 desired	 diol	 with	 an	 ee	 of	 over	
75%.	 The	 most	 enantioselective	 variants	 were	 pro‐RR‐8	 which	 contains	 five	
mutations	and	produces	(R,R)‐1b	with	an	ee	of	85%	and	pro‐SS‐16	which	has	seven	
mutations	and	forms	(S,S)‐1b	with	90%	ee	(Table	6‐2).	Variants	pro‐RR‐8	and	pro‐
SS‐16	 each	 have	 a	 bulky	 residue	 (L103F	 and	 L35W,	 respectively)	 that	 was	
introduced	to	incorporate	steric	hindrance	and	prevent	a	binding	mode	that	would	
allow	nucleophilic	attack	by	water	at	the	unwanted	position	((2S)‐	and	(1R)‐carbon	
atoms,	 respectively	 (Figure	 6‐4),	 which	 we	 consider	 essential	 for	 the	 high	 chiral	
selectivity	of	these	variants.	
	
Table 6-2. Computationally predicted and experimentally observed enantioselectivities of limonene epoxide hydrolase 
variants for the hydrolysis of cyclopentene oxide (1a) 
 Computational predictions Experimental analysis 













(LEH-P) none   (R,R)-1b 23.9 0.083  0.002 
pro-RR-8 M32L/L74I/I80V/L103F/F139L 5.95 0.004 (R,R)-1b 85.5 0.015  0.001 
pro-SS-16 M32L/L35W/L74F/M78F/I80A/I116V/F139L 0.69 48.1 (S,S)-1b 90.2 0.010  0.001 
 
A All mutations were introduced in the thermostable variant LEH-P.[14a] The NAC percentages are those from 10  100 ps 
MD simulations 
	
The	 results	 suggest	 that	 there	 is	 a	 good	 correlation	 between	 the	 predicted	
and	 the	 experimental	 ee	 (Figure	 6‐1).	 For	 several	 variants,	 an	 erroneously	 high	
eepred	 was	 observed	 (Table	 6‐1);	 this	 can	 occur	 due	 to	 conformational	
undersampling	 of	 the	 enzyme‐substrate	 complex	 during	 MD	 simulations[18].	
However,	experimental	characterization	of	the	mutant	enzymes	revealed	that	90%	
of	the	designs	were	catalytically	active.	Furthermore,	88%	of	the	active	pro‐RR	and	






approach	 can	 be	 used	 for	 producing	mutant	 libraries	 highly	 enriched	 in	 variants	
with	the	desired	enantioselectivity.	
The	two	most	selective	variants	(pro‐RR‐8	and	pro‐SS‐16)	for	either	pro‐RR	
or	 pro‐SS	 attack	 were	 characterized	 in	 more	 detail	 to	 compare	 rates,	 chiral	
selectivity	and	protein	production	 levels.	Both	variants	were	well	expressed	at	50	
mg	protein/L	culture	broth,	which	 is	comparable	to	 the	yield	of	variant	LEH‐P[14a].	
Using	 purified	 enzymes,	 the	 chiral	 selectivity	 for	 the	 formation	 of	 diol	 1b	 was	
determined.	 Pro‐RR‐8	 produced	 (R,R)‐1b	 with	 an	 ee	 of	 85.5%	 while	 pro‐SS‐16	
showed	 an	 ee	 of	 90.2%	 for	 the	 production	 of	 (S,S)‐1b	 (Figure	 6‐3).	 This	
demonstrates	 that,	 respectively,	92%	and	94%	of	 the	nucleophilic	attack	occurred	
on	 the	 correct	 carbon	 atom	 (see	 equation	 1).	 The	 two	 variants	 maintained	 good	
catalytic	 activity	 for	 the	 hydrolysis	 of	 1a,	 albeit	 with	 eight‐fold	 lower	 rates	 than	
displayed	 by	 the	 thermostable	 LEH‐P	 from	 which	 they	 originated	 (Table	 6‐2).	
Variants	pro‐RR‐8	and	pro‐SS‐16	had	apparent	melting	temperatures	of	69.5°C	and	
66.5°C	 respectively,	while	 the	 parent	 LEH‐P	 had	 a	melting	 temperature	 of	 68.0°C.	
These	 results	 indicate	 that	 the	 five	 or	 seven	 introduced	mutations	 do	 not	 have	 a	
large	effect	on	the	protein	stability.		
	
Table 6-3. Catalytic rates and stereoselectivity of LEH variants for larger epoxides. 
 
   
Substrate                    2a                 .                    3a                    .                    4aA                   . 










WT (LEH-P) 3.1 (R,R) 2.93  0.21 24.6 (S,S) 0.583  0.004 97.7 (S,S) 55.2  2.5 
pro-RR-8 74.7 (R,R) 0.29  0.01 39.1 
(R,R) 
0.030  0.001 97.1 (S,S) 2.6  0.1 
pro-SS-16 93.5 (S,S) 0.18  0.01 91.9 (S,S) 0.007  0.001 99.4 (S,S) 62.7  1.4 
 
A Substrate converted in an enantioconvergent manner; both (1R,2S,4R)-4a and (1S,2R,4R)-4a are 
converted to (1S,2S,4R)-4b due to different regioselectivity of nucleophilic attack for the substrate 
enantiomers[19a, 20b] . 
B Units: mol min-1 mg-1 
	
The	selectivity	of	the	pro‐RR‐8‐and	pro‐SS‐16	variants	was	also	determined	
for	 hydrolysis	 of	 the	 larger	 alicyclic	 epoxides	 2a	 and	 3a	 (Scheme	 6‐1)	 and	 the	




moderately	 (R,R)	 selective	 while	 pro‐SS‐16	was	 highly	 (S,S)‐selective	 (Table	 6‐3).	
The	 catalytic	 activities	 for	 hydrolysis	 of	 epoxides	2a	 and	3a	 were	 reduced	 up	 to	





At	 the	 same	 time,	 both	designed	variants	 remained	highly	 selective	 for	 the	
conversion	of	4a	to	the	(1S,2S,4R)	enantiomer	of	4b,	which	is	the	reaction	catalyzed	
with	 the	 highest	 rate	 by	 LEH	 (Scheme	6‐4).	 Furthermore,	 pro‐SS‐16	 catalyzes	 the	







Figure	6‐3.	 Chiral	 gas	 chromatography	elution	profiles	of	1b‐diol	 enantiomers,	 as	
produced	 by	 LEH‐P,	 variant	 pro‐SS‐16	 or	 variant	 pro‐RR‐8,	 demonstrating	 high	







Comparison	of	 computational	design	 to	directed	 evolution	 –	Enantioselective	
catalysis	is	one	of	the	most	useful	properties	of	enzymes	for	chemical	synthesis,	and	
protein	 engineering	 methods	 that	 introduce	 or	 modify	 enzyme	 enantioselectivity	
are	 highly	 relevant[13,	 30].	 Whereas	 directed	 evolution	 with	 high‐throughput	
screening	 appears	 highly	 successful,	 methods	 of	 CPD	 provide	 an	 opportunity	 to	
design	 enzymes	 for	 non‐natural	 reactions	 but	 often	 lack	 the	 level	 of	 accurate	
substrate	positioning	required	for	high	selectivity	 [15b,	16‐17].	To	accurately	place	the	
substrate	 in	 a	 position	 required	 for	 regioselective	 attack	 we	 used	 RosettaDesign,	
with	 additionally	 imposed	 steric	 constraints	 and	 ranking	 by	 high‐throughput	 MD	
simulations.	 This	 CASCO	 framework	 enabled	 the	 design	 of	 highly	 enantioselective	
enzymes	without	the	need	for	a	large	screening	effort.	
The	most	selective	variants	obtained,	pro‐RR‐8	and	pro‐SS‐16,	produced	the	
desired	 diol	with	 an	 ee	 of	 86%	 and	 90%,	 respectively	 (Table	 6‐2),	while	 variants	
that	 were	 discovered	 by	 directed	 evolution[13b],	 H173	 and	 H178,	 produced	 (R,R)‐	
and	 (S,S)‐cyclopentanediol	 with	 an	 ee	 of	 80%	 and	 93	 %,	 respectively.	 Thus,	 the	
enantioselectivities	 of	 the	 best	 variants	 obtained	 by	 CPD	 are	 as	 good	 as	 those	
obtained	by	directed	evolution.	The	variants	pro‐RR‐8	and	pro‐SS‐16	each	only	have	
only	 one	 substitution	 in	 common	 with	 the	 most	 selective	 directed	 evolution	




that	 are	 produced	 and	 especially	 also	 in	 the	 experimental	 screening	 effort,	which	
encompassed	 4,700	 variants	 examined	 by	 chiral	 GC	 for	 directed	 evolution[13b]	 but	
only	 37	 mutants	 for	 the	 CASCO	 CPD	 approach	 described	 here.	 High‐throughput	
screening	of	enzymes	variants	 is	often	 laborious,	especially	 if	 the	required	protein	
expression	host	has	a	 low	transformation	efficiency	and	 if	 the	performance	assays	
are	unsuitable	 for	miniaturization.	Furthermore,	CPD	can	 introduce	 large	 jumps	 in	
sequence	 space	 in	 a	 single	 round,	 which	 is	 especially	 important	 when	 multiple	
mutations	acting	in	synergy	provide	the	desired	change	in	functionality[31].		
HTMI‐MD	 for	 scoring	designs	 –	Within	 the	 CASCO	 framework	 (Scheme	 6‐3),	 all	
variants	produced	by	RosettaDesign	are	subjected	to	a	computationally	inexpensive	
HTMI‐MD	protocol	 that	 samples	 the	occurrence	of	 near‐attack	 conformations.	MD	




prevent	 trapping	 in	 local	 energy	 minima	 and	 to	 ensure	 effective	 sampling	 of	
conformational	space.	This	MD‐based	ranking	adds	significantly	to	the	scoring	and	
selection	 of	 variants	 obtained	 by	 RosettaDesign[11,	24].	 First,	MD	 simulations	 allow	
protein	structures	to	escape	from	local	energy	minima	and	sample	different	parts	of	
conformational	space.	Second,	explicit	water	is	present	during	the	MD	simulations,	
which	 can	 compete	 with	 internal	 protein	 hydrogen	 bonds	 and	 protein‐substrate	
hydrogen	 bonds	 and	 thus	 will	 provide	 a	 more	 accurate	 modeling	 of	 solvent	
interactions	than	the	implicit	solvation	energy	model	used	within	Rosetta.	Third,	the	
HTMI‐MD	 ranking	 uses	 a	 fully	 flexible	 protein‐backbone	 and	 substrate,	 whereas	
Rosetta	 backbone	 sampling	 allows	 only	 restricted	 backbone	 motions,	 which	 is	
considered	an	 important	 limitation[17a].	Finally,	 the	MD	simulations	use	a	different	
energy	 function	 compared	 to	 the	Rosetta	molecular	mechanics	 function.	Thus,	 the	
MD	ranking	is	orthogonal	to	the	Rosetta	scoring	function	and	provides	an	additional	
filter	before	experimental	verification	is	pursued.	
Origin	 of	 enantioselectivity	 –	 To	 discover	 structural	 causes	 of	 the	 change	 in	
enantioselectivity,	 the	modeled	structures	of	 the	 two	most	 selective	variants	were	
investigated.	 For	 variant	 pro‐RR‐8,	 this	 analysis	 showed	 that	 major	 effects	 are	
introduced	by	 the	mutations	L74I	and	 I80V,	which	create	space	 for	binding	of	 the	
substrate	 in	 the	 pro‐RR	 orientation	 while	 binding	 in	 the	 undesired	 orientation	 is	
prevented	by	the	L103F	mutation	(Figure	6‐4A).	In	variant	pro‐SS‐16,	the	residues	
introduced	by	the	mutations	L35W	and	L74F	sterically	hinder	the	binding	of	1a	 in	
the	pro‐RR	 orientation.	The	 substitution	M78F	prevents	 a	potential	 clash	with	 the	
introduced	 side‐chain	 of	 F74.	 Concurrently,	 the	 smaller	 side	 group	 introduced	 by	
the	mutation	I116V	enlarges	the	pocket	where	1a	can	bind	in	the	pro‐SS	orientation	
(Figure	6‐4B).	Furthermore,	the	mutation	I80A	creates	a	pocket	in	the	inside	of	the	




likely	 optimize	 the	 packing	 around	 the	 mutated	 residues.	 While	 such	 dependent	
mutations	 are	 often	 required	 for	 introducing	 new	 enzyme	 activities[31],	 their	
introduction	can	be	problematic	when	using	enzyme	engineering	methods	such	as	










The	water	molecule	performing	 the	nucleophilic	 attack	 is	 also	 indicated.	Residues	
that	were	introduced	to	prevent	binding	in	the	opposite	pose	are	labeled	in	bold.		
Conclusions	 –	 We	 successfully	 developed	 a	 protocol	 for	 redesign	 of	 catalytic	
selectivity	 by	 computation	 (CASCO)	 which	 involves	 docking	 of	 substrate	 in	 the	
active	 site	 in	 a	 near‐attack	 conformation	 required	 for	 selective	 catalysis	 and	
computational	 design	 of	 a	 large	 set	 of	 multi‐site	 mutants	 that	 are	 predicted	 to	
stabilize	this	reactive	pose.	Furthermore,	the	procedure		prevents	unwanted	binding	
modes	 by	 incorporating	 steric	 hindrance	 and	 performs	 in	 silico	 ranking	 of	 these	
primary	 designs	 for	 enantioselectivity	 by	molecular	 dynamics	 simulations[18].	 The	
use	of	high‐throughput	molecular	dynamics	with	independent	initialization	(HTMI‐
MD)	provided,	at	low	computational	cost,	an	independent	ranking	scheme	that	was	
instrumental	 both	 for	 improving	 the	 design	 methodologies	 and	 for	 selecting	 the	
most	 promising	 variants.	 The	use	 of	 this	 combined	design	 and	 screening	protocol	
resulted	 in	 the	 rapid	 discovery	 of	 enantio‐complementary	 epoxide	 hydrolase	
variants.	 In	 total	 only	 37	 different	 mutants	 carrying	 three	 to	 nine	 substitutions	
needed	 to	 be	 screened	 experimentally	 to	 obtain	 tailored	 epoxide	 hydrolases	 that	
produced	 (R,R)	 or	 (S,S)‐1b	with	 high	 enantiomeric	 excess.	We	 anticipate	 that	 this	






CPD:	 An	 ensemble	 of	 different	 conformations	 of	 cyclopentene	 oxide	was	 generated	using	
Openeye’s	Omega	software[32].	Only	the	chair	conformation	of	cyclopentene	oxide	was	used	
for	CPD	since	it	is	lower	in	potential	energy	than	the	boat	conformation[19a].	Furthermore,	an	
ensemble	of	different	 enzyme	 conformations	was	used	 as	 template	 for	 the	 computational	
design.	This	was	 implemented	by	performing	 the	computational	design	both	on	 the	X‐ray	
structure	of	wild	type	LEH	(pdb	code	1NWW)	and	on	structures	of	55	snapshots	collected	
from	 five	 independent	 1	 ns	MD	 simulations,	 carried	 out	 using	 cyclopentene	 oxide	 bound	
wild‐type	 LEH.	 Prior	 to	MD	 simulation,	 this	 substrate	was	 docked	 using	 Rosetta	 enzyme	
design[11].	The	snapshots	from	MD	simulations	were	collected	every	50	ps	between	500	and	
1000	 ps.	 During	 these	 five	 MD	 simulations,	 the	 enzyme	 remained	 in	 catalytically	 active	




oriented	 the	 substrate	 optimally	 for	 either	 pro‐SS	 or	 pro‐RR	attack	 by	 applying	 in	 silico	




(REU)	 Å‐2[11].	 For	 other	 constraints,	 10‐fold	 smaller	 force	 constants	 (10	 REU	 Å‐2)	 were	
sufficient	 to	 keep	 the	 substrate	 in	 a	 NAC.	 The	 distance	 between	 epoxide	 oxygen	 and	 the	
oxygen	 of	 Asp101	 was	 maintained	 at	 3.0	 	 0.2	 Å.	 The	 H‐bond	 distances	 between	 the	




Ranking	of	 the	designs	using	HTMI‐MD:	 Rosetta	 enzyme	design	 automatically	 provides	
3D	 structures	 of	 the	 designs	 which	 were	 used	 for	 subsequent	 ranking.	 The	 ranking	 and	
selection	 within	 RosettaDesign	 eliminates	 all	 structures	 that	 violate	 the	 sum	 of	 penalty	
energies	for	the	above	constraints	by	more	than	15	REU,	after	an	energy	minimization.	The	
remaining	designs	were	selected	for	 further	analysis	by	MD‐simulations.	 If	more	than	one	
design	 had	 the	 same	 amino	 acid	 sequence,	 both	 the	 design	 with	 the	 least	 violations	 of	
constraints	and	the	design	with	the	 lowest	overall	energy	score	were	selected	for	ranking	
by	HTMI‐MD.		
All	MD	 simulations	were	carried	out	with	 explicit	water	 (TIP3P)	and	counter	 ions	






periodic	boundary	of	 the	simulation	cell.	All	original	water	molecules	present	 in	 the	wild‐
type	 LEH	 structure	 (pdb:	 1NWW)	were	placed	 back	 at	 the	 original	 positions,	 unless	 they	
clashed	with	the	designed	protein	structure	(as	indicated	by	a	distance	longer	than	1.5	Å	to	
any	heavy	atom	of	the	protein).	The	salt	ions	were	positioned	at	electrostatically	favorable	





of	 1.33	 fs.	 The	 non‐bonded	 interaction	 list	 was	 updated	 every	 three	 time‐steps	 and	 a	
Berendsen	thermostat	was	applied	to	preserve	neutral	pressure	temperature	conditions[34a,	
36].	 LINCS	 and	 SETTLE	 algorithms	 prevented	 hydrogen	 atoms	 from	 heating	 up[37].	
Furthermore,	the	charges	of	the	substrate	were	assigned	with	the	AM1‐BCC	method[38]	and	
a	 particle	 mesh	 Ewald	 algorithm	 was	 used	 to	 calculate	 the	 long	 range	 (>	 7.86	 Å)	
electrostatics	interactions[39].	




after	which	NACs	were	 sampled	 on	 the	 fly	 every	 20	 fs	 for	 the	 next	 5	 ps	 (only	 geometric	
information	was	saved,	no	snapshots	were	recorded).	Earlier,	this	protocol	was	found	to	be	




Subsequently,	 the	 best	 variants	 were	 selected	 for	 a	 2nd	 stage	 of	 ranking,	 which	
consisted	of	10	 longer	simulations	of	100	ps,	of	which	the	last	50	ps	were	used	to	sample	
NACs.	The	longer	equilibration	time	used	during	the	100	ps	simulation	(50	instead	of	5	ps)	




the	 selection	 criteria	 were:	 NACs	 during	 more	 than	 2.5%	 of	 the	 simulation	 time	 and	 a	
predicted	 ee	 of	 >	 90	%	were.	 These	 settings	were	more	 stringent	 since	more	 potentially	







mutations	 S15P,	 A19K,	 E45K,	 T76K,	 T85V,	 N92K,	 Y96F	 and	 E124D[14a].	 These	 mutations	
improve	the	thermostability	while	their	combined	introduction	did	not	reduce	the	catalytic	
activity	or	selectivity	for	the	hydrolysis	of	epoxide	4[14a].	Mutants	were	grouped	according	to	
the	 common	 ancestor	 from	 whom	 they	 could	 be	 constructed.	 These	 common	 ancestors	
were	 created	 by	 single‐site	 mutagenesis	 using	 a	 QuikChange	 kit	 (PfuUltra	 Hotstart	 PCR	
Master	Mix	 #600630,	 Agilent,	 CA,	 USA)	 using	 the	 LEH	 gene	 cloned	 in	 a	 pBAD/Myc‐His‐C	
expression	plasmid[14a].	Subsequently,	all	variants	could	be	created	from	these	ancestors	by	
one	 to	 three	 additional	 rounds	 of	 QuikChange	 mutagenesis.	 For	 all	 reactions,	 the	
QuikChange	master	mix	was	 used	 as	 recommended	 by	 the	 supplier.	 The	 sequence	 of	 the	
resulting	 plasmids	 was	 analyzed	 by	 DNA	 sequencing.	 Once	 the	 correct	 plasmid	 was	
obtained,	it	was	transformed	into	E.	coli	TOP10	cells	for	expression	and	protein	production.		
Protein	 purification:	 Overnight	 E.	 coli	 cultures	 containing	 plasmids	 encoding	 the	 LEH	





protein	 production	 by	 the	 cells	 was	 induced	 by	 the	 addition	 of	 0.02%	 L‐arabinose.	 The	





Protein	 was	 purified	 out	 of	 cell‐free	 extract	 using	 immobilized	 metal	 ion	 affinity	




NaCl)	 to	 remove	 unbound	 contaminants	 and	 the	 protein	 was	 eluted	 by	 applying	 400	 μl	
elution	buffer	on	the	column	(50	mM	Hepes,	pH	8.0,	300	mM	imidazole,	500	mM	NaCl).	


















Figure	6‐5.	 SDS‐page	 of	 purified	 LEH	 variants	 pro‐SS‐16	 and	 pro‐RR‐8.	 The	 sizes	 of	 the	
proteins	in	the	molecular	weight	marker	(M,	in	kDa)	are	indicated	to	the	left	of	the	gel.			




for	 the	 substrate)	 to	 initiate	 conversion	 in	 a	 10	 ml	 volume.	 Ten	 aliquots	 of	 1	 mL	 were	
transferred	to	different	Eppendorf	tubes	and	incubated	at	30°C.	At	regular	intervals,	a	tube	
was	removed	from	the	incubator	and	the	reaction	was	quenched	by	the	addition	of	800	μl	




injected	 into	 a	 type	 2014	 gas	 chromatograph	 (Shimadzu,	 Kyoto,	 Japan)	 equipped	 with	 a	
Heliflex	AT5	column	(Alltech	Associates,	Inc.,	IL,	USA)	using	flame	ionization	detection.	The	
oven	 temperature	 programs	 used	 for	 the	 separation	 of	 the	 different	 compounds	were	 as	
follows.	For	1	and	2:	4	min	at	40°C,	subsequently	heating	the	column	at	10°C/min	to	90°C	
and	at	20°C/min	 to	250°C;	 for	3:	 an	 isothermal	 program	of	 20	min	 at	 140°C	 followed	by	


















obtained	 residue	 was	 resuspended	 in	 100	 μl	 ethylacetate	 supplemented	 with	 1	 mm	
dodecane	as	internal	standard.	
Of	 the	 ethylacetate	 extracts,	 2	 μl	 was	 injected	 on	 a	 Hydrodex	 b‐TBDAc	 column	
(Aurora	 Borealis,	 The	 Netherlands)	 in	 an	 Agilent	 HP	 6890N	 GC	 using	 FID	 detection.	 The	
enantiomers	of	1b	were	separated	during	an	isothermal	incubation	step	of	10	min	at	150°C.	
During	 this	 procedure,	 the	 injector	 and	detector	 temperatures	were	 kept	 at	 250°C.	Using	
these	 conditions,	 the	 two	 enantiomers	 of	1b	 could	 be	 baseline	 separated,	 with	 retention	
times	of	6.5	and	6.8	min	for	the	(S,S)	and	(R,R)	enantiomers,	respectively.	The	enantiomeric	
excess	was	calculated	using	equation	1.	
The	 enantiomeric	 composition	 of	 diols	2b	 and	3b	 was	measured	 using	 the	 same	
procedure.	 The	 retention	 times	 for	 the	 diols	 were:	 4.7	 and	 4.9	 min	 for	 (S,S)	 and	 (R,R)	
enantiomers	of	2b;	6.2	min	and	6.5	min	for	the	(S,S)	and	(R,R)	enantiomers	3b.	At	least	one	
of	 the	 enantiomers	 of	 diols	 1b‐4b	 was	 commercially	 available	 from	 Sigma	 Aldrich	 (MO,	










Plate	 seal,	 Biorad).	 Subsequently,	 the	 fluorescence	 (excitation	 at	 490	 nm	and	 emission	 at	














and	DB.	RJF	 constructed	 and	 characterized	 the	 enzyme	variants	 and	designed	 the	
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design	 approaches	 for	 improving	 enzyme	 stability	 and	 enantioselectivity.	 The	
developed	workflows	were	verified	by	experimental	analysis	of	enzyme	variants	
predicted	 to	 have	 improved	 properties.	 Next	 to	 this,	 the	 thesis	 describes	
structure‐activity	 and	 structure‐stability	 relationships	 observed	 in	 engineered	
proteins,	which	can	be	used	to	further	improve	protein	engineering	methods	that	
employ	 computational	 approaches.	 Finally,	 a	 future	 perspective	 sketches	






Kinetic	 and	 structural	 investigations	 on	 an	 evolved	 halohydrin	
dehalogenase	
To	 change	 the	 stability	 and	activity	of	 enzymes	by	protein	 engineering,	 insight	
from	 structural	 and	 kinetic	 investigations	 on	 proteins	 that	 are	 improved	 by	
directed	 evolution	 can	 be	 very	 useful.	 Chapter	 2	 describes	 biochemical	 and	




HheC	variant	 catalyzes	both	a	dehalogenation	and	 cyanolysis	 reaction	 (scheme	
1)	and	carries	37	mutations	compared	to	the	wild‐type	enzyme.	The	main	focus	
of	this	study	was	to	understand	how	the	introduced	mutations	lead	to	improved	
activity.	Kinetic	measurements	 revealed	 that	 the	 cyanolysis	 rate	of	 the	enzyme	
was	significantly	improved.	The	stereoselectivity	in	the	synthesis	of	(R)‐4‐cyano‐
3‐hydroxybutyrate	 is	 not	 obtained	 by	HheC,	 but	 by	 a	 ketoreductase	 catalyzing	
the	 reduction	 of	 ethyl	 4‐chloroacetoacetate	 to	 yield	 (S)‐4‐chloro‐3‐
hydroxybutyrate	 (Scheme	 7‐1).	 Wild‐type	 HheC	 preferably	 converts	 (R)‐







Scheme	7‐1.	 Sequential	 transfomation	 of	 prochiral	 ethyl	 4‐chloroacetoacetate	
into	 (R)‐4‐cyano‐3‐	 hydroxybutyrate	 by	 a	 ketoreductase	 and	 halohydrin	
dehalogenase	
To	find	the	structural	basis	for	the	enhanced	activity	and	stability,	the	3D	
structure	of	 the	 improved	HheC	variant	was	solved	by	X‐ray	crystallography	 in	
the	 uncomplexed	 state,	with	 bound	 epoxide	 and	with	 bound	 cyanohydrin.	 The	
structures	 revealed	 that	 the	 size	 of	 the	 cavity	 that	 binds	 the	 acyl	 group	 of	 the	
ester	was	increased	by	several	mutations.	This	created	space	for	the	binding	of	
the	 butyrate	 group	 in	 the	 active	 site	 and	 made	 the	 enzyme	 no	 longer	 (R)‐
selective.	The	 increase	 in	 size	was	primarily	 caused	by	a	distant	mutation	 that	







also	 revealed	 other	 examples	 of	 proline‐induced	 backbone	 changes	 in	 loops.	
Thus,	 prolines	 introduced	 at	 a	 rather	 distant	 position	 can	 have	 important	
structural	effects	by	changing	the	Cα	position	and	side‐chain	orientation	of	other	










Figure	 7‐2.	 Overview	 of	 the	 locations	 of	 stabilizing	 mutations	 discovered	 in	
limonene	 epoxide	 hydrolase	 (1NU3)	 by	 the	 FRESCO	 approach.	 Spheres	 with	
different	colours	indicate	the	effect	of	the	mutations	on	the	TM,app.	
The	HheC	structures	also	revealed	the	compensatory	effect	of	some	other	




individual	 substitutions	 and	 cause	 destabilization	 of	 the	 enzyme	 (Figure	 7‐1).	
These	 observations	 suggest	 that	 it	 is	 best	 to	 examine	 the	 possibility	 of	
introducing	 compensating	 mutations	 simultaneous	 with	 the	 functional	
mutations.	 The	 results	 also	 suggest	 that	 the	 stability	 of	 enzymes	 is	 preferably	
optimized	 beforehand,	 thereby	 avoiding	 destabilizing	 effects	 of	 steric	 clashes	
that	would	result	from	the	introduction	of	functional	mutations[2].	Alternatively,	
one	 might	 aim	 for	 the	 combined	 introduction	 of	 stabilizing	 mutations	 and	
functional	mutations	for	successful	directed	evolution	of	enzymes[3].		
Computational	library	design	for	enzyme	stabilization		
The	 chapters	 3,	 4	 and	 5	 deal	 with	 the	 development,	 use	 and	 validation	 of	 a	
computational	approach	to	discover	stabilizing	mutations	and	screen	them	in	a	
small	 library:	 FRESCO	 (Framework	 for	 Rapid	 Enzyme	 Stabilization	 by	
Computational	libraries).	This	approach	uses	the	computer	programs	Rosetta[4],	
FoldX[5]	 and	 dynamic	 disulfide	 discovery	 (DDD)	 to	 predict	 mutations	 that	
stabilize	 a	 protein.	 FoldX	 and	 Rosetta	 can	 calculate	 the	 difference	 in	 the	 free	
energy	 of	 folding	 between	 a	 mutant	 and	 wild‐type	 enzyme	 and	 thus	 discover	






computational	 selection	 are	 tested	 experimentally.	 For	 stability	 assays,	
laboratory	 methods	 were	 developed	 to	 construct	 mutants	 on	 a	 medium	
throughput	 scale.	 The	 stabilities	 of	 the	 resulting	mutant	 proteins	 are	 analyzed	
using	 the	 thermofluor	 method,	 which	 uses	 a	 reporter	 dye	 to	 quantify	 protein	
unfolding.	The	fluorescence	of	this	reporter	dye	is	monitored	while	the	protein‐
dye	 mixture	 is	 heated	 in	 a	 thermal	 cycler.	 Finally,	 the	 discovered	 improved	
variants	are	characterized	on	a	larger	scale	for	retained	catalytic	performance.		
	




vitro,	 which	 is	 a	 very	 good	 result	 for	 an	 enzyme	 stabilization	 method.	 The	
combined	 introduction	 of	 the	 ten	 most	 stabilizing	 mutations	 improved	 the	










to	 reduce	 the	 catalytic	 activity.	 This	 approach	 was	 successful,	 since	 the	 final	
variant	maintained	its	catalytic	activity	and	selectivity	for	the	hydrolysis	of	(4R)‐





In	Chapter	4	 the	use	of	FRESCO	 for	 the	stabilization	of	another	enzyme,	
the	monomeric	 haloalkane	 dehalogenase	 LinB,	 is	 described.	 A	 single	 round	 of	
FRESCO	 discovered	 eleven	 stabilizing	 mutations	 in	 this	 enzyme.	 However,	 a	
much	lower	fraction	of	the	predicted	mutations	was	confirmed	to	be	stabilizing	
when	tested	experimentally	than	in	the	case	of	limonene	epoxide	hydrolase.	It	is	
likely	 that	 a	 part	 of	 the	 protein	 that	 is	 important	 for	 thermostability	 was	
excluded	from	mutagenesis,	since	mutations	were	not	introduced	near	the	active	







Figure	 7‐3.	 Overview	 of	 the	 positions	 of	 stabilizing	 mutations	 discovered	 in	








was	constructed,	of	which	 the	apparent	melting	 temperature	was	 improved	by	
10°C.	The	dehalogenation	activity	 of	 this	mutant	 for	 a	 variety	 of	 chloroalkanes	
and	cycloalkanes	was	maintained.	Furthermore,	the	resistance	of	this	variant	to	
organic	cosolvents	was	also	significantly	improved.	This	LinB	variant	was	stable	
for	several	hours	 in	 the	presence	of	25%	DMSO	(Figure	7‐4)	or	several	days	 in	
10%	 THF,	 while	 the	 wild‐type	 enzyme	 inactivated	 much	 faster	 under	 these	
conditions.	In	a	cosolvent/buffer	mixture,	the	improved	enzyme	could	hydrolyze	
higher	 concentrations	 of	 the	 pesticide	 β‐hexachlorocyclohexane	 (β‐HCH)	
compared	 to	 the	 results	 obtained	 in	 buffer	 alone[6].	 The	 stabilized	 haloalkane	
dehalogenase	 was	 successfully	 used	 for	 the	 kinetic	 resolution	 of	 t‐butyl‐2‐(2‐
bromopropanamido)‐acetate	in	a	solution	of	10%	THF	and	buffer.	Enzymes	that	
can	withstand	THF	are	highly	interesting	for	biocatalysis,	since	THF	can	be	more	












Chapter	 3	 are	 elucidated	 and	 analyzed	 in	 Chapter	 5.	 The	 elucidated	 structures	







flexible	N‐terminus	and	 the	 residues	 in	 the	 interior	 and	between	 two	different	
subunits.		
FoldX	uses	predicted	mutant	structures	to	quantify	differences	in	van	der	
Waals	 interactions,	 solvation	 and	 hydrogen	 bonding	 energies	 and	 changes	 in	
electrostatic	 interactions.	 Rosetta	 analyzes	 differences	 in	 the	 conformation	 of	
residues,	 Lenard	 Jones	 interactions	 and	 hydrogen	 bonding	 and	 electrostatic	
energies	 based	 on	 predicted	 structures.	 Furthermore,	 MD	 simulations	 use	 the	
predicted	 structures	 as	 starting	 structures.	 The	 MD	 simulations	 are	 used	 to	
examine	 mutations	 predicted	 by	 Rosetta,	 FoldX	 or	 DDD	 for	 effects	 on	 local	
interactions,	 stability	 and	 flexibility	 before	 testing	 them	 experimentally.	
Therefore,	 a	 correct	 prediction	 of	 mutant	 structures	 is	 crucial	 for	 all	
computational	 procedures	 used.	 A	 comparison	 between	 the	 calculated	 and	
elucidated	 structures	 revealed	 that	 the	 structural	 changes	 caused	 by	 point	
mutants	 were	 predicted	 rather	 accurately	 (for	 examples,	 see	 Figure	 7‐5).	
However,	mutations	that	can	have	a	larger	effect	on	the	protein	backbone,	such	
as	 the	 introduction	of	a	disulfide	bond	or	a	proline,	were	not	always	predicted	











Computational	 library	 design	 to	 change	 the	 enantioselectivity	 during	
asymmetric	synthesis		
Chapter	 6	 describes	 the	 use	 of	 CASCO	 (catalytic	 active	 site	 by	 computation),	 a	
workflow	to	design	mutations	 that	change	 the	orientation	of	a	substrate	 in	 the	
active	 site	 and	 thereby	may	 improve	 enzyme	 enantioselectivity.	This	 approach	
was	used	to	change	the	enantioselectivity	of	limonene	epoxide	hydrolase	for	the	
hydrolysis	 of	 meso	 epoxides	 (Scheme	 7‐2).	 The	 reaction	 proceeds	 by	 direct	
nucleophilic	displacement	of	the	oxygen	substituent	 from	the	carbon	atom	that	
undergoes	attack	by	water.	In	case	of	(1R,2S)‐cyclopentene	oxide,	attack	of	water	
on	 the	 (1R)‐carbon	 atom	 gives	 (1S,2S)‐epoxide,	 whereas	 attack	 on	 the	 (2S)‐
carbon	gives	(1R,2R)‐epoxide.	In	our	work,	CASCO	used	Rosetta	and	geometries	
reflecting	the	transition	state	of	epoxide	hydrolysis	to	design	mutations	that	bind	







enzyme	variants	 and	 near	 attack	 conformations	 (NACs)	 for	 epoxide	 hydrolysis	
were	 scored	 for	 both	 the	 pro‐RR	 and	 pro‐SS	 orientations.	 These	 NACs	 are	
conformations	of	enzyme	and	substrate	that	have	a	geometry	close	to	that	of	the	
transition	 state	 of	 the	 reaction	 and	 can	 thus	 be	 used	 to	 probe	 whether	 the	
enzyme‐substrate	 complex	 adopts	 reactive	 conformations.	 Previous	 work	
showed	that	NACs	can	be	used	to	predict	the	enantioselectivity	of	the	haloalkane	
dehalogenase	LinB[8],	 suggesting	 that	 LEH	mutants	designed	by	Rosetta	 can	be	
screened	 for	 improved	 enantioselectivity	 using	 this	 near	 attack	 approach.	
Subsequently,	the	variants	with	the	highest	predicted	E‐values	(defined	as	ratios	
of	 frequencies	of	occurrence	of	NACs)	were	experimentally	screened	 in	a	small	
library.	 This	 library	was	 constructed	 in	 a	 thermostabilized	 variant	 obtained	 in	
Chapter	3,	and	for	which	the	structure	was	solved	in	Chapter	5.	
During	 the	 computational	 procedure,	 only	 hydrophobic	 groups	 were	
introduced	and	tested	for	orienting	the	substrate,	since	the	effect	of	hydrophobic	
interactions	on	substrate	binding	and	orientation	can	be	more	easily	calculated	
















to	 find	 highly	 enantioselective	 variants:	 85%	 of	 the	 active	 variants	 had	 the	
intended	 enantioselectivity.	 Furthermore,	 27%	 of	 the	 variants	 formed	 the	
desired	 enantiomer	 of	 the	 diol	 with	 an	 ee	 higher	 than	 75%	 (Figure	 7‐6).	 The	
most	selective	variants	were	also	highly	selective	in	the	hydrolysis	of	the	larger	
substrates	 cyclohexane	 epoxide	 and	 heptane	 epoxide	 while	 they	 maintained	
enantioselectivity	 for	 the	 hydrolysis	 of	 (4R)‐limonene	 (1,2)‐epoxide.	 The	











The	 enzyme	 variants	 obtained	 by	 computational	 design	were	 similar	 in	
specificity	 to	 those	 obtained	 by	 directed	 evolution	 for	 the	 same	 reaction[9].	
However,	 the	 computational	 approach	 required	 approximately	 100‐fold	 less	
experimental	 screening	 compared	 to	 directed	 evolution.	 The	 sequences	 of	 the	
best	variants	of	 the	 two	different	approaches	differed	 significantly.	This	 shows	
that	completely	different	combinations	of	mutations	can	have	a	similar	effect	on	
substrate	 orientation	 and	 catalysis.	 Future	 experiments	 should	 reveal	 if	 the	
CASCO	 approach	 can	 also	 be	 used	 to	 improve	 the	 enantioselectivity	 of	 other	
enzymes,	including	enzymes	that	can	be	used	for	asymmetric	synthesis	or	kinetic	
resolution.	 If	so,	 this	method	could	be	highly	useful	 for	biocatalyst	engineering,	





a	 library	 of	 computationally	 predicted	 mutants	 can	 be	 an	 efficient	 protein	
engineering	method.	As	 an	example,	 FRESCO	was	used	 to	 stabilize	 a	 variety	of	
enzymes	 with	 different	 catalytic	 properties	 from	 different	 protein	 folds,	 both	
monomers	 and	 dimers.	 A	 challenge	 for	 the	 future	 will	 be	 to	 use	 FRESCO	 to	
stabilize	 industrially	 relevant	 enzymes,	 of	 which	 lower	 stability	 limits	 an	
economically	feasible	application.		






from	phytic	acid.	Phosphate	 is	an	essential	 ingredient	of	animal	 feed	and	extra	
phosphate	 increases	 the	 animal	 growth.	 The	 use	 of	 phytase	 reduces	 both	 the	
need	to	add	phosphate	to	animal	feed	and	the	presence	of	phosphates	in	animal	
waste.	Furthermore,	so‐called	non‐starch	polysaccharide	degrading	enzymes	can	
enhance	 the	 digestibility	 of	 feed	 for	 pigs	 and	 poultry.	 Surviving	 the	 high	
temperatures	used	 in	 the	processing	 	and	pelleting	of	 feed	remains	a	challenge	







Thirdly,	 an	 important	 challenge	 remains	 to	 stabilize	 enzymes	 that	
produce	 biobased	 chemicals,	 for	 example	 amylases	 used	 for	 the	 production	 of	
monosugars	 based	 on	 starch,	 cellulases	 for	 the	 hydrolysis	 of	 ligno‐cellulosic	
materials	 into	 fermentable	 sugars,	 or	 enzymes	 involved	 in	 the	 Krebs	 cycle	 to	
catalyze	the	formation	of	organic	acids	from	sugars[13].		
Finally,	 the	experiments	described	 in	Chapter	4	 show	 that	 thermostable	
enzymes	can	also	have	a	better	resistance	to	organic	co‐solvents,	such	as	DMSO,	
dioxane	 or	 THF.	 This	 allows	 such	 thermostable	 biocatalysts	 to	 be	more	 easily	




lead	 to	 incorrectly	 predicted	 mutations[15].	 A	 recurrent	 problem	 is	 inaccurate	
prediction	 of	 the	 interactions	 of	 surface‐exposed	 hydrophobic	 residues	 and	 of	
surface‐located	charged	residues.	Also	incorrect	prediction	of	backbone	changes	
resulting	 from	 introduction	 or	 removal	 of	 proline	 remains	 a	 problem.	 This	
results	in	a	moderate	correlation	between	the	predicted	and	observed	stabilizing	
effects.	A	significant	fraction	of	the	enzymes	predicted	to	be	stabilizing	does	not	
improve	 the	 melting	 temperature	 in	 vitro.	 Developments	 in	 the	 use	 of	
computational	 design	 are	 possible	 by	 using	 a	 combination	 of	 design	 with	
sequence	 profiles[16]	 or	 by	 pursuing	 improvements	 in	 Rosetta[17],	 for	 example	
preventing	 the	 formation	 of	 hydrophobic	 patches	 on	 the	 surface[15a].	




be	 predicted.	 Furthermore,	 FRESCO	 could	 possibly	 be	 improved	 by	 including	
additional	algorithms	to	find	stabilizing	mutations,	which	are	overlooked	by	the	
currently	 used	 methods.	 Examples	 are	 the	 use	 of	 constrained	 network	
analysis[20]	 to	 identify	 regions	 in	 the	protein	structure	 that	are	weak	spots	and	
involved	 in	 early	 unfolding,	 or	 methods	 that	 specifically	 predict	 the	 effect	 of	
surface	charges	on	protein	stability[10b,	21].	
Our	work	(Chapters	2,	4,	and	5)	and	several	other	published	studies	have	
identified	 a	 relationship	 between	 the	 contribution	 of	 a	mutation	 to	 the	 overall	
enzyme	stability	and	 its	position	in	the	structure[22].	Most	stabilizing	mutations	
found	in	limonene	epoxide	hydrolase	were	either	located	in	or	close‐by	flexible	




monomers.	 Especially	 surface	 loops	 and	 loops	 near	 the	 chain	 termini	 can	 be	
early	unfolding	regions.	Partial	unfolding	of	these	areas	can	result	in	irreversible	
inactivation	 of	 the	 protein	 via	 aggregation	 involving	 hydrophobic	 patches.	
Unfolding	starting	by	dissociation	into	subunits	is	another	common	inactivation	
mechanism[23].	Mutations	that	improve	the	stability	of	these	areas	can	contribute	
more	 to	 the	overall	 stability	 than	substitutions	 in	other	regions[22].	 It	would	be	
very	attractive	to	accurately	predict	such	sensitive	and	early	unfolding	regions,	
where	 mutations	 have	 a	 larger	 chance	 to	 improve	 the	 stability,	 since	 this	
information	can	be	used	to	further	focus	library	design	and	reduce	the	number	of	
variants	 that	need	 to	be	screened	 to	discover	useful	mutations[24].	One	method	
employing	 this	 principle	 of	 introducing	mutations	 only	 in	 flexible	 areas	 of	 the	
protein	is	the	B‐fitter	approach[24],	which	attempts	to	identify	flexible	regions	by	
their	crystallographic	B‐factors.	However,	Chapters	2,	3	and	4	show	that	several	
mutations	 of	 residues	 that	 do	 not	 have	 a	 high	 B‐factor	 can	 still	 have	 a	 large	
influence	 on	 the	 stability	 and	 thus	 methods	 purely	 based	 on	 B‐factors	 are	 an	
oversimplification.		
Future	research	 in	 this	direction	should	 therefore	use	effective	methods	
to	 detect	 early	 unfolding	 regions	 and	 thereby	 design	 more	 efficient	 libraries	
harboring	 stabilizing	 mutations.	 For	 example,	 hydrogen‐deuterium	 exchange	
mass	spectrometry	could	be	used	to	identify	areas	of	the	protein	that	have	high	
exchange	 rates	 of	 amide	 proteins,	which	 is	 correlated	with	 flexibility	 and	 thus	
identifies	 regions	 that	 are	 more	 prone	 to	 unfolding[23b,	 25].	 Alternatively,	 a	
computational	 simulation	 of	 protein	 unfolding	 can	 be	 used	 to	 identify	 flexible	





The	 use	 of	 computational	 methods	 to	 engineer	 the	 active	 site	 (CASCO)	 of	
limonene	epoxide	hydrolase	worked	remarkably	well	 for	 the	design	of	enzyme	
variants	 with	 improved	 enantioselectivity	 during	 asymmetric	 synthesis.	
However,	several	studies	have	shown	that	rational	design	can	obtain	the	desired	
effect	 by	 a	 different	mechanism	 than	 intended	 and	 that	 unintended	 secondary	
structural	effects	may	occur[27].	Therefore,	structures	of	the	enantioselective	LEH	
variants	 bound	 to	 substrates	 or	 substrate	 mimics	 will	 be	 highly	 important	 to	
investigate	the	structural	basis	of	the	enhanced	enantioselectivity,	analogous	to	






side‐chains	 of	 introduced	 residues	 are	 predicted,	 (ii)	 whether	 the	 change	 in	





The	 design	 of	 enantioselective	 enzymes	 is	 an	 important	 challenge	 for	
biotechnology.	Enzymatic	kinetic	resolution	and	asymmetric	synthesis	can	be	an	
environment‐friendly	way	 to	 produce	 chiral	 compounds,	 but	 require	 selective,	
active	 and	 stable	 enzymes[14d‐f,	 28].	 Chapter	 1	 describes	 that	 both	 directed	
evolution	 and	 computational	 design	 using	 Rosetta	 software	 could	 be	 used	 to	
improve	 the	 enantioselectivity	 of	 enzymes.	 The	 computational	 approach	 called	
CASCO,	 which	 includes	 ranking	 of	 Rosetta‐generated	 designs	 by	 molecular	
dynamics	 simulations	 with	 scoring	 for	 frequencies	 of	 near‐attack	 conformers,	
was	 described	 in	 Chapter	 6.	 In	 this	 work,	 we	 only	 manipulated	 hydrophobic	
interactions	in	the	active	site,	resulting	in	a	different	orientation	of	the	substrate	
and	a	 change	of	 the	enantioselectivity	 for	 the	asymmetric	 synthesis	of	 alicyclic	
diols.		
We	 have	 not	 explored	 within	 CASCO	 the	 use	 of	 Rosetta	 to	 design	
mutations	 that	 change	 hydrogen	 bonding	 or	 ionic	 interactions	 between	 the	
enzyme	 and	 substrate.	 Such	polar	 interactions	might	 be	 required	 to	 position	 a	
substrate	in	large	active	sites,	to	influence	the	orientation	of	small	substrates,	or	
to	 design	 interactions	 in	 surface‐located	 active	 sites.	 Therefore,	 the	 CASCO	
approach	 should	 be	 further	 explored	 on	 enzymes	 with	 large	 cavities	 and/or	
polar	 substrates	 with	 manipulation	 of	 the	 binding	 and	 orientation	 of	 the	
substrate	 by	 computing	 polar	 interactions.	 Such	 hydrogen	 bonding	 and	
electrostatic	 interactions	 are	 more	 challenging	 to	 compute	 compared	 to	
hydrophobic	 interactions	 because	 the	 current	 models	 for	 electrostatic	
interactions	are	less	accurate[29].	 Improvement	in	electrostatic	energy	functions	
are	 believed	 to	 reduce	 this	 problem[29c,	 29d].	 When	 successful,	 designing	
electrostatic	interactions	can	expand	the	possibilities	of	computational	methods	








binding	 mode.	 Other	 foreseeable	 applications	 are	 re‐engineering	 of	
enantioselectivity	 in	 kinetic	 resolution,	 which	 requires	 substrate	 enantio‐




perform	 design	 based	 on	 homology	 models	 instead	 of	 experimentally	 solved	
structures.	FRESCO	and	CASCO	need	a	good	3D	structure	of	an	enzyme	to	predict	
functional	 mutations.	 However,	 for	 many	 interesting	 enzymes	 no	 structure	 is	
available.	 A	 good	 homology	model	might	 replace	 an	 experimental	 structure	 in	
such	 a	 case.	 The	 overall	 structure	 is	 often	 predicted	 correctly	 by	 homology	
models,	but	the	local	details	of	the	enzyme	structure	are	often	less	accurate,	such	
as	side‐chain	conformations	or	the	main‐chain	structure	in	 loops.	This	problem	
is	 expected	 to	 be	 reduced	 in	 the	 future	 by	 improvement	 in	 prediction	
algorithms[30].		
Recently,	a	study	was	published	which	uses	a	homology	model	to	predict	
stabilizing	 disulfide	 bond	 in	 cyclohexanone	 monooxygenase	 by	 FRESCO.	 This	
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Om	 in	de	 consumptie	 van	de	 groeiende	wereldbevolking	op	 een	verantwoorde	
manier	 te	voorzien	moeten	wij	minder	grondstoffen	gebruiken	en	tegelijkertijd	
ook	 minder	 afval	 produceren.	 Dit	 geldt	 in	 een	 belangrijke	 mate	 ook	 voor	 de	
chemische	industrie.	Hiervoor	worden	op	dit	moment	veel	initiatieven	ontplooid.	
Het	gebruik	van	enzymatische	katalyse	kan	een	belangrijke	verduurzaming	van	
de	 fijnchemie	 opleveren.	 Enzymen	 hebben	 vaak	 een	 hoge	 selectiviteit	 en	
activiteit,	waardoor	een	grondstof	efficiënt	wordt	omgezet	in	een	product	zonder	
dat	 er	 veel	 bijproducten	 worden	 gevormd.	 Op	 dit	 moment	 worden	 enzymen	
toegepast	bij	de	synthese	van	het	cholesterolverlagende	middelen,	anti‐diabetes	
medicijnen,	antivirale	middelen	tegen	hepatitis	C		en	antibiotica	maar	ook	bij	de	
productie	 van	 esters	 voor	 cosmetica	 en	 de	 enantiozuivere	 productie	 van	
aminozuren.		
Een	 belangrijke	 beperking	 is	 dat	 enzymen	 vaak	 niet	 stabiel	 genoeg	 zijn	
om	 gebruikt	 te	worden	 in	 industriële	 processen.	 Door	 het	 gebruik	 van	 hogere	
temperaturen	 of	 organische	 oplosmiddelen	 verliezen	 veel	 enzymen	 hun	
activiteit.	 Daarom	 zijn	 stabielere	 enzymen	 noodzakelijk.	 Hiervoor	 zijn	 twee	
verschillende	 aanpakken	 mogelijk.	 Ten	 eerste	 kunnen	 enzymen	 meer	 hitte‐
resistent	 gemaakt	 worden	 door	 ze	 te	 immobiliseren.	 Ten	 tweede	 kan	 de	






Een	 belangrijk	 doel	 in	 de	 enzym	 biotechnologie	 is	 het	 op	 voorhand	
voorspellen	welke	mutaties	 nodig	 zijn	 om	 een	 eiwit	 te	 verbeteren.	Dit	 zou	 het	
aanpassen	van	enzymen	veel	efficiënter	maken.	Met	de	huidige	methoden	is	het	
lastig	 om	 de	 vereiste	 mutaties	 te	 voorspellen,	 hoewel	 er	 op	 dit	 gebied	 veel	
vooruitgang	wordt	geboekt.	De	meeste	enzymverbeteringsmethoden	maken	een	
groot	 aantal	 (semi)‐willekeurige	 mutaties	 en	 karakteriseren	 vervolgens	 de	
resulterende	 mutanten.	 Hoewel	 dit	 succesvol	 kan	 zijn,	 blijft	 het	 vaak	 een	
inefficiënt	proces.	Het	is	lastig	toe	te	passen	wanneer	het	aanpassen	van	het	DNA	
of	 het	 analyseren	 van	 mutanten	 tijdrovend	 is.	 Daarom	 zijn	 alternatieve	
methoden	noodzakelijk.		
Dit	 proefschrift	 beschrijft	 de	 FRESCO	 methode	 voor	 het	 vinden	 van	
stabielere	 enzym‐varianten.	 De	 methode	 combineert	 computervoorspellingen		
en	experimentele	analyse.	De	computerprogramma’s	voorspellen	de	ruimtelijke	
structuur	 van	 mutanten	 en	 berekenen	 de	 stabiliteit	 van	 de	 mutanten.	 Omdat	
deze	 voorspellingen	 aanzienlijke	 fouten	 bevatten,	 herhalen	 de	 algoritmen	 dit	
proces	voor	een	paar	duizend	verschillende	mutanten.	Hierna	worden	de	vijftig	
tot	 tweehonderd	 beste	 varianten	 geconstrueerd	 in	 het	 lab	 en	 worden	 hun	
eigenschappen	 bepaald.	 Met	 deze	 resultaten	 kan	 bepaald	 worden	 of	 de	
stabiliteitsvoorspellingen	kloppen	en	er	kunnen	ook		stabielere	biokatalysatoren	
verkregen	worden.		
Naast	 het	 ontwikkelen	 van	 computerprogramma's	 om	 het	 effect	 van	
mutaties	te	voorspellen,	is	het	ook	belangrijk	methoden	te	ontwikkelen	om	deze	
voorspelde	 varianten	 efficiënt	 experimenteel	 te	 testen.	 In	 de	 projecten	
beschreven	 in	 hoofdstukken	 drie	 en	 vier	 werd	 er	 gezocht	 naar	 varianten	 van	
twee	 enzymen	 met	 een	 verbeterde	 stabiliteit.	 Hierbij	 werd	 een	 fluorescente	
indicator	 gebruikt	 om	 de	 ontvouwingstemperatuur	 van	 een	 grote	 reeks	
mutanten	 in	parallel	 te	analyseren.	Dit	maakt	de	experimentele	analyse	van	de	
stabiliteit	van	mutanten	efficiënter.		
Gedurende	 beide	 projecten	 werden	 veel	 stabielere	 enzymvarianten	
ontwikkeld,	 die	 bij	 een	 twintig	 tot	 dertig	 graden	 hogere	 temperatuur	 konden	
worden	gebruikt	zonder	te	ontvouwen.	Bovendien	konden	de	enzymen	reacties	
sneller	 katalyseren	 bij	 deze	 hogere	 temperaturen.	 De	 verbeterde	 mutanten	
werden	 gevonden	 na	 het	 analyseren	 van	 slechts	 vijftig	 tot	 tweehonderd	
mutanten,	 dit	 is	 een	 enorme	 verbetering	 ten	 opzichte	 van	methoden	 die	 geen	
voorspellingen	 vooraf	 gebruiken.	 De	 ontwikkelde	 FRESCO	 methode	 kan	 in	 de	
toekomst	uitgroeien	tot	een	generieke	methode	om	enzymen	stabieler	te	maken	





In	 hoofdstuk	 zes	 van	 dit	 proefschrift	 wordt	 een	 vergelijkbare	 aanpak	
beschreven	om	varianten	te	ontwikkelen	met	een	verbeterde	enantioselectiviteit,	
genaamd	CASCO.	Enantioselectief	betekent	dat	deze	mutanten	voornamelijk	één	
stereoisomeer	 van	 een	 verbinding	 maken.	 Dit	 is	 vereist	 bij	 de	 synthese	 van	
ingrediënten	 voor	 veel	 medicijnen.	 In	 het	 menselijk	 lichaam	 hebben	
verschillende	stereoisomeren	vaak	een	ander	biologisch	effect	en	daarom	is	het	
belangrijk	om	alleen	het	gewenste	isomeer	te	maken.	Sommige	enzymen	zijn	uit	
zichzelf	 enantioselectief	 en	 kunnen	 daarom	 toegepast	 worden	 in	 chemische	
syntheses.	 Andere	 enzymen	 vormen	 een	 mengsel	 van	 isomeren.	 Om	 deze	





CASCO	 gebruikt	 een	 combinatie	 van	 computervoorspellingen	 en	
experimentele	 analyse	 om	 mutanten	 te	 vinden	 met	 een	 verhoogde	
enantioselectiviteit.	Hierbij	is	het	belangrijk	om	de	interacties	van	een	substraat	
met	 een	 enzym	goed	 te	modelleren	 en	 te	bepalen	hoe	mutaties	de	 selectiviteit	
beïnvloeden.	Toepassing	van	de	CASCO	methode	op	het	enzym	limonene	epoxide	
hydrolase	resulteerde	in	het	ontwerp	van	zeer	enantioselectieve	varianten	voor	
de	 productie	 van	 beide	 enantiomeren	 van	 verschillende	 epoxides.	 Dit	 werd	
bereikt	na	de	analyse	van	slechts	vijftig	varianten.	De	verkregen	mutanten	waren	
minder	 actief	 dan	 het	wild‐type	 enzym.	 Een	 volgend	 onderzoeksproject	 zal	 dit	
moeten	verbeteren.	De	CASCO	aanpak	heeft	veel	potentie	om	uit	 te	groeien	 tot	
een	generieke	methode	om	de	enantioselectiviteit	van	eiwitten	te	verbeteren.		
Om	 te	 verklaren	 welke	 ruimtelijke	 veranderingen	 de	 geobserveerde	
verbeteringen	 in	 activiteit	 en	 selectiviteit	 veroorzaken,	 werden	 3D	 structuren	
van	verschillende	mutanten	opgehelderd	en	vergeleken	met	die	van	de	eiwitten	
waarvan	 zij	 afstammen	 (beschreven	 in	 hoofdstukken	 twee	 en	 vijf).	 Dit	 werd	
onder	andere	gedaan	voor	een	mutant	van	het	enzym	halohydrin	dehalogenase	
met	37	mutaties.	Uit	deze	vergelijking	bleek	dat	er	geen	grote	veranderingen	in	
de	 ruimtelijke	 structuur	 waren	 opgetreden	 als	 gevolg	 van	 de	 mutaties.	 Wel	
beïnvloeden	 sommige	 gemuteerde	 residuen	 de	 conformaties	 van	 andere	
aminozuren.	 De	 verplaatste	 zijketens	 hadden	 andere	 interacties	 met	 het	
substraat	 en	 belemmerden	 de	 binding	 van	 grotere	 substraten.	 Hierdoor	 werd	
dus	indirect	de	substraatspecificiteit	beïnvloed.	Andere	mutaties	introduceerden	





mutaties	 uit	 zichzelf	 geen	 grote	 veranderingen	 veroorzaken	maar	 een	 botsing	
tussen	 een	 geïntroduceerd	 aminozuur	 en	 een	 ander	 gedeelte	 van	 een	 eiwit	
voorkomen.	 Samenvattend	 laten	 deze	 structuren	 zien	 dat	 een	 combinatie	 van	
direct	 werkende	 en	 ondersteunde	 mutaties	 nodig	 kan	 zijn	 om	 grotere	
veranderingen	in	enzymselectiviteit	en	stabiliteit	te	bewerkstelligen.		
In	 hoofdstuk	 vijf	 worden	 structuren	 beschreven	 van	 thermostabiele	
enzym‐varianten	die	met	behulp	van	de	FRESCO	methode	waren	ontwikkeld.	Dit	
werd	 gedaan	 om	 te	 analyseren	 hoe	 accuraat	 de	 gebruikte	
structuursvoorspellingprogramma's	 werkten.	 Het	 bleek	 dat	 de	 voorspelde	
structuren	 van	 deze	 varianten	 overeenkwamen	 met	 de	 geobserveerde	
structuren.	Dit	is	essentieel	voor	het	slagen	van	de	FRESCO	en	CASCO	aanpakken.	
Met	de	projecten	beschreven	in	dit	proefschrift	wordt	bijgedragen	aan	de	
ontwikkeling	 van	 efficiëntere	 methoden	 om	 enzymen	 te	 verbeteren	 en	 te	
gebruiken	 in	 de	 chemische	 industrie.	 Een	 combinatie	 van	
computervoorspellingen	en	efficiënte	experimentele	methoden	was	noodzakelijk	
om	verbeterde	mutanten	te	vinden	zonder	grote	aantallen	mutaties	in	het	lab	te	
testen.	 De	 voorspelde	 ruimtelijke	 structuren	 komen	 goed	 overeen	 met	 de	
werkelijke	 structuren.	 Toekomstige	 projecten	 kunnen	 de	 CASCO	 en	 FRESCO	
methoden	 dus	 toepassen	 voor	 het	 verbeteren	 enzymen	 met	 een	 grotere	
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